what incivo is incivo reduces the amount of the virus that causes hepatitis c infection in adults and adolescents who are at risk of chronic hepatitis c infecting them . it is used in adult patients ( aged 18 years and older ) who are already taking peginterferon alfa , ribavirin and telaprevir , medicines called ns3 - 4a protease inhibitors . how incivo works incivo acts on the nns3 - foura protein . by blocking the nntr protein , incivo stops the production of hepatitis c virus in these patients who have previously been treated with an interferon
do not take incivo if you are allergic to telaprevir or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before taking incivo , if : you are taking peginterferon alfa or ribavirin . your doctor may need to adjust your dose of incivo and / or their duration ( e . g . pregnancy precautions ) during treatment with incivo . you are being treated for a condition that affects the ability of the body to produce its own protein ( called alpha - 1 - adrenoreceptor antagonists ) 56 you
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . your doctor will prescribe the appropriate dose regimen for you . the recommended dose regimen is 3 mg , 6 mg , 2 mg , 8 mg and 6 mg once daily . if you have both hepatitis c virus infection and human immunodeficiency virus infection , your doctor may prescribe efavirenz . if any of the above applies to you , tell your doctor , pharmacist or nurse before you take incivo . if your doctor tells you to take more incivo than you should if you take more
like all medicines , this medicine can cause side effects , although not everybody gets them . tell your doctor immediately if you get an itchy skin rash . the rash is usually mild to moderate . if the rash gets worse or if other symptoms occur , stop using incivo and seek urgent medical attention straight away . if you have a severe skin reaction , contact your doctor or the nearest hospital immediately . a skin rash may be severe and needs immediate medical attention . your doctor may decide to treat your rash with other symptoms . a rash may include fever , tiredness , swelling of the face and swelling of lymph glands , a wide - spread
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the bottle after exp . this medicine does not require any special storage conditions . incivo tablets should be kept in the bottle tightly closed in order to protect from moisture .
what incivo contains - the active substance is telaprevir . each tablet of incivo consists of 375 mg teleprevir ( as mesilate ). - the other ingredients are tablet core hypromellose acetate succinate , calcium hydrogen phosphate ( anhydrous ), microcrystalline cellulose , silica colloidal anhydrated , sodium lauryl sulphate , croscarmellose sodium , sodium stearyl fumarate . film - coat polyvinyl alcohol , macrogol , talc , titanium dioxide ( e171 ) and iron oxide yellow ( e172 ). what inc
the active substance of zinbryta is daclizumab beta , a monoclonal antibody ( a type of protein that recognises and attaches to a specific target substance in the body ). how zinryta works and why it has been prescribed for you by your doctor , your doctor or pharmacist is familiar with the use of this medicine in multiple sclerosis . it is used in combination with therapy ( two ms treatment ) or other treatments to reduce inflammation of the protective sheath around the nerves in the central nervous system ( brain and spinal cord ). this loss of myelin ( demyelination )
do not take zinbryta : if you have previously had a serious allergic reaction to daclizumab or any of the other ingredients of this medicine ( listed in section 6 . warnings and precautions talk to your doctor , pharmacist or nurse before taking this medicine if : you have liver problems . your doctor may want to monitor you more closely while you are being treated with this medicine . you have or have ever had any other autoimmune disorders . you are taking any other medicines , including herbal supplements . you should tell your doctor if you take any medicines or supplements that increase the risk of liver side effects . these medicines
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much to use the recommended dose of zinbryta is 150 mg once a day . your doctor will ask you to have a blood test to check how well your liver is working . if you have the impression that the effect is too strong or too weak , talk to your doctor , pharmacist or nurse . the usual dose is one or two tablets once a week . the recommended starting dose is two tablets twice a day ( two tablets in the morning and one tablet in the evening ). your
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects may happen with zinbryta : tell your doctor straight away if you notice any of the following serious side effects : liver problems : very common ( may affect more than 1 in 10 people ): unexplained nausea ( feeling sick ) vomiting ( being sick ) stomach pain increased tiredness loss of appetite ( anorexia ) changes in your skin or whites of your eyes turn yellow dark ( tea - coloured ) urine 41 uncommon ( might affect up to 1 in 100 people ): severe inflammation of the liver that may lead to death
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the syringe label after exp . store in a refrigerator ( 2 - 8 ). do not freeze . keep the zinbryta pre - filled syringe in its original package in order to protect from light . if you need to use a new syringe / pen , in - use storage times and conditions prior to use are the responsibility of the user and would normally not be longer than 30 days at 2 to 8 , unless the solution is clear to slightly opales
what zinbryta contains - the active substance is daclizumab beta . each pre - filled syringe contains 150 mg of dacluzumabbeta . 1 ml of solution for injection : each prefilled pen contains either 150 mg or two 150 mg mg dlizumb beta ( see section 2 ' zinbalta contains sodium '). - the other ingredients are : sodium succinate , succinic acid , sodium chloride , polysorbate 80 ( e433 ) and water for injections ( see also section 2 " zinbulta contains lactose and sodium ') what zin
wilzin belongs to a group of medicines called metabolism products . wilson ' s disease is due to a rare inherited defect in copper excretion from the liver to the eyes and brain . this defect leads to liver damage and neurological disorders . wilzin works by reducing the amount of copper in the intestine and its further accumulation in the body . this is thought to play an important role in the development and progression of wilson's disease . if you have any questions about this treatment , ask your doctor .
do not use wilzin - if you are allergic ( hypersensitive ) to zinc or any of the other ingredients of wilzin ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before using wilzin wilzin is used for initial therapy in adults with signs and symptoms of wilson ' s disease . you are currently being treated with another anti - copper agent called penicillamine . wilzin should be used during the initial treatment in combination with other anti - copper agents such as penicillinamine . if your symptoms do not improve after the treatment has been started , your doctor may
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the different dose regimens are listed below . the recommended dose is 25 mg / 50 mg twice a day . the usual dose is 1 mg wilzin 50 mg once a day for 2 weeks . your doctor will tell you how many capsules of wilzin to take and how long you should continue to take them . the dose may need to be adjusted by your doctor . if you take more wilzin than you should if you accidentally take more than the prescribed dose , contact your doctor immediately . the doctor will
like all medicines , wilzin can cause side effects , although not everybody gets them . the frequency of possible side effects listed below is defined using the following convention : very common ( affects more than 1 user in 10 ) uncommon ( affects 1 to 10 users in 100 ) very rare ( affects less than 1 users in 1 , 000 ) not known ( frequency cannot be estimated from the available data ) very common : may affect up to 1 in 10 people 10 , 000 not known : frequency is not known for the exact number of units of wilzin in the blood . gastric irritation has been reported following treatment . changes in blood tests
keep out of the reach and sight of children . do not store above 25 . medicines should not be disposed of via wastewater or household waste . ask your pharmacist how to dispose of medicines no longer required . these measures will help to protect the environment .
what wilzin contains - the active substance is zinc . each hard capsule contains 25 mg of zinc ( equivalent to 83 . 92 mg zinc acetate dihydrate ). each 50 mg hard capsule also contains 25mg of zinc , equivalent to 167 . 84 mg ( 3 . 0 mg zincacetate diydrate ). - the other ingredients are magnesium stearate . - the capsule shell is composed of gelatin , titanium dioxide ( e171 ) and brilliant blue fcf ( e132 ). what wilzin looks like and contents of the pack wilzin 25 mg hard capsules are white to off - white , oblong , bicon
biktarvy contains the active substance bictegravir . it is an antiretroviral medicine ( also known as an integrase strand transfer inhibitor ) emtricitabine . this is a combination of two active substances , a nucleoside reverse transcriptase inhibitor ( nrti ) tenofovir alafenamide . these are both active ingredients , and are combined with an antiviral medicine , known as a nucleotide reverse transcriptase inhibitors ( trti ). biktarv is used for the treatment of human immunodeficiency virus 1 ( hiv - 1
do not take biktarvy : if you are allergic to bictegravir , emtricitabine , tenofovir alafenamide or any of the other ingredients of this medicine ( listed in section 6 ). if you take the following medicines : - rifampicin used to treat some bacterial infections such as tuberculosis - st . john ' s wort ( hypericum perforatum ) a herbal remedy used for depression and anxiety . warnings and precautions talk to your doctor , pharmacist or nurse before taking bikarvy : - if you have liver problems . liver disease :
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose of biktarvy is : antacids to help prevent stomach ulcers , heartburn and acid reflux , aluminium and magnesium hydroxide mineral supplements , vitamins , magnesium and iron ( see section 2 " bisktarvy contains lactose "). take these medicines at the same time each day . do not swallow the tablets . if you have any further questions on the use of this medicine , ask your doctor , pharmacist or nurse . use in children and adolescents bik
like all medicines , this medicine can cause side effects , although not everybody gets them . tell your doctor immediately if you notice any of the following serious side effects : inflammation or infection in patients with advanced hiv infection ( opportunistic infections ( infections caused by a weak immune system ). symptoms of inflammation or previous infections may occur during hiv treatment . these symptoms may be due to an improvement in the body ' s immune response , which is needed to fight infections . there are no obvious symptoms of autoimmune disorders , in which the immune system attacks other parts of the body tissue . medicines given to suppress the body may increase the chance of getting
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the outer carton and the seal after exp . this medicinal product does not require any special temperature storage conditions . store in a refrigerator ( 2 - 8 ). do not freeze . keep the seal tightly closed in order to protect from light .
what biktarvy contains - the active substances are bictegravir , emtricitabine and tenofovir alafenamide . each biktravir sodium equivalent to 50 micrograms of the active substance in each tablet ( bic tegravira 200 microgram per tablet ) is also available in tablet core microcrystalline cellulose , croscarmellose sodium and magnesium stearate . - film - coating polyvinyl alcohol , titanium dioxide ( e171 ), macrogol , talc , iron oxide red ( e172 ), iron oxide black (
novondorm is an oral antidiabetic medicine containing repaglinide , which helps your pancreas make better use of insulin when your blood sugar is high ( glucose ). type 2 diabetes is a disease in which a person cannot make enough insulin to control the sugar in their blood or where their body does not make enough of the insulin it produces . novonorm helps control the level of sugar in your blood after you have started treatment with diet and exercise and weight reduction . it is also used to lower the blood sugar in combination with metformin , a medicine used to treat diabetes . your doctor has prescribed novon
do not take novonorm : - if you are allergic to repaglinide or any of the other ingredients of this medicine ( listed in section 6 ). if you have type 1 diabetes . if the acid level in your blood is too low ( diabetic ketoacidosis ). warnings and precautions talk to your doctor , pharmacist or nurse before taking this medicine if you : - have a severe liver disease . - are taking gemfibrozil ( a medicine used to lower increased fat levels in the blood ). 47 - have liver problems . if any of these apply to you , tell your doctor before taking novon
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one 0 . 5 mg tablet once a day . swallow the tablet whole with a glass of water . you can take novonorm with or without food . do not exceed the recommended daily dose of 30 mg . your doctor may increase your dose by 4 mg to 30 mg every 16 weeks depending on how you respond to the medicine . your blood sugar may increase if you take a hypo . if you have any further questions on the use of this medicine , ask your doctor , pharm
like all medicines , this medicine can cause side effects , although not everybody gets them . hypoglycaemia is the most common side effect of novonorm ( may affect up to 1 in 10 people ). if you have a hypo in section 2 , you should contact your doctor immediately . if you experience any of the following symptoms : swelling , difficulty in breathing , rapid heartbeat , feeling dizzy or sweating ( signs of anaphylactic reaction ). other side effects may include : very common ( may affects more than 1 user in 10 ) - stomach pain - diarrhoea rare ( likely to affect 1 in 1 , 000
what novonorm contains - the active substance is repaglinide . - the other ingredients are microcrystalline cellulose , calcium hydrogen phosphate anhydrous , maize starch , polacrilin potassium , povidone ( polyvidone ), glycerol , magnesium stearate , meglumine , poloxamer , iron oxide yellow ( e172 ) ( 1 mg ) and iron oxide red ( 2 mg ) ( see end of section 2 " no vonorm contains lactose and sodium "). - the tablet coating is white to off - white and is printed with " pfizer "
pumarix is a vaccine for use in adults aged 18 years and older who have been vaccinated against pandemic flu ( influenza ). it is a type of influenza that happens every few decades and which spreads rapidly around the world . it is very similar to influenza that occurs every 10 years . pandemic influenza is similar to ordinary flu but may be more serious . when a person is given the vaccine , the immune system ( the body ' s natural defence system ) will produce its own protection against the disease . none of the ingredients in the vaccine can cause flu . as with all vaccines , pumarix may not fully protect all persons
do not use pumarix if you have had a sudden life - threatening allergic reaction to any ingredient of this vaccine ( listed in section 6 ) or to any of the other ingredients of the vaccine ( see section 4 ). these ingredients are : egg , chicken protein , ovalbumin , formaldehyde and sodium deoxycholate . signs of an allergic reaction may include itchy skin rash , shortness of breath and swelling of the face or tongue . if this happens , the vaccine may not be fully effective and you may need medical treatment . if you experience signs of such allergic reaction , contact your doctor immediately . warnings and precautions
pumarix is recommended for use in adults aged 18 years and older . pumarix contains a similar h5n1 as03 to those of the other ingredients in this vaccine ( listed in section 6 ). use in children and adolescents ( from 18 years of age and older ) the recommended dose is one vaccine ( 0 . 5 ml ) per kg body weight , given once every three weeks . the recommended duration of use for children aged 3 - 9 years is 10 - 17 weeks . if you have any further questions on the use of this vaccine , ask your doctor , pharmacist or nurse .
like all medicines , this vaccine can cause side effects , although not everybody gets them . allergic reactions allergic reactions may lead to dangerously low blood pressure , shock and emergency treatment . tell your doctor straight away if you notice any of the following side effects : very common ( may affect more than 1 in 10 people pain at the site of the injection headache feeling tired aching muscles joint pain common ( likely to affect up to 1 in every 10 people ) redness or swelling where the injection was given fever sweating shivering diarrhoea feeling sick uncommon ( likely not to affect above 1 in 100 people ) bruising a hard lump or itching warmth
keep this vaccine out of the sight and reach of children . do not use this vaccine after the expiry date which is stated on the label and carton after exp . store in a refrigerator ( 2 - 8 ). do not freeze . keep the vaccine in the sachet in order to protect from light . after preparation , the suspension should be used immediately . if not used immediately , in - use storage times and conditions prior to use are the responsibility of the user and would normally not be longer than 24 hours at 30 .
what pumarix contains - the active substance is split influenza virus ( 5 / 2005 , pr8 - ibcdc - rg2 ) in 0 . 5 ml of solution . - the other ingredients are haemagglutinin , which is present in the pandemic . - in the vaccine , an ' adjuvant ' as03 is used . - this adjuvvant contains squalene , dl - Î± - tocopherol , polysorbate 80 and adjuvants . - other ingredients of the vaccine are : sodium chloride , disodium hydrogen phosphate , potassium dihydrogen phosphate ,
somakit t is a radiopharmaceutical product containing an active substance called edotreotide . the powder contains a radioactive substance called gallium ( 68ga ) chloride . the active substance in this procedure is a substance that dissolves in the blood and which is then excreted in the urine . it is then used to dissolve the dissolved substance in a vein in your body areas . this medical imaging procedure ( positron emission tomography ) is carried out in adults , children and pet . the purpose of this medical procedure is to obtain images of the abnormal cells and tumours in your disease . somakit
do not take somakittoc - if you are allergic to edotreotide or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before taking this medicine if you experience any signs of allergic reaction ( see section 4 ). if you have kidney or liver problems . if you suffer from renal or hepatic disease . children and adolescents do not give this medicine to children under 18 years of age because of the risk of dehydration . the examination will be repeated every 28 days . other medical conditions that may affect your body ( e . g . cushing
there are strict laws on the use , handling and disposal of radiopharmaceutical products . somakittoc will only be handled and given to you by people who are trained and qualified to use it safely . these persons will keep you informed of their actions and their actions . the nuclear medicine doctor supervising the procedure will decide on the quantity of somackittoc to be used . the usual dose is between 100 mg and 200 mg megabecquerel per kilogram body weight . if you have the impression that the effect is too strong or too weak , talk to your nuclear medicine physician . the administration of som
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects may happen with somakittoc : allergic reactions ( hypersensitivity ) have been reported in patients treated with somackittoc . symptoms include warm flush , redness of the skin , swelling , itching , nausea and difficulty breathing . allergic reactions may also include stinging at the injection site due to ionising radiation , cancer and hereditary abnormalities . reporting of side effects if you get any side effects talk to your nuclear medicine doctor . this includes any possible side effects not listed in this leaflet . you can also report side effects
you will not have to store this medicine . this medicine is stored under the responsibility of the specialist in appropriate premises . storage of radiopharmaceuticals will be in accordance with national regulation on radioactive materials and radiolabelling . the following information is intended for the specialist only : keep this medicine out of the sight and reach of children . do not use somakittoc after the expiry date which is stated on the outer carton and on the vial label after exp . store in a refrigerator ( 2 - 8 ). do not freeze . after storage at room temperature ( up to 25 ) the product should be used
what somakit t contains - the active substance is edotreotide . one vial of powder contains 40 mg edotereotide ( as 10 - phenanthroline ). - the other ingredients are gentisic acid , mannitol , formic acid ( e421 ), sodium hydroxide , water for injections , sodium and radiolabelling . - the solution contains hydrochloric acid which is used to adjust the amount of radioactivity in the solution after reconstitution with radiopharmaceutical preparation in a glass vial with black flip - off cap . - a white powder is contained in a
afinitor is an anticancer medicine that contains the active substance erolimus . everolimus stops the growth and spread of cancer cells . afinitor inhibits the activity of hormone receptor - positive advanced breast cancer in postmenopausal women . it belongs to a group of non - steroidal aromatase inhibitors , which are used to keep the disease under control . it is used in combination with a medicine called exemestane ( a steroid inhibitor ) and hormonal anticancer therapy to treat advanced tumours ( neuroendocrine tumours in the stomach , bowels , lung and pancreas ) where the tum
do not take afinitor if you are being treated for cancer treatment . warnings and precautions talk to your doctor , pharmacist or nurse before you are given afinit if you : - are allergic to everolimus , sirolimus , temsirolamus or any of the other ingredients of this medicine ( listed in section 6 ). if you think you may be allergic , ask your doctor for advice . - are breast - feeding . if any of these apply to you ( or you are not sure ), tell your doctor or pharmacist before you receive afininitor . - have any problems with your liver
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one 10 mg tablet once a day . you should take afinitor at the same time each day . if you have liver problems , your doctor may prescribe a lower dose of Afinitor ( between 5 mg and 5 mg ) or a higher dose of 7 . 5 mg depending on the severity of certain side effects . your doctor will tell you how many tablets to take . if necessary , you can take the tablet with or without food . do not take more tablets than your doctor
like all medicines , this medicine can cause side effects , although not everybody gets them . stop taking afinitor and tell your doctor straight away if you experience any of the following signs of an allergic reaction : difficulty breathing or swallowing swelling of the face , lips , tongue or throat severe itching of the skin , with a red rash or raised bumps . the following side effects have been reported with the combination of the two active substances of afinavitor : very common ( may affect more than 1 in 10 people ) - increased temperature - chills ( signs of infection ) - fever - coughing - difficulty breathing - wheezing - inflammation
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the blister after exp . store below 25 . store in the original package in order to protect from moisture . after first opening the blister , the tablets should be used immediately . this medicine does not require any special temperature storage conditions , and should not be disposed of via wastewater or household waste . ask your pharmacist how to dispose of medicines no longer required . these measures will help to protect the environment .
what afinitor contains - the active substance is everolimus . - the other ingredients are : - tablet core : alfentanil ( e553b ). - tablet - coating : alfa - 2 . 5 mg : each tablet contains two million international units ( iu ) ( 1 . 5 micrograms ) ( 3 . 5 milligrams ) ( 6 . 0 microgram ) ( 5 . 0 milligram ) - tablet coating : allafinitor is available in packs containing 10 tablets ( 10 tablets ) ( 4 . 1 microgram ). - tablets - the ingredients in the tablet core are
what laventair ellipta is and what it is used for the active substance in this inhalation is umeclidinium bromide , vilanterol . this belongs to a group of medicines called bronchodilators . what lavent air ellipta looks like and contents of the pack this medicine is a clear , colourless to pale yellow inhalation . it is given to adults with chronic obstructive pulmonary disease ( copd ). copd is a long - term condition characterised by breathing difficulties . in copd the muscles around the airways tighten . this medicine works by tightening these muscles in
do not use laventair ellipta 31 - if you are allergic to umeclidinium , vilanterol or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before using this medicine if : - you have asthma . this medicine should not be used in patients with asthma . - you suffer from heart problems or high blood pressure . this is because you may have an eye problem called narrow - angle glaucoma ( an enlarged prostate , difficulty passing urine , or a blockage in your bladder ). - you are suffering from
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one inhalation once a day . this medicine should be used every day for 24 hours . do not use more laventair ellipta than your doctor tells you to . if you have any further questions on the use of this medicine , ask your doctor , pharmacist or nurse . use in children and adolescents do not give this medicine to children less than 24 years of age because there is no experience with this medicine in this age group . use a quick - acting reliever inhaler (
like all medicines , this medicine can cause side effects , although not everybody gets them . allergic reactions if you experience any of the following symptoms stop taking laventair ellipta and contact your doctor immediately : uncommon side effects ( may affect up to 1 in 100 people ): skin rash ( hives ) and redness rare side effects : may affect 1 in 1 , 000 people : swelling mainly of the face or mouth ( angioedema ), feeling very wheezy , coughing , having difficulty in breathing , feeling weak or light headed , collapse or loss of consciousness . immediate breathing difficulties if you have immediate breathing difficulty , stop taking
what laventair ellipta contains - the active substances are umeclidinium bromide and vilanterol . each single inhalation provides a delivered dose of 55 micrograms of the active substance , umeklidinnium . each delivered dose delivers a delivered delivered dose , equivalent to 65 microgramms of umelidinIUMbromide . each deliverance provides a deliverance delivered dose ( delivered dose ) equivalent to 22 microgramrams of vilterol ( as trifenatate ). - the other ingredients are lactose monohydrate ( see section 2 under '
the active substance of tremfya is guselkumab , a monoclonal antibody . this medicine contains the active substance " il - 23 ". this belongs to a group of proteins called cytokines , and is used to treat psoriasis in adults . it is used in adults with moderate to severe " plaque psorgiasis " which is an inflammatory condition that affects the skin and nails . it can be used to improve the condition on the skin or to reduce symptoms such as scaling , shedding , flaking , itching , pain and burning .
do not use tremfya if you are allergic to guselkumab or any of the other ingredients of this medicine ( listed in section 6 ). if you think you may be allergic , ask your doctor for advice . warnings and precautions talk to your doctor , pharmacist or nurse before you are given this medicine if you : - have an active infection or active tuberculosis warnings , precautions , and precautions while you are being treated with tremfia , tell your doctor or pharmacist if you have an infection or an infection with tuberculosis . tuberculosis is a type of tuberculosis that affects up to 36 people . if you develop an infection
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose of tremfya is 100 micrograms ( 1 pre - filled syringe ) given by injection under the skin ( subcutaneous injection ) every 4 to 8 weeks . your doctor will decide how many injections you need and how often you need to use it . if you have any further questions on the use of this medicine , ask your doctor , pharmacist or nurse .
like all medicines , this medicine can cause side effects , although not everybody gets them . serious side effects tell your doctor straight away if you notice any of the following side effects : signs of serious allergic reaction , such as difficulty breathing or swallowing , swelling of the face , lips , tongue or throat , severe itching of the skin , a red rash and raised bumps other side effects talk to your doctor , pharmacist or nurse before you are given tremfya . this includes any possible side effects not listed in this leaflet . you can also report side effects directly via the national reporting system listed in appendix v . by reporting side effects
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the outer carton and on the pre - filled syringe label after exp . this medicine does not require any special storage conditions . if you notice that the solution is cloudy or contains large particles , or if the liquid is discoloured , do not throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what tremfya contains - the active substance is guselkumab . one ml of each pre - filled syringe contains 100 mg of gusel kumab in 1 ml of solution . - the other ingredients are histidine , histidine monohydrochloride monohydrate , polysorbate 80 , sucrose and water for injections . what tremfa looks like and contents of the pack solution for injection in a vial is a clear , colourless to pale yellow solution . the solution is supplied in a carton pack containing one single - dose glass syringe and a multipack containing 2 packs of 1
the active substance of trepulmix , treprostinil , is a member of a group of medicines called prostacyclins ( a type of hormone that helps to control blood pressure ). by relaxing blood vessels and preventing them from clotting together , it prevents the condition from returning to its normal level and prevents it from becoming too severe and irreversible ( cteph ). it is used for the treatment of persistent or recurrentcteph in adults whose condition has not responded to surgical treatment or exercise capacity . symptoms of the disease are similar to those of chronic thromboembolic pulmonary hypertension . in patients with chronic
do not take trepulmix if you are allergic to treprostinil or any of the other ingredients of this medicine ( listed in section 6 ). if you have a disease called " pulmonary veno - occlusive disease ". this is a disease in which the blood vessels in the lungs become swollen , leading to a higher pressure in the blood arteries between the heart and the lungs . if you suffer from severe liver disease . warnings and precautions talk to your doctor , pharmacist or nurse before taking this medicine if you : have a heart problem . have had a heart attack ( myocardial infarction ) in
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . trepulmix is given as a continuous subcutaneous infusion ( injection under the skin ) into a small tube ( cannula ) in the abdomen or thigh . your doctor will decide how many doses you need . your dose will be calculated by your doctor using your treprostinil per kilogram of body weight . the pump will be connected to the infusion line in order to prevent accidental overdose . the recommended dose is 1 mg , 2 . 5 mg , 5 mg or 10 mg per kil
like all medicines , this medicine can cause side effects , although not everybody gets them . very common ( may affect more than 1 in 10 people ): widening of blood vessels pain at the infusion site reaction , including the infusion site bleeding , bruising and / or swelling of the infusionsite headaches , nausea , diarrhoea jaw pain common : dizziness , light - headedness , fainting low blood pressure skin rashes , muscle pain ( myalgia ) joint pain ( arthralgia ) swelling of feet , ankles , legs , fluid retention , hot flush pain in arms and/_ or legs 36 uncommon : 36 uncommon
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the label of the vial after exp . store in a refrigerator ( 2 - 8 ). do not freeze . keep a trepulmix vial in the outer carton in order to protect from light . after reconstitution , the product may be used within 30 days for continuous subcutaneous infusion . if not used immediately , in - use storage times and conditions prior to use are the responsibility of the user and would normally not be longer than 72 hours at 2
what trepulmix contains - the active substance is treprostinil ( as sodium salt ). each tablet ( 1 mg / ml ) contains 1 mg or 2 . 5 mg of treprosteinil , sodium salt . each 10 mg tablet ( 10 mg ) contains 10 mg or 10 mg treprostallinil . - the other ingredients are sodium salt ( see section 2 " trepulemix contains sodium salt ") and water for injections . each 20 mg and 25 mg tablets ( 3 mg ) tablet ( 5 mg ) tablets ( 10 milligrams ) contains one mg or 25 mg of Trepro
the active substance of thorinane is enoxaparin sodium . it is a low molecular weight heparin ( lmwh ). the recommended dose of thorzinane is 1 milligram per kilogram of body weight to prevent existing blood clots from forming ( see section 2 ). the other ingredient is enocaparin , which is a substance present in the pancreas . your doctor will test your blood regularly to make sure that it is not clogged . the doctor will also check your blood before , during and after an operation if you have an acute illness called unstable angina . if your heart is
do not use thorinane if you are allergic to enoxaparin sodium or any of the other ingredients of this medicine ( listed in section 6 ). signs of an allergic reaction may include rash , swallowing or breathing problems , swelling of your lips , face , throat or tongue . if you think you may be allergic to heparin or other low molecular weight heparins ( e . g . nadroparin , tinzaparin , dalteparin ). if you have ever had a reaction to any of these , including a severe drop in the number of your clotting cells ( platelets ). this reaction
like other similar medicines ( medicines to prevent blood clotting ), thorinane is used to prevent bleeding . the bleeding should be under control immediately . if you experience any bleeding event that does not stop or shows signs of excessive bleeding ( exceptional weakness , tiredness , paleness , dizziness , headache , unexplained swelling ), stop taking your medicine and contact your doctor immediately . your doctor may decide to temporarily or permanently stop your medicine . talk to your doctor , pharmacist or nurse before taking the next dose of the medicine . if any of the following apply to you ( or you are not sure ), tell your doctor or pharmacist immediately
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the syringe label after exp . store in a refrigerator ( 2 - 8 ). do not freeze . after dilution the solution should be used immediately . if not used immediately , in - use storage times and conditions prior to use are the responsibility of the user and would normally not be longer than 8 hours at 2 to 8 , unless dilution has taken place in controlled and validated aseptic conditions . this medicine is for single use only . the thorinane pre
what thorinane contains - the active substance is enoxaparin sodium . each pre - filled syringe contains 100 micrograms ( 0 . 2 ml ) of solution for injection in a vial ( equivalent to 2 , 000 microlitres ) of the corresponding amount of solution . - the other ingredient ( s ) ( excipients ) ( for reconstitution ) ( see end of section 2 ) is : - solvent ( e . g ., water for injections ) - 0. 2 ml colourless type i neutral glass syringe barrel with fixed needle and needle shield with chlorobutyl rubber stopper
sensend contains the active substances lidocaine and prilocaine . both belong to a group of medicines called local anaesthetics . senstend is used to prevent lifelong premature ejaculation in adult men . it works by attaching itself to the head of the penis and causing ejaculation .
do not use senstend if you are allergic to lidocaine , prilocaine or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before using this medicine if you have a history of allergy or sensitivity to local anaesthetics ( see section 4 ). if you know that you are being treated with amide - type local analgeshetics . if you suffer from a genetic disease or other condition that affects your red blood cells ( glucose and phosphate deficiency ) or anaemia ( methaemoglobinaemia ). medicine sensitivities and sensitivity
always use this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . how much to use the recommended dose of senstend is 3 sprays ( 1 spray ) per head of your penis , every 3 hours for 24 hours ( see section 4 " how to use "). use the spray container immediately after using it . the pumpchanism is the valve that allows contact with eyes , nose , mouth and ears . after using the pump , 1 spray should be applied to the foreskin of your head , penis , or valve . 1 spray will be
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects have been reported with this medicine : very common ( may affect more than 1 in 10 people ) inability to develop or maintain an erection in the penis feeling of burning in the area of the penis uncommon ( might affect up to 1 in 100 people ) headache local irritation of the throat , irritation on the skin redness failure to ejaculate during sexual intercourse abnormal orgasm tingling in and around the penis not known ( frequency cannot be estimated from the available data ) discomfort around the penis itching in and outside the penis a high
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the label and carton after exp . store below 25 for a maximum period of 12 months . keep the metal container in the outer carton in order to protect from light . after first opening , puncture and burn the container immediately . if you notice any visible signs of tampering , do not throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help to protect the environment .
what senstend contains - the active substances are lidocaine and prilocaine . each ml of solution contains 150 micrograms ( 0 . 5 ml ) lidocain ( 50 microgram ) and 1 . 5 microgram ( 5 . 0 microgram ). - the other ingredients are : - each spray container contains either 50 microlitres ( 1 ml ) or 7 . 5 micrometres ( 2 . 5 milligrams ) of lidocaine ( 10 microgram / ml ). - eachspray container contains 6 . 5 to 20 microliters ( 20 microgram per spray ). -
opdivo is a medicine used for the treatment of advanced melanoma ( a type of skin cancer ) in adults melanoma is advanced after complete resesection in adults ( treatment without surgery or adjuvant therapy ). advanced non - small cell lung cancer is a form of lung cancer that has spread to other organs . in adults advanced renal cell carcinoma has advanced kidney cancer has advanced lymphoma has been previously treated with previous therapies , including an autologous stem - cell transplant or a transplant . advanced cancer of the head and neck has been treated with adults advanced urothelial carcinoma ( bladder and urinary tract cancer )
do not take opdivo - if you are allergic to nivolumab or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before you are given opsdivo if : - you notice a change in the rhythm of the heartbeat or an abnormal heart rhythm . - you have problems with your lungs such as breathing difficulties or cough , inflammation of the lungs ( pneumonitis or interstitial lung disease ), diarrhoea , watery , loose or soft stools , or any symptoms that might indicate inflammation of any intestines ( colitis
always take opdivo exactly as your doctor has told you . you should check with your doctor or pharmacist if you are not sure . how much to take the recommended dose of opdivone is 240 mg once a day ( 2 tablets of 480 mg ) for 4 weeks . your doctor will prescribe the dose that is right for you . the dose will depend on your condition and the type of skin cancer you are being treated with . the usual dose is 1 mg of nivolumab per kilogram of your body weight . this will be given as a single dose of 4 mg . the doctor will also prescribe the
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the outer carton and on the vial label after exp . store in a refrigerator ( 2 - 8 ). do not freeze . opdivo may be stored at room temperature ( up to 25 ) for up to 48 hours . the infusion solution should be used immediately . any unused medicine or waste material should be disposed of in accordance with local requirements .
what opdivo contains - the active substance is nivolumab . each ml of concentrate for solution for infusion contains 10 mg of nivlumab ( as 40 mg / ml ). each 4 ml vial contains 100 mg of 10 mg or 240 mg of 24 mg ( as 300 mg / l ). - the other ingredients are : tablet core : sodium citrate dihydrate , sodium chloride ( see section 2 under ' opDivo contains sodium '), mannitol ( e421 ), pentetic acid , polysorbate 80 , sodium hydroxide , hydrochloric acid and water for injections
clopidogrel tad contains the active substance ' clopidigrel '. it belongs to a group of medicines called antiplatelet medicinal products . platelets are very small structures in the blood , which clump together during blood clotting . by preventing this clumping , antiplatelets medicinal products reduce the chances of blood clots forming ( a process called thrombosis ). clopridogrel tetad is taken by adults to prevent blood clumps ( thrombi ) from forming in hardened blood vessels ( arteries ), a process known as atherothrombinosis , which can lead to at
do not take clopidogrel tad : if you are more than 30 years of age . if you think you may ( or might not be able to take ) any of the following conditions : - if you currently have bleeding from a stomach ulcer or bleeding within the brain ( severe liver disease ). if any of these apply to you ( or you are not sure ), talk to your doctor or pharmacist . warnings and precautions the use of clopidineogrel tetad is not recommended if you : - have an increased risk of bleeding - have a medical condition that puts you at risk of internal bleeding ( such
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose , including for patients with a condition called ' atrial fibrillation ' ( an irregular heartbeat ), is one 75 mg tablet of clopidogrel tad per day to be taken orally with or without food , and at the same time each day . if you have experienced severe chest pain ( unstable angina or heart attack ), your doctor may prescribe a lower or higher dose ( 300 mg of one half a millilitre of one of the active substances in the tablet ) of
like all medicines , this medicine can cause side effects , although not everybody gets them . contact your doctor immediately if you experience : - fever , signs of infection or extreme tiredness . these may be due to rare decrease of some blood cells . - signs of liver problems such as yellowing of the skin and / or the eyes ( jaundice ), which may cause bleeding which appears under the skin as red pinpoint dots or confusion ( see section 2 ' warnings and precautions '). - swelling in the mouth or skin disorders such as rashes and itching , blisters of theskin . these could be the signs of an allergic reaction
what clopidogrel tad contains - the active substance is clopridogrel . each film - coated tablet contains 75 mg of clopigrel ( as hydrochloride ). - the other ingredients are : tablet core : microcrystalline cellulose , colloidal anhydrous silica , crospovidone , macrogol 6000 and hydrogenated castor oil ( see section 6 ). tablet coating : polyvinyl alcohol , titanium dioxide ( e171 ), red iron oxide ( e172 ), yellow iron oxide [ e172 ] and talc . printing ink : shellac , talc and
tacforius contains the active substance tacrolimus , which is an immunosuppressant . tacforius is used after your organ transplant to protect your liver and kidney from the effects of your body ' s immune system ( anti - rejection ) on their function . it is used in adults , adolescents and children aged one month and older to prevent rejection of the transplanted organ by your liver , kidney or heart after any previous treatment you were taking after your transplantation .
do not take tacforius if you are allergic to tacrolimus or any of the other ingredients of this medicine ( listed in section 6 ). if you think you may be allergic to sirolimus , to any macrolide , antibiotic , erythromycin , clarithromycin or josamycin . tacrulimus immediate release capsules ( e . g . tacni ) are not recommended for use in children and adolescents under the age of 18 years because of the lack of data on the safety and efficacy of tac forius prolonged - release capsules in this age group ( see section 4 ).
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose of this medicine for transplant patients is the same tacrolimus medicine as for transplant recipients . however , your doctor may prescribe a different tacrolamus medicine . your doctor will tell you exactly how much tacforius to take and how often to take it . this medicine is for oral use . you should swallow the capsule whole with a glass of water . do not chew or crush the capsule . if you have the impression that the medicine is not suitable for you , talk to your
like all medicines , this medicine can cause side effects , although not everybody gets them . infections tell your doctor straight away if you notice any of the following serious or potentially life - threatening infections while being treated with tacforius : severe effects including allergic and anaphylactic reactions ( benign and malignant tumours ) have been reported in patients receiving ticforius treatment : pure red cell aplasia ( a very severe reduction in red blood cell counts ), agranulocytosis ( a severely lowered number of white blood cells ), haemolytic anaemia ( decreased number of red blood cells due to abnormal breakdown
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the blister after exp . store in a refrigerator ( 2 - 8 ). do not freeze . keep all the prolonged - release hard capsules in the outer carton in order to protect from light . after opening the aluminium wrapping , tacforius should be used immediately .
what tacforius contains - the active substance is tacrolimus . each hard capsule contains 0 . 5 mg ( as monohydrate ). each capsule contains 1 mg of tacrolamus ( asmonohydrate ). - the other ingredients are capsule content hypromellose , 2910 , ethylcellulose , lactose , magnesium stearate . - capsule shell tacofius 0 . 0 mg ( 1 mg ) and 3 mg ( 3 mg ) hard capsules : each capsule contain tacrulimus ( so monohydrate ) . - printing ink : shellac , propylene glycol , black iron oxide (
clopidogrel zentiva contains the active substance ' clopilogrel '. it belongs to a group of medicines called antiplatelet medicinal products . platelets are very small structures in the blood , which clump together during blood clotting . by preventing this clumping , antiplatelets medicinal products reduce the chances of blood clots forming ( a process known as thrombosis ). clopidogsrelzentiva is taken by adults to reduce the number of bloodclots ( thrombi ) that can form in hardened blood vessels ( arteries ), an event known as atherothromb
do not take clopidogrel zentiva - if you are allergic ( hypersensitive ) to clopiperrel or any of the other ingredients of this medicine ( listed in section 6 ). if you have a medical condition that is currently causing bleeding such as a stomach ulcer or bleeding within the brain . if you suffer from severe liver disease . if any of these apply to you ( or you are in any doubt at all ), talk to your doctor or pharmacist . warnings and precautions take special care with clopridogrelzentiva if you : - have an increased risk of bleeding ( e . g
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose , including for patients with a condition called ' atrial fibrillation ' ( an irregular heartbeat ), is one 75 mg tablet of clopidogrel zentiva per day to be taken orally with or without food , and at the same time each day . if you have experienced severe chest pain ( unstable angina or heart attack ), your doctor may prescribe a lower dose ( 300 mg ) of the tablet once a day . this will be given as an additional 300 mg tablet once
like all medicines , this medicine can cause side effects , although not everybody gets them . contact your doctor immediately if you experience : - fever , signs of infection or extreme tiredness . these may be due to rare decrease of some blood cells . - signs of liver problems such as yellowing of the skin and / or the eyes ( jaundice ), which may be associated with bleeding which appears under the skin as red pinpoint dots or confusion ( see section 2 ' warnings and precautions '). - swelling in the mouth or skin disorders such as rashes and itching , blisters of theskin . these could be the signs of an
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the blister after exp . this medicine does not require any special storage conditions . clopidogrel zentiva is for single use only . aluminium blisters : do not store above 30 . store in the original package in order to protect from light . doxorbed on the tablet when you are not using it . keep the tablet in the outer carton in order for it to reach room temperature ( not above 30 ). do not throw away any medicines via wastewater
what clopidogrel zentiva contains - the active substance is clopridogrel . each tablet contains 75 mg of clopidoogrel ( as hydrogen sulphate ). - the other ingredients ( excipients ) are ( see section 2 for further information on the contents of the tablet ). - clopiderelzentiva is also available in tablet form as ' lactose ' and as low - substituted hydroxypropylcellulose , lactose monohydrate ( milk sugar ), hypromellose ( e464 ), triacetin , red iron oxide ( e172 ), titanium dioxide ( e
yttriga is a radioactive medicine . it must not be used after the expiry date which is stated on the label and carton after exp . this medicine does not require any special storage conditions . it is stored in the original package in order to protect from light and light . it can be used either in combination with another medicine or in tiny radiation doses . the treatment should be supervised by a doctor experienced in the use of radiolabelled medicinal product .
you must not be given yttriga - if you are allergic ( hypersensitive ) to chloride or any of the other ingredients of this medicine ( listed in section 6 ). if you think you may be pregnant or are planning to become pregnant . warnings and precautions talk to your nuclear medicine doctor or nuclear medicine nurse before you are given this medicine . - if the product is a radioactive medicine or another medicinal product containing radiopharmaceuticals , the nuclear medicine physician will not be able to give you ytriga because it contains radioactive material . - radioactive medicinal products should not be disposed of via wastewater or household waste . ask
yttriga will be administered under the supervision of a doctor experienced in the treatment of radiolabelling of medicinal products for specific diseases . the treatment will be supervised by a healthcare professional who is trained in the diagnosis and treatment of overdose . appropriate treatment is recommended .
like all medicines , yttriga can cause side effects , although not everybody gets them . reporting of side effects if you get any side effects talk to your doctor or pharmacist . this includes any possible side effects not listed in this leaflet . you can also report side effects directly via the national reporting system listed in appendix v . by reporting side effects you can help provide more information on the safety of this medicine .
yttriga will be stored under the responsibility of the specialist in appropriate premises and under local regulations . storage of radioactive substances will be in accordance with national regulation on radioactive materials .
what yttriga contains - the active substance is chloride . 1 ml sterile solution contains 1 mg of hydrochloric acid ( equivalent to 3 mg / ml ). - the vial is closed with a v - capped bottom and is supplied in a colourless type i glass vial of 10 ml with a flat bottom and a silicon stopper and an aluminium seal .
ciambra is a medicine used in the treatment of cancer . the active substance in ciambra , cisplatin , is another anti - cancer medicine . it is used for treatment of malignant pleural mesothelioma ( a form of cancer that affects the lining of the lung ) in adults who have not received prior chemotherapy . in this type of cancer , the other active ingredient in the medicine is called porphyrin . in patients who have been previously treated with povyrin , the initial treatment is usually given by a doctor or nurse . if you have lung cancer , your doctor may decide to
do not use ciambra : - if you are allergic ( hypersensitive ) to pemetrexed or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before you are given this medicine . breast - feeding is not recommended during treatment with cinembra . if you have recently received a vaccine against yellow fever , you should not be given this type of medicine ( see section 4 ). if you think any of these apply to you , tell your doctor or pharmacist before you receive this medicine , as they may need to be adjusted . warnings and
the recommended dose of ciambra is 500 micrograms for every square metre of your body ' s surface area . this means that your height and weight are measured in square meters ( mÂ² ) of body surface area each day . your doctor will work out the right dose for you based on this bodysurface area and will adjust your dose depending on your response to treatment and on your blood cell counts . the doctor or nurse will have mixed the cimbra powder with 9 mg / ml ( 0 . 9 %) sodium chloride solution before it is given to you by your doctor . you will be given ciamra by
like all medicines , this medicine can cause side effects , although not everybody gets them . 52 tell your doctor straight away if you experience fever or signs of infection ( with a temperature of 38Âºc or greater ), sweating , or any other sign of infection . if you have less white blood cells than normal which could indicate infection ( sepsis ), which could be life - threatening and could lead to death . chest pain with a fast heart rate , pain , redness , swelling or sores in your mouth ( signs of allergic reaction ). skin rash , often with burning or prickling sensation and fever . skin reactions may be severe
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the outer carton and on the vial label after exp . store in a refrigerator ( 2 - 8 ). do not freeze . the reconstituted solution should be used immediately . if not used immediately , in - use storage times and conditions prior to use are the responsibility of the user and would normally not be longer than 24 hours at 2 to 8 and 15 to 25 . any unused solution must be disposed of in accordance with local requirements .
what ciambra contains - the active substance is pemetrexed . each vial contains 100 mg / ml of pemphigus . each ml of the solution contains 100 milligrams of petrexed ( as pemetreed disodium hemipentahydrate ). each ml ( 0 . 25 ml ) contains 500 milligram of pemetereed (as peytoin disodium emphigas ). after reconstitution , the solution should be used immediately . if not used immediately , in - use storage times and conditions prior to use are the responsibility of the user and
immunogam belongs to a group of medicines called immunoglobulins ( antibodies ) used to treat certain infections in your blood . immunogam can be used in adults to prevent increased levels of human hepatitis b immunoglubulins and in children and adolescents . the active substance in immunogloglobulin g ( gg ) is a protein found in the blood plasma of infected adults . your doctor will test your body for this protein before and during treatment with immunogogam . what immunogom is used for the treatment of hepatitis b virus in haemodialysed patients is a type of
you must not be given immunogam : if you have had an allergic reaction to human immunoglobulins or other blood products , or if you suffer from an iga deficiency . if you had an allergy reaction to iga containing products . children and adolescents ( from 18 years of age ) who are immunoglubulins . signs of adverse reactions may include chills , headache , fever and vomiting . allergic reactions may also include nausea ( arthralgia ), joint pain , low blood pressure and moderate low back pain . antibodies may be present in hepatitis b Immunoglobulin regularly during human hepatitis b immun
immunogam will be given to you by a doctor or nurse who is experienced in the diagnosis and treatment of hepatitis b virus . the first vaccine dose will be administered in combination with human hepatitis b immunoglobulin ( hbv ). administration prevention the recommended dose for hepatitis b is 500 micrograms per kg body weight given every 24 hours for 72 weeks . the recommended starting dose for patients with hepatitis b in haemodialysed patients is 500 mgrams given every 2 weeks ( followed by seroconversion ). vaccination against hepatitis b will be initiated in accordance with the recommendations of the world health organisation .
like all medicines , immunogam can cause side effects , although not everybody gets them . the following side effects have been reported : very common ( affects more than 1 user in 10 ) uncommon ( affects 1 to 10 users in 100 ) not known ( frequency cannot be estimated from the available data ): very rare ( affects less than 1 users in 1 , 000 ) rare : very rare : may affect up to 1 in 10 , 000 not known : frequency cannot been estimated from available data . if any of the side effects gets serious , or if you notice any undesirable effects not listed in this leaflet , please tell your doctor .
keep out of the reach and sight of children . do not use immunogam after the expiry date which is stated on the outer carton and on the label of the vial after exp . store in a refrigerator ( 2 8 ). do not freeze . keep in the original carton in order to protect from light . keep away from the light . immunogaman should not be used if the solution is cloudy or contains deposits . medicines should not throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help to protect the environment .
what immunogam contains - the active substance is human hepatitis b immunoglobulin . one vial contains 1 mg or 5 mg of human plasma protein , corresponding to a concentration of 96 micrograms / ml . - the other ingredients are polysorbate 80 and water for injections ( see end of section 2 ). what Immunogam looks like and contents of the pack immunogamer is a solution for injection in a glass vial . the solution is a clear to slightly opalescent , colourless to pale yellow liquid . it is supplied in packs of 1 or 2 vials .
remicade contains the active substance infliximab . infliximab is a monoclonal antibody a type of protein that recognises and attaches to a specific target substance in the body called tumour necrosis factor ( tnfÎ± ). remicade belongs to a group of medicines called ' ntrf blockers '. it is used to treat the following inflammatory diseases : rheumatoid arthritis , psoriatic arthritis , ankylosing spondylitis ( bechterew ' s disease ), psoriasis in adults and children aged 6 years and older . these include crohn ' s
do not take remicade : - if you are allergic to infliximab or any of the other ingredients of the active substance ( listed in section 6 ) - if your doctor thinks you may be allergic ( hypersensitive ) to tb or to another serious infection ( e . g . pneumonia , sepsis , heart failure ). warnings and precautions talk to your doctor , pharmacist or nurse before taking the medicine . if you have been given reminade before , tell your doctor or pharmacist before you are given the medicine , if you think you may have had it in the past . do not stop remic
what remicade is used for the treatment of rheumatoid arthritis the recommended dose is 3 mg for every kg of body weight . psoriatic arthritis , ankylosing spondylitis ( bechterew ' s disease ), psoriasis , ulcerative colitis and crohn ' s diseases the recommended starting dose is 5 mg for each kg of weight . your doctor will calculate your body weight based on your height and weight and will tell you how many tablets you should take each day . how and how often you will be given the medicine you will receive an infusion ( drip ) over 2 hours
like all medicines , this medicine can cause side effects , although not everybody gets them . most side effects are mild to moderate . however , some may be serious and require treatment . if you notice any of the following side effects during your treatment with remicade , tell your doctor straight away : - an allergic reaction - swelling of your face , lips , mouth or throat , which may cause difficulty in swallowing or breathing , skin rash , hives and swelling of the hands , feet or ankles . these reactions are usually mild and disappear within a few days . - an allergy reaction ( see section 2 " allergic side effects "). -
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the outer carton and on the vial label after exp . store in a refrigerator ( 2 8 ). do not freeze . remicade may be stored at room temperature ( up to 25 ) for a single period of up to three months . after reconstitution , the product should be used immediately . if not used immediately , in - use storage times and conditions prior to infusion are the responsibility of the user and would normally not be longer than 3 hours at 2 to 8 , but may be
what remicade contains - the active substance is infliximab . each vial contains 100 mg of inflixamab . after reconstitution , each ml of solution contains 10 mg ( 1 . 5 mg ) inflixumab . - the other ingredients ( excipients ) are sucrose , polysorbate 80 , monobasic sodium phosphate , dibasicodium phosphate . see section 2 for further information about some of the ingredients . what remicades looks like and contents of the pack remicada is supplied as a glass vial containing a powder for concentrate for solution for infusion
rasagiline mylan is used to treat parkinson ' s disease in adults . it is used in combination with levodopa ( another medicine used in the treatment of parkinson's disease ). in parkinson ', s disease , there is a loss of cells that produce dopamine in the brain . dopamine is a chemical that helps the brain to perform its function , such as movement control . rasagilinea mylan increases the amount of dopamine produced by the brain in this way .
do not take rasagiline mylan : - if you are allergic to the active substance or any of the other ingredients of this medicine ( listed in section 6 ). if you have severe liver problems . warnings and precautions talk to your doctor , pharmacist or nurse before taking the following medicines : - rasaline mylan ( monoamine oxidase ( mao ) inhibitors , used to treat depression and parkinson ' s disease ) - medicinal or natural products containing st . john ' s wort ( pethidine ) - a strong pain killer that has been used for 14 days during the course of the ras
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is 1 tablet once a day by mouth . take rasagiline mylan at about the same time each day . you can take it with or without food . swallow the tablet whole with a glass of water . do not crush , chew or break the tablet . if necessary , you may be able to take it at any time during the day or at night . if you have any further questions on the use of this medicine , ask your doctor , pharmacist or nurse . if
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects have been reported with rasagiline mylan and placebo ( frequency not known ): very common abnormal movements ( dyskinesia ) headache common abdominal pain uncommon rare ( may affect up to 1 in 1 , 000 people ) fall allergy fever flu ( influenza ) feeling of being unwell neck pain chest pain ( angina pectoris ) low blood pressure with symptoms such as light headedness ( orthostatic hypotension ) decreased appetite constipation dry mouth nausea vomiting flatulence abnormal results of blood ( leucopen
what rasagiline mylan contains - the active substance is rasagailine . each tablet contains a single - use tablet called a " ramithromycin ". - the other ingredients are : - tablet core : raspiline tartrate 1 mg - tablet coating : microcrystalline cellulose , tartric acid , maize starch , pregelatinized maize starch ( maize starch ), talc , stearic acid . see section 2 for further information about some of the ingredients of the tablet core . what rasaggiline melan looks like and contents of the pack rasagleil
do not use hulio if you are allergic to adalimumab or any of the other ingredients of this medicine ( listed in section 6 ). if you have a severe infection such as tuberculosis . if symptoms of infections such as fever , wounds , feeling tired or dental problems occur , tell your doctor . if you suffer from moderate or severe heart failure or have a serious heart condition . allergic reaction allergic reactions may occur with symptoms such as chest tightness , wheezing , dizziness , swelling or a rash . if any of these reactions occur , contact your doctor immediately . infections if you or your child have an infection such
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . polyarticular juvenile idiopathic arthritis in children and adolescents from 2 to 17 years of age weighing 10 kg or more the usual dose is 30 mg once a day . hulio 20 mg is available in two strengths : 2 mg and 17 mg . each tablet contains 30 mg ( 1 tablet ) of hulaio and 40 mg ( 2 tablets ) of enthesitis - related arthritis . in children from 6 months of age and 17 kg to less than 30 kg the usual dosage is 20
like all medicines , this medicine can cause side effects , although not everybody gets them . most side effects are mild to moderate . however , some may require urgent medical treatment . tell your doctor straight away if you notice any of the following serious side effects ( seen in section 4 of this leaflet ) after the last hulio injection : allergic reaction ( e . g . heart failure , severe rash , hives swollen face , hands or feet , trouble breathing or swallowing , pale complexion , dizziness , persistent fever , bruising or bleeding ). signs and symptoms of infection such as fever , feeling sick , wounds , dental problems ,
what hulio contains - the active substance is adalimumab . - the other ingredients are monosodium glutumate , sorbitol , methionine , polysorbate 80 , hydrochloric acid and water for injections ( see end of section 2 ). what hulaio looks like and contents of the pack hulios 40 mg is a sterile solution for injection in a vial . each vial contains 40 mg of addalimumab in 0 . 8 ml of solution . the solution is clear and colourless to slightly opalescent . the vial is closed with a rubber stopper
the active substance of yellox is bromfenac . it belongs to a group of medicines called non - steroidal anti - inflammatory drugs ( nsaids ), which reduce inflammation . yellox has been prescribed for the treatment of eye inflammation following cataract surgery in adults .
do not use yellox if you are allergic to bromfenac or any of the other ingredients of this medicine ( listed in section 6 ). if you have asthma , skin allergy or intense inflammation in your nose . warnings and precautions talk to your doctor , pharmacist or nurse before using this medicine . nsaids may include acetylsalicylic acid , ibuprofen , ketoprofen and diclofenac . this medicine should not be used in combination with topical steroids such as cortisone , as it may increase the risk of unwanted side effects and bleeding problems ( e . g .,
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much to use the recommended dose of yellox is one drop in each eye ( s ) twice a day . use in children and adolescents your doctor will work out the correct dose for your child . this will depend on your child ' s age and body weight and on how well your child responds to the medicine . how long to use your cataract surgery the usual method of administration yellox is for oral use . wash your hands after using the eye drops . remove the bottle cap from the
what yellox contains - the active substance is bromfenac . each ml of solution contains bromenac ( as sodium sesquihydrate ). each vial of 33 ml contains 33 mg of bromnac . - the other ingredients are : boric acid , borax , sodium sulphite anhydrous , benzalkonium chloride , tyloxapol , povidone ( k30 ), disodium edetate and sodium hydroxide to maintain acidity levels . what yellox looks like and contents of the pack yellox is a clear yellow liquid ( solution )
dzuveo contains the active substance sufentanil . it belongs to a group of strong painkillers called opioids . it is used to treat sudden moderate - to - severe pain in adults .
do not take dzuveo if you are allergic to sufentanil or any of the other ingredients of this medicine ( listed in section 6 ). if you have a serious lung or breathing problem . warnings and precautions talk to your doctor , pharmacist or nurse before taking dzuvoo if : you have any condition that affects your breathing ( e . g . asthma , wheezing or shortness of breath ). your doctor may want to monitor you more closely , or adjust your dose , or if you feel that dzveo may affect your breathing during treatment . you have had a head injury or brain
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much to take the single - dose administration device is included in the package leaflet of this medicine . dzuveo can be taken with or without strong painkillers such as sufentanil . the recommended dose is 30 mg once a day . the sublingual tablet should be swallowed whole with a glass of water . the tablet can be divided into equal doses using the disposablesingle - dose applicator . the applicator should be inserted into the tongue . if the tablets dissolve in the
like all medicines , this medicine can cause side effects , although not everybody gets them . serious side effects tell your doctor straight away if you notice any of the following side effects : - severe breathing problems , especially slow and shallow breathing . stop taking dzuveo and see a doctor immediately . very common side effects ( may affect more than 1 in 10 people ): - nausea , feeling sick , vomiting , being sick and feeling hot . commonside effects ( might affect up to 1 in every 10 people ) - inability or difficulty sleeping , feeling anxious or confused , dizziness , headache , drowsiness , feeling sleepy , increased heart
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the label and carton after exp . store in a refrigerator ( 2 - 8 ). do not freeze . keep the container in the outer carton in order to protect from light and oxygen . this medicine does not require any special temperature storage conditions . dzuveo must not be used if you notice any visible sign of deterioration . medicines should not be disposed of via wastewater or household waste . ask your pharmacist how to dispose of medicines no longer required . these measures will help protect the environment .
what dzuveo contains - the active substance is sufentanil . each tablet contains 30 mg of sufantanil ( as citrate ). - the other ingredients are mannitol ( e421 ), dicalcium phosphate , hypromellose ( e464 ), croscarmellose sodium , indigo carmine ( e132 ), stearic acid and magnesium stearate . the tablet is white to off - white and has round edges . each carton contains 3 tablets . - a single - dose applicator ( labelled [ sublingual tablet ]). the applicator contains one su
elleada is a cancer medicine that contains the active substance apalutamide . it is used to treat adult men with prostate cancer that has spread to other parts of the body and cannot be removed by surgical treatments . it also helps to control the level of testosterone in your blood when you have resistant prostate cancer . erleada increases the levels of androgens in the blood when the cancer has spread . the two active substances in the medicine work together by blocking the effects of both androgens , which are involved in the growth and spread of prostate cancer cells .
do not take erleada if you are allergic to apalutamide or any of the other ingredients of this medicine ( listed in section 6 ). if you think you may be pregnant or are planning to become pregnant ( see section " pregnancy , breast - feeding and contraception section "). warnings and precautions talk to your doctor , pharmacist or nurse before taking this medicine . this medicine may affect the way some other medicines work . this is because this medicine can cause seizures . tell your doctor if you take , have recently taken or might take any medicines that could increase the risk of blood clots ( e . g . warfar
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is 240 mg twice a day . your doctor may increase your dose to 60 mg once a day depending on how you respond to erleada . this medicine should be taken by mouth . you should swallow the tablets whole with a glass of water . do not chew , crush or split the tablets . if you have any further questions on the use of this medicine , ask your doctor , pharmacist or nurse . taking other medicines please tell your doctor if you take , have recently taken or might
like all medicines , this medicine can cause side effects , although not everybody gets them . stop taking erleada and see a doctor straight away if you notice any of the following symptoms : reddish , non - elevated , target - like , circular patches on the trunk , central blisters , skin peeling and ulcers of mouth , throat , nose , genitals and eyes . these serious skin rashes may be accompanied by fever and flu - like symptoms . toxic epidermal necrolysis is a group of serious side effects . the most common side effects are fits ( seizure ). uncommon ( may affect up to 1 in
what erleada contains - the active substance is apalutamide . each film - coated tablet contains 60 mg of appalutamide ( as mesilate ). - the other ingredients are : tablet core : colloidal anhydrous silica , croscarmellose sodium , hypromellose acetate succinate , magnesium stearate , microcrystalline cellulose , silica . tablet coating : polyvinyl alcohol ( e1203 ), talc , and titanium dioxide ( e171 ). printing ink : shellac , iron oxide black ( e172 ), iron oxide yellow , macrogol ,
this medicine is a radiopharmaceutical product . axumin contains the active ingredient fluciclovine . it is used for the scan ( a pet scan ) in adults who have previously had treatment for prostate cancer and who have had other tests to measure prostate specific antigen ( psa ) ( the type of the cancer that affects the prostate ). an axumin pet scan is used to find out if the cancer has spread to other parts of the body . the scan will be done under the supervision of a doctor who is experienced in the diagnosis and treatment of prostate cancer . your doctor will carry out this procedure in accordance with national
do not use axumin - if you are allergic to fluciclovine or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before using axumin . if you have kidney problems . you should follow a low sodium diet . axumin is given once a day for the duration of the axumin scan ( see section 4 " axumin contains sodium "). during the scan , you will be given your usual medicines for the latest 60 minutes . you may also be given a lower dose ( 0 . 5 ml ) for 60 minutes after the ax
there are strict laws on the use , handling and disposal of radiopharmaceutical products . axumin will only be handled and given to you by people who are trained and qualified to use it safely . always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the nuclear medicine doctor supervising the procedure will decide the correct dose of axumin . the usual dose is 370 megabecquerel per kilogram of body weight . you will be given axumin once a day . during the procedure axumin is injected into a vein by a flush of sodium
like all medicines , this medicine can cause side effects , although not everybody gets them . in clinical studies , the following side effects were reported : very common ( may affect more than 1 in 100 people ): when using the medicine , side effects associated with axumin were uncommon ( might affect up to 1 in every 100 people ). they included pain , rash , altered taste in the mouth and altered sense of smell . this radiopharmaceutical emits low amounts of ionising radiation , which may increase the risk of cancer and hereditary abnormalities . reporting of side effects if you get any side effects talk to your nuclear medicine doctor . this includes any
you will not have to store this medicine . this medicine is stored under the responsibility of the specialist in appropriate premises . storage of radiopharmaceuticals will be in accordance with national regulation on radioactive materials .
what axumin contains - the active substance is fluciclovine . axumin 1600 mg : each vial contains 1600 mg fluciniclovine in 1600 mg ( corresponding to 16000 mg ). axumin 3200 mg : one vial delivers 3200 micrograms of flucinlovine at 3200 international units ( iu ), corresponding to 32000 mg . - the other ingredients are sodium citrate , concentrated hydrochloric acid and sodium hydroxide ( see section 2 " axumin and multidose "). what axumin looks like and contents of the pack white to off - white ,
azopt contains brinzolamide which belongs to a group of medicines called carbonic anhydrase inhibitors . it works by reducing pressure within the eye . azopt eye drops help to reduce high pressure in the eye , which can lead to an illness called glaucoma . if the pressure in your eye is too high , it can damage your sight .
do not take azopt if you have severe kidney problems if you are allergic to brinzolamide or any of the other ingredients of this medicine ( listed in section 6 ). if you think you may be allergic to medicines containing sulphonamides ( medicines used to treat diabetes or infections ) or to diuretics ( water tablets ). warnings and precautions talk to your doctor , pharmacist or nurse before taking azopt . the same allergy may be associated with too much acidity in your blood ( hyperchloraemic acidosis ). if any of these apply to you , tell your doctor or pharmacist before you take az
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . azopt should only be used in the eyes . the recommended dose is 1 drop in the eye each day . do not use azopt in both eyes at the same time each day ( see section 1 , 2 , 3 ). keep the azopt bottle tightly closed in order to protect from moisture . wash your hands before using the cap . remove the cap and snap collar from the bottle . hold the bottle tightly with your thumb and a finger . tilt your head back . pull down your eyelid with a
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects have been reported with azopt : common side effects ( may affect up to 1 in 10 people ) - effects in the eye : blurred vision , eye irritation , eye pain , eye discharge , itchy eye , dry eye , abnormal eye sensation , redness of the eye . other side effects may include : bad taste . uncommon side effects : - effects on the eye ( sensitivity to light , inflammation , infection of the conjunctiva ), eye swelling , eyelid itching , red , swelling , deposits in eye , glare ,
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and the bottle after exp . the expiration date refers to the last day of that month . this medicine does not require any special storage conditions to protect from infections . a pack containing a single bottle should not be used .
what azopt contains - the active substance is brinzolamide . each vial contains 10 mg of brin zolamide ( as benzalkonium chloride ). - the other ingredients are carbomer 974p , edetate disodium , mannitol , purified water , sodium chloride , tyloxapol , hydrochloric acid and sodium hydroxide ( for acidity levels and ph levels ). what azopt looks like and contents of the pack azopt is a milky liquid ( a suspension ) supplied in a 5 ml plastic ( droptainer ) bottle with a screw cap . a
the active substance of forxiga is dapagliflozin . it belongs to a group of medicines called medicines taken by mouth to treat diabetes . it works by helping control the level of sugar in your blood . it is used in adults and adolescents ( aged 18 years and older ) to treat adult diabetes . type 1 diabetes is a type of diabetes that occurs when your body does not produce enough insulin . your body also does not make enough insulin to control the diabetes . your doctor will check whether your blood and your urine are adequately hydrated . if you have type 2 diabetes , your body may not use enough insulin or
do not take forxiga - if you are allergic to dapagliflozin or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before taking for xiga : if you experience feeling sick or being sick ( stomach pain , excessive thirst , fast and deep breathing , confusion , unusual sleepiness or tiredness ), a sweet smell to your breath , a sweet or metallic taste in your mouth , a different odour to your urine or sweat , rapid weight loss . tell your doctor straight away if you have one or more of the above symptoms
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much to take the recommended dose of forxiga is one tablet once a day . if you have type 2 diabetes , your doctor may increase your dose to between 10 mg and 5 mg . you have a liver problem . your doctor will tell you how many tablets to take . how long to take for xiga your doctor can tell you if you need to take a smaller dose . in type 1 diabetes , the usual starting dose is between 5 mg and 10 mg . if your doctor tells you to
like all medicines , this medicine can cause side effects , although not everybody gets them . tell your doctor straight away if you notice any of the following serious side effects : angioedema ( rare , may affect up to 1 in 10 , 000 people ): if you experience any of these , stop taking forxiga and seek urgent medical attention straight away : - swelling of the face , tongue or throat , which may cause difficulties swallowing , hives and breathing problems . diabetic ketoacidosis ( rare ), if you have type 1 diabetes ( very common ), or if you are more than 10 years of age . type 2 diabetes
what forxiga contains - the active substance is dapagliflozin . eachforxiga 5 mg film - coated tablet ( tablet ) contains a single tablet called ' dpaglifllozin propanediol monohydrate equivalent to 5 mg dapgliflzin '. - the other ingredients are microcrystalline cellulose , lactose ( see section 2 ' for important information about lactose '), crospovidone , silicon dioxide , magnesium stearate . film - coating : polyvinyl alcohol , titanium dioxide ( e171 ), macrogol 3350 , yellow iron oxide (
mifamurtide contains the active substance mepact , which stops the growth of certain bacteria in the immune system ( the body ' s natural defence system ). mypact is used to treat adult patients with osteosarcoma ( bone cancer that has spread between 2 and 30 years ) after surgery to remove the tumour . it can be used alone or in combination with chemotherapy to stop cancer cells from growing and cancer may come back .
do not take mepact : - if you are allergic to mifamurtide or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before taking this medicine if : - you are taking medicines containing ciclosporin or other calcineurin inhibitors ( non - steroidal - anti - inflammatory drugs ) ( nsaids ) - you have problems with your heart or blood vessels such as blood clots ( thrombosis ) - bleeding ( haemorrhage ) - inflammation of the veins ( vasculitis )
treatment mepact will be given to you by a doctor or nurse . always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much to take your doctor will tell you how many tablets to take and how often you should take them . the recommended dose of meepact is 2 mg mifamurtide per kilogram of body weight every 12 hours for up to 24 hours . your doctor may change your mepact treatments depending on your chemotherapy schedule and on how you respond to your chemotherapy . the usual dose is 36 mg once a day .
like all medicines , mepact can cause side effects , although not everybody gets them . chills , fever and fatigue have been reported in patients treated with mepanact ( transient use of paracetamol ) and have been associated with fever . treatment with the combined use of the two active substances in mepenact may lead to stomach problems ( nausea and vomiting ) and loss of appetite . if you are receiving chemotherapy , tell your doctor immediately if you experience continuing fever and chills within 8 hours after you received the first dose of treatment with mypact . signs of an infection such as rash , any problems breathing ,
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the vial in outer carton and on the carton after exp . store in a refrigerator ( 2 8 ). do not freeze . reconstituted suspension : sodium chloride 9 mg / ml ( 0 . 9 %) solution for injection may be stored at room temperature ( up to 30 ) for up to 6 hours at 2 - 8 , but do not refrigerate or freeze . this medicine is for single use only . any unused product or waste material should be disposed of in accordance with local
what mepact contains - the active substance is mifamurtide . each vial contains 4 mg mifamanurtide ( as besilate ). after reconstitution and suspension , each ml contains 0 . 08 mg of mifmurtide in each ml . - the other ingredients are : 1 - palmitoyl - 2 - oleoyl- sn - glycero - 3 - phosphocholine ( see section 2 under ' important information about some of the ingredients ') 2 - diolayl - sn - gglycero 3 - phosphate - l - serine mon
mirvaso contains the active substance brimonidine which belongs to a group of medicines called alpha agonists . mirvaso is used on the skin and face to reduce redness ( rosacea ) and redness of the face ( stevens - johnson syndrome ) associated with high levels of blood flow in theacial skin and enlargement ( dilution ) of the small blood vessels of the skin . by reducing the amount of blood that is pumped through these blood vessels , it prevents the excess blood flow and reduces redness .
do not take mirvaso - if you are allergic to brimonidine or any of the other ingredients of this medicine ( listed in section 6 and section 2 " possible side effects "). warnings and precautions talk to your doctor , pharmacist or nurse before taking the medicine . the medicine should not be injected under the skin . certain medicines used to treat depression and parkinson ' s disease ( monoamine oxidase ( mao ) inhibitors such as selegiline , moclobemide , tricyclic antidepressants ( such as imipramine ), tetracyclic antidepressant such as maprotiline
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . mirvaso should be injected under the skin ( usually on the face ). this medicine should not be injected into any other part of your body . if your body surfaces , such as your eyes , mouth , nose or vagina , you should not use mirvasos . if you have any further questions on the use of this medicine , ask your doctor , pharmacist or nurse . how much to use your doctor will tell you how many tablets to use and how often you should use it . the usual dose
like all medicines , this medicine can cause side effects , although not everybody gets them . uncommon side effects ( may affect up to 1 in 10 people ): severe skin irritation , inflammation , skin rash , skin pain , discomfort , dry skin , warm skin sensation , tingling , sensation of pins and needles or swelling . if you notice any of these , stop taking mirvaso and tell your doctor straight away . common side effects : worsening of rosacea . the treatment should be stopped immediately and symptoms should be treated as soon as possible ( see section 2 under ' warnings and precautions '). contact allergy if you have allergic reaction
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and tube and pump after exp . store in the original package in order to protect from moisture .
what mirvaso contains - the active substance is brimonidine . each ml of gel contains 3 . 3 mg of bromonidine . after reconstitution , each vial of 5 ml contains 5 mg / ml of brimonididine tartrate . - the other ingredients are : carbomer , methylparahydroxybenzoate , phenoxyethanol , glycerol , titanium dioxide ( e171 ), propylene glycol , sodium hydroxide , purified water ( see section 2 under " miraso contains methyl parahydroxybenzzoate "), propylene Glycol . what
mvasi contains the active substance bevacizumab , which is a humanised monoclonal antibody ( a type of protein that recognises and attaches to a specific target in the immune system , the body ' s natural defences ). it is used to defend the body from infection and cancer by preventing it from multiplying and multiplying . in mvasi , the strength of bevocizumb binds to a protein called human vascular endothelial growth factor ( vegf ), which is found in lymph vessels all over the body . the veg f protein is found on blood vessels that provide blood with nutrients
do not use this medicine if you are allergic ( hypersensitive ) to bevacizumab or any of the other ingredients of this medicine ( listed in section 6 ). if you think you may be allergic , hypersensitive , to chinese hamster ovary ( cho ) cell products . if you or your child are pregnant or breast - feeding . warnings and precautions talk to your doctor or pharmacist before using mvasi . if any of these apply to you , or you are not sure , ask your doctor , pharmacist or nurse for advice before using this medicine . children and adolescents do not give this medicine to
dose and frequency of administration the dose of mvasi you receive will depend on your body weight and the type of cancer you have . the recommended dose is 5 mg , 7 . 5 mg or 10 mg per kg of body weight , given once every 15 days . your doctor will work out the right dose for you based on your weight and will tell you how many treatments you need . if you have the impression that the effect of this medicine is too strong or too weak , talk to your doctor or pharmacist . if your doctor thinks you may be having too much of a problem with your tumour growing , tell your doctor
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects may happen with mvasi and chemotherapy : tell your doctor or nurse straight away if you notice any of these side effects while you are being given this medicine : allergic reactions . signs of an allergic reaction may include difficulty in breathing , chest pain , redness or flushing of the skin , a rash , chills or shivering , feeling sick ( nausea ) or being sick ( vomiting ). other side effects include : severe side effects ( may affect up to 1 in 10 people ): high blood pressure , numbness or t
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the outer carton and vial label after exp . store in a refrigerator ( 2 8 ). do not freeze . keep the vial in the outercarton in order to protect from light . infusion solutions should be used immediately after dilution . if not used immediately , in - use storage times and conditions prior to use are the responsibility of the user and would normally not be longer than 24 hours at 2 to 8 , unless dilution has taken place in a sterile environment . mvasi is
what mvasi contains - the active substance is bevacizumab . each ml of concentrate contains 25 mg / ml ( 1 . 4 mg / 16 . 5 mg ) solution . each 4 ml vial contains 100 mg / m2 of beviacizumumab in 1 . 3 ml of solution . every 16 ml ampoule contains 400 mg / s ( 2 . 0 mg / 25 ml ). - the other ingredients are : trehalose dihydrate , sodium phosphate , polysorbate 20 and water for injections . what mvasis looks like and contents of the pack mvas
tecartus is a gene therapy medicine used to treat mantle cell lymphoma in adults . it is used in combination with other medicines for the treatment of refractory mantle cell lipoma in adult patients . tecartus contains your own white blood cells called autologous anti - cd19 - transfduced cd3 + cells . mantle cell lysisoma is a cancer that affects the immune system ( the body ' s natural defences ) that affects b - lymphocytes ( the type of blood that makes up lymphocytes ). mantle cell leukaemia is a disease in which the b- lymphocytes multiply in an uncontrolled way
do not use tecartus if you are allergic to the active substance or any of the other ingredients of this medicine ( listed in section 6 ). if you think you may be allergic , ask your doctor for advice . warnings and precautions talk to your doctor , pharmacist or nurse before you are given this medicine : - if you have had tests to check the number of white blood cells in your blood ( lymphodepleting chemotherapy ) ( see section 3 ). - if your doctor thinks you may have a low number of these white blood cell counts ( autologous use ). your doctor will do tests ( checks ) to check
tecartus will be given to you by a doctor or nurse who is trained in the use of your own white blood cells . your cells will be collected from your blood by a catheter placed in your vein ( a procedure call leukapheresis ) and given to your doctor . how tecartus is given you will have a procedure called lymphodepleting chemotherapy . your doctor will decide how many treatments you need and how long you will need to be treated . the recommended dose is one infusion per day . the number of treatments you will receive will depend on the type of medicine you are being treated with .
like all medicines , this medicine can cause side effects , although not everybody gets them . contact your doctor immediately if your side effects become serious or if you notice any of the following serious side effects you may need urgent medical attention : the following side effects have been reported during the tecartus infusion : very common ( may affect more than 1 in 10 people ): fever , chills , reduced blood pressure with symptoms such as dizziness , lightheadedness , fluid in the lungs . all symptoms could be signs of a condition called cytokine release syndrome ( loss of consciousness ). decreased level of consciousness , confusion , memory loss , disturbances of
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the label and carton after exp . store in a refrigerator ( 2 - 8 ). do not freeze . keep the vial in the outer carton in order to protect from light . infusion bag contains liquid nitrogen ( equivalent to 150 mg ). this medicine is made from genetically modified human blood cells and human - derived material . the product is stable for 36 hours .
what tecartus contains - the active substance is autologous anti - cd19 - transduced cd3+ cells in a specific single infusion bag . each vial contains a dispersion of anti -cd19 car t cells ( equivalent to 68 x 2 cd3 + cells ). - the other ingredients are : 106 anti , sodium chloride , human albumin ( see section 2 " teCartus contains sodium ") and water for injections . what tecartu looks like and contents of the pack tecartucus is a clear , colourless to pale yellow solution for infusion . it is supplied in an infusion bag
januvia contains the active substance sitagliptin and belongs to a group of medicines called dpp - 4 inhibitors ( dipeptidyl peptidase - 4 inhibitor ) which are used to control blood sugar levels in adult patients with type 2 diabetes mellitus . this medicine helps to increase the levels of insulin produced after a meal and decreases the amount of sugar made by the body . your doctor has prescribed this medicine to help lower your blood sugar , which is too high because of your type2 diabetes . your diabetes can also be treated with certain other medicines ( insulin , metformin , sulphonylureas
do not take januvia : if you are allergic to sitagliptin or any of the other ingredients of this medicine ( listed in section 6 ). if you have inflammation of the pancreas ( pancreatitis ). warnings and precautions talk to your doctor , pharmacist or nurse before you are given this medicine : - if you experience blistering of the skin ( bullous pemphigoid ) while you are being treated with juvia . this could be a sign of a disease of the pancreatreas called pancreatitis ( gallstones ). - if your family has alcohol dependence or very high levels of triglycerides
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one 100 mg film - coated tablet 63 mg taken by mouth once daily . if you have kidney problems , your doctor may increase your dose to 25 mg or 50 mg once daily depending on how you respond to this medicine . your doctor will tell you how many tablets of this medicine to take . this medicine can be taken with or without certain other medicines that lower blood sugar . diet and exercise januvia is for oral use . swallow the tablet whole with a glass of water . you
like all medicines , this medicine can cause side effects , although not everybody gets them . stop taking januvia and contact your doctor immediately if you notice any of the following serious side effects : severe and persistent pain in the abdomen ( stomach area ), which may reach through to your back , nausea and vomiting ( signs of an inflamed pancreas ). pancreatitis is a serious allergic reaction with frequency not known ( frequency cannot be estimated from the available data ): rash , hives , blisters on the skin , peeling skin , swelling of the face , lips , tongue , and throat that may cause difficulty in breathing or swallowing
what januvia contains - the active substance is sitagliptin . one tablet of each film - coated tablet ( tablet ) contains the following excipients : tablet core : sitaglptin phosphate monohydrate , equivalent to 25 mg sitaglioptin . tablet coating : microcrystalline cellulose , calcium hydrogen phosphate , croscarmellose sodium , magnesium stearate , sodium stearyl fumarate . the tablet film - coating : poly ( vinyl alcohol ), macrogol 3350 , talc , titanium dioxide ( e171 ), red iron oxide ( e172 ), yellow iron oxide . what
xultophy is used to lower blood glucose in adults with type 2 diabetes mellitus . diabetes is a condition in which your body does not produce enough insulin to control the level of sugar in your blood . the insulin that helps control blood sugar is called insulin degludec . it is a long - acting basal insulin . it helps control your blood sugar levels when you are taking liraglutide ( a type of glp - 1 ) or insulin during meals . xultophy can be used alone or with oral medicines for diabetes . it may also be used with other oral medicines ( such as metformin
do not take xultophy - if you are allergic to insulin degludec , liraglutide or any of the other ingredients of this medicine ( listed in section 6 ). - if 39 you are taking a sulfonylurea such as glimepiride or glibenclamide . you should continue to take your sulfonyluurea dose at the same time each day to maintain your blood sugar levels . warnings and precautions talk to your doctor , pharmacist or nurse before you start taking this medicine : if you have type 1 diabetes mellitus or ' ketoacidosis '. this is
always use this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . the recommended dose is one tablet once a day . you may need to take xultophy for as long as you are blind or have poor eyesight . your doctor will work out your blood sugar level and will tell you how many tablets to take each day . the usual starting dose for adults and older people is two tablets once daily ( one tablet in the morning and two tablets in the evening ). your doctor may prescribe a higher or lower dose depending on your condition and on your
like all medicines , this medicine can cause side effects , although not everybody gets them . tell your doctor straight away if you notice any of the following serious side effects : low blood sugar ( very common : may affect more than 1 in 10 people ) if your blood sugar level gets low you may pass out or become unconscious . this could be a sign of serious hypoglycaemia ( which may lead to brain damage ). if you are not sure , talk to your doctor , pharmacist or nurse before you take xultophy . if you think you may be getting low , ask your doctor for advice . your doctor may want to
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the blister after exp . this medicinal product does not require any special storage conditions . after first opening : store in a refrigerator ( 2 - 8 ). do not freeze . after opening : do not store above 30 . store in the original package in order to protect from light . if not used immediately , in - use storage times and conditions prior to use are the responsibility of the user and would normally not be longer than 8 hours at room temperature ( up to 21 ). however ,
what xultophy contains - the active substances are insulin degludec and liraglutide . each vial contains 100 units of insulin degluudec ( equivalent to 3 . 6 mg of lirabutide ) in 3 ml solution . each ml contains 300 units ( 3 . 8 mg of insulin gludec ) in 10 . 8 ml solution for injection . - the other ingredients are glycerol , phenol , zinc acetate , hydrochloric acid , sodium hydroxide ( for ph adjustment ) and water for injections ( see section 2 " xultphil contains sodium ").
giotrif is a medicine that contains the active substance afatinib . it works by blocking two proteins called egfr [ epidermal growth factor receptor - 1 ] ( egfr1 ] and her2 [ erbb2 ] ( erbb3 ]). these proteins are involved in the growth of cancer cells . this medicine stops these proteins from working and stops them from multiplying and growing . this helps to stop cancer cells from growing . your doctor has prescribed this medicine for the treatment of cancer of the lung ( non - small cell lung cancer ). your doctor will prescribe giotriff for you as your first treatment
do not take giotrif if you are allergic to afatinib or any of the other ingredients of this medicine ( listed in section 6 ). if you have low body weight ( less than 50 kg ). warnings and precautions talk to your doctor , pharmacist or nurse before taking this medicine if you : have kidney problems . your doctor may want to monitor you more closely for side effects such as lung inflammation ( interstitial lung disease ) or liver problems . some liver tests have shown that this medicine can cause a severe liver disease . have eye problems . have severe dry eyes . have inflammation of the transparent layer at the back of
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the usual starting dose is one 40 mg tablet once a day . your doctor will tell you how many tablets of this medicine to take . giotrif can be taken with or without food . swallow the tablet whole with a glass of water . you can take the tablet at any time of the day . do not chew or crush the tablet . this medicine is for oral use . if you take more this medicine than you should if you accidentally take too many tablets , talk to a doctor or go to
like all medicines , giotrif can cause side effects , although not everybody gets them . the following side effects have been reported during treatment : diarrhoea ( common : may affect up to 1 in 10 people ) if you have diarrhoehoea , see section 2 under ' warnings and precautions '. severe diarrhea with or without fluid loss ( very common ): may affect more than 1in 10 people if you suffer from low blood potassium and worsening kidney function . if you experience any of the above , talk to your doctor or pharmacist before you are given giorif . skin rash if you get the rash , talk
what giotrif contains - the active substance is afatinib . each film - coated tablet contains 20 mg of afinib . - the other ingredients are : tablet core : lactose monohydrate , microcrystalline cellulose , colloidal anhydrous silica , crospovidone , magnesium stearate . tablet coating : hypromellose , macrogol 400 , titanium dioxide ( e171 ), polysorbate 80 , and water for injections . what giotratif looks like and contents of the pack white to off - white , oval - shaped , 20 mm tablet deboss
orkambi contains two active substances called lumacaftor and ivacafor . it is a medicine used for long - term treatment of cystic fibrosis ( cf ) in patients aged 6 years and older with a mutation called f508del mutation . this mutation affects the function of a protein called cftr , which is involved in the normal function of the lungs . the mutation results in an abnormal cfr protein that does not respond to the medicine or to the other active substances in the body ( e . g ., lumacavor ). by interfering with the activity of this protein , orkamb
do not take orkambi - if you are allergic to lumacaftor or ivacafor or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before you are given and while you are being treated with either kambi : - if the f508del mutation has been detected in your blood . - if your doctor thinks that you may be having liver or kidney disease . your doctor may lower the dose of orkammi if you have abnormal blood tests of the liver . if any of these symptoms occur , tell your doctor
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much to take the recommended starting dose is one 6 mg tablet once a day for 12 weeks . your doctor will tell you how many tablets to take . the recommended orkambi tablet is 6 to 11 mg twice a day . if you take more or kambi than you should if you accidentally take too many tablets , talk to a doctor or go to a hospital straight away . the dose may need to be adjusted by your doctor . if possible , you can take the tablets with ork
like all medicines , this medicine can cause side effects , although not everybody gets them . the majority of the side effects seen with orkambi and ivacaftor have been mild to moderate . however , some may be serious and need immediate medical attention . if you have any of the following serious side effects while you are being treated with orkyambi : raised levels of liver enzymes in the blood which may increase the risk of liver injury in patients with pre - existing severe liver disease and the worsening of liver function . other side effects include : uncommon ( may affect up to 1 in 100 people ): pain or discomfort in
what orkambi contains - the active substance is lumacaftor . - each tablet contains ivaconaftor ( 123 mg ). - each of the 100 mg tablets contains either a single dose of either a 100 mg or a 125 mg tablet of lumacftor ( 125 mg ) or a dual dose ( a 500 mg and a 200 mg tablet ) of either lumacaptor ( 133 mg or 125 mg tablets of either orkyambi ( 200 mg or 250 mg tablets ) of ivacafto ( 125mg or a 500mg tablet of orkammi ( 100 mg , 250 mg or
the active substance of lynparza is olaparib . olaparateib is a type of cancer medicine known as a parp inhibitor ( poly [ adenosine diphosphate - ribose ] polymerase inhibitor ). it works by preventing mutations ( changes ) in a gene called brca ( breast cancer gene ). in some types of cancer , parp inhibitors cause death of cancer cells by interfering with an enzyme needed to repair dna . lynparzar is used to treat adult patients with ovarian cancer ( brca - mutated ovarian cancer ). it is used when the cancer has responded to previous treatment with standard platinum
you must not be given lynparza if you are allergic to olaparib or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before you are given this medicine . children and adolescents do not give this medicine to children below the age of 6 years . children under 2 years is not recommended . if you have any further questions on the use of this product , ask your doctor or pharmacist . do not breast - feed your child while being treated with this product . if any of these apply to your child , please tell your doctor . if
always take lynparza capsules exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much to take the recommended starting dose for adults is one 100 mg capsule twice a day . your doctor may increase your dose to 150 mg once a day depending on how you respond to the dose . the doses of yalparza tablets and tablets should be taken at the same time each day . if you take more than one tablet a day , take it as soon as you remember and then take your next tablet at the usual time . do not take a double dose to make up for
like all medicines , this medicine can cause side effects , although not everybody gets them . very common ( may affect more than 1 in 10 people ): feeling short of breath , feeling very tired , pale skin , fast heart beat . these may be symptoms of a decrease in the number of red blood cells ( anaemia ). uncommon ( might affect up to 1 in 100 people ): allergic reactions such as hives , difficulty breathing or swallowing , dizziness . signs and symptoms of hypersensitivity reactions are listed below . other side effects very common : may affect less than 1in 10 people : feeling sick ( nausea ) being sick ( vomiting )
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the blister after exp . store in a refrigerator ( 2 - 8 ). do not freeze . keep any lynparza capsules in the outer carton in order to protect from light . after first opening : store in the original carton at 30 for a maximum period of 3 days . discard any capsules that have been opened after this period . the capsules should be used within this period of time .
what lynparza contains - the active substance is olaparib . each hard capsule contains 50 mg olaparateib . - the other ingredients are lauroyl macrogol - 32 glycerides , hypromellose , titanium dioxide ( e171 ), gellan gum , potassium acetate , iron oxide black ( e172 ). what lynparz looks like and contents of the pack white , opaque , hard capsule imprinted with " olam 50 mg " on one side and " astrazeneca logo on the other side . the hard capsule is engraved with " nvr " on the cap and
what nyxoid is this medicine contains the active substance naloxone which is used to treat opioid overdose in adults , adolescents and children aged 14 years and older . it is used in combination with heroin , methadone , fentanyl , oxycodone , buprenorphine and morphine . how nxoid works nyxoids is a nasal spray that is used for the emergency treatment of opioid overdose . opioid overdose can occur in up to 14 people . overdose may cause breathing problems and severe sleepiness . if you experience an opioid overdose , stop taking opioids and contact your doctor or go to the nearest hospital emergency medical
do not use nyxoid - if you are allergic to naloxone or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before using this medicine . you may need emergency medical care or emergency services if you have an opioid overdose . it is important to know the signs and symptoms that may indicate an overdose . if you use this nasal spray for more than 2 to 3 days , use a new nasal spray at the same time each day . this medicine is not recommended for use in people who are physically dependent on opioids or who are addicted to
always use nyxoid nasal spray exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . the recommended dose is one inhalation once a day . use in children and adolescents do not exceed the prescribed dose . do not use more than your doctor tells you to use . if you have symptoms such as : shoulders , ears , breastbone , sternum or inside the ear . fingernail : clear the mouth and nose of any blockages . breathe in through the mouth or nose . 1 . breathing is the chest moving through the chest . you can hear
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects may happen with this medicine : nyxoid may cause acute withdrawal symptoms from opioid drugs . symptoms may include fast heart rate , high blood pressure body aches , stomach cramps , feeling sick , vomiting , diarrhoea , sweating , fever , goose bumps , shivering , trembling changes in behaviour , including violent behaviour , nervousness , anxiety , excitement , restlessness , irritability unpleasant or uncomfortable mood increased skin sensitivity difficulty in sleeping . if you experience any of these symptoms , tell your doctor . uncommon : may affect up
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . this medicine does not require any special storage conditions . medicines should not be disposed of via wastewater or household waste . ask your pharmacist how to dispose of medicines no longer required . these measures will help to protect the environment .
what nyxoid contains - the active substance is naloxone . each nasal spray contains 1 . 8 mg of ndaloxone ( as hydrochloride dihydrate ). - the other ingredients are : trisodium citrate diydrate , sodium chloride , hydrochloric acid , sodium hydroxide and purified water . - the concentration is 0 . 1 mg / ml in a pre - filled nasal spray . a single dose container can be used to store nxoid in a carton . 2 nasal sprays are packed in blisters . each nasal spray contains one dose of nalxone
what ovaleap is this medicine contains the active substance follitropin alfa , which is a gonadotropin ( a type of hormone that is produced naturally in the body ). fsh is involved in the growth and development of the sac ( follicles ) in the ovaries , and in the production of sperm ( a immature egg cell ). treatment with a medicine called " clomifene citrate " is used in assisted reproductive technology procedures ( procedures to help a woman become pregnant ) in women who are unable to take a medicine known as " luteinising hormone " and who are not able to take
do not use ovaleap if you are allergic to follitropin alfa , follicle stimulating hormone or any of the other ingredients of this medicine ( listed in section 6 ) if you have a tumour in your hypothalamus or pituitary gland ( the brain ), large ovaries ( sacs of fluids in the ovaries ), ovarian cysts , unexplained vaginal bleeding , cancer in your ovaries , womb or breasts , any condition that makes normal pregnancy impossible , ovarian failure , early menopause , fibroid tumours of the womb , malformed reproductive organs or testicular failure . if any of these apply
always use this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . this medicine is given as an injection into the tissue just under the skin ( subcutaneous injection ). if you have irregular periods , your doctor may give you this medicine for the first 7 days of your menstrual cycle . your doctor will tell you how many days of the cycle you need to use the medicine . the recommended dose is one 75 mg or 150 mg injection of this medicine every 7 days ( corresponding to 14 days ). the usual dose is 37 . 5 mg of 75 mg
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects may happen with ovaleap : serious side effects in women allergic reactions such as skin rash and raised itchy areas of skin . severe allergic reactions may include weakness , drop in blood pressure , difficulty breathing and swelling of the face . 37 common ( may affect up to 1 in 10 , 000 people ): if you experience this type of reaction , stop your ovalesap injection immediately and contact your doctor or seek medical help immediately . serious sideeffects in women lower stomach ache , nausea and vomiting are the symptoms of ovarian hyper
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the label and carton after exp . store in a refrigerator ( 2 8 ). do not freeze . keep the cartridge in the outer carton in order to protect from light . after first opening , this medicine may be stored for a maximum of 3 days at room temperature ( up to 25 ) before being used . if not used immediately , in - use storage times and conditions prior to use are the responsibility of the user and would normally not be longer than 3 days . once the cartridge has been opened
what ovaleap contains - the active substance is follitropin alfa . each ml of solution for injection ( injection ) contains either : one 300 micrograms / 0 . 5 ml solution for injections ( equivalent to 300 microlitres / 22 ml of follitrofa in 0 . 0 ml ). one 600 - grams / 1 . 5ml solution for injecting ( injection ). each cartridge contains 900 microgramsis / 66 ml of the active ingredient ( in this case , the other ingredients are sodium dihydrogen phosphate dihydrate , sodium hydroxide , mannitol , methionine , poly
voriconazole accord is an antifungal medicine that works by killing or stopping the growth of the fungi that cause infections . it is used in adults and children from the age of 2 years to treat invasive aspergillosis ( a type of fungal infection ) in adults , adolescents and children of all ages ( including those born without a doctor ' s prescription ) to treat candida sp . infections in non - neutropenic patients who have abnormally low white blood cells count due to the presence of the fungus fluconazole , another antivungal medication to treat serious fungal infections caused by sc
do not take voriconazole accord : - if you are allergic to the active substance or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before taking this medicine if : - you are taking any other medicines , including herbal medicines . in particular , tell your doctor or pharmacist if you have any questions about the medicines that you may be taking , or if they have changed or are not suitable for you . during the course of voricazole accord treatment 46 terfenadine ( for allergy ) astemizole (
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . your doctor will work out your dose based on your weight and the type of infection you have . the usual starting dose is 40 mg twice a day . this will be increased to 40 mg once a day for 24 hours . the dose may be adjusted to 400 mg three times a day ( for 12 hours ) and then to 200 mg once every 12 hours . this may be increased every 24 hours to 100 mg after treatment . the recommended dose is 300 mg once daily . if you have mild to moderate cir
like all medicines , this medicine can cause side effects , although not everybody gets them . if you notice any side effects not listed in this leaflet , please tell your doctor or pharmacist . serious side effects of voriconazole accord include rash , jaundice , changes in blood tests of liver function and pancreatitis . other side effects include : very common ( may affect more than 1 in 10 people ): visual impairment ( change in vision , blurred vision , visual color alterations , abnormal intolerance to visual perception of light , colour blindness , eye disorder , halo vision , night blindness , swinging vision , seeing sparks , visual
what voriconazole accord contains - the active substance is voricazole . each film - coated tablet contains 50 mg ( as film - coating ). - each tablet contains 200 mg of vorinazole ( as monohydrate ). - the other ingredients are : - the 50 mg tablet core : lactose monohydrate , pregelatinised starch , croscarmellose sodium , povidone , magnesium stearate , hypromellose ( e464 ), titanium dioxide ( e171 ) - the 40 mg tablets also contain lactosemonohydrate and triacetin . - the film -
mvabea is a vaccine used to prevent ebola virus disease in the future . it is given to adults , adolescents and children from 1 year of age and older who are at high risk of getting ebola . a 2 - dose course of vaccinations will be given to protect you against ebola virus disease caused by the zaire ebolavirus or filovirus . this vaccine contains less than 1 million international units ( iu ) of the whole ebolairus . if you think you have ebola fever disease , talk to your doctor , pharmacist or nurse before you are given it . warnings and precautions
follow carefully all instructions given to you by your doctor , pharmacist or nurse while you are being given the vaccine . if you have had a severe allergic reaction to any of the ingredients of mvabea ( listed in section 6 ). if you think you may have a severe allergy reaction to an antibiotic called ' gentamicin ' ( see ' other ingredients of the vaccine '). warnings and precautions talk to your doctor or pharmacist before you are given movabea if : you have ever had or are at an increased risk of having asevere allergic reaction after any other vaccine injection you have fainted following an injection you
your doctor , nurse or pharmacist will give you the vaccine by injection into a muscle ( intramuscular injection ), usually in the upper arm or thigh or into a blood vessel . the recommended dose of vaccination is one zabdeno vaccine 8 weeks later . if you are given more mvabea vaccine than you should the second vaccine should be given at the same time as the first vaccine . primary vaccination first vaccination with zab deno red cap vial ( 0 . 5 ml ) the second vaccination with m vabea yellow cap vials ( 1 . 8 ml ) will be given after the first vaccination
like all medicines , this vaccine can cause side effects , although not everybody gets them . the following side effects may happen with mvabea : very common ( may affect more than 1 in 10 people ): pain , warmth and swelling at the site of the injection very tired muscle ache joint pain common : may affect up to 1 in every 10 people : feeling sick ( vomiting ) itching at the place where the injection was given uncommon : may effect up to one in every 1 , 100 people : redness and skin hardness after the injection generalised itching other side effects that have been reported in children and adolescents aged 1 to 17
what mvabea contains - the active substance is zaire ebolavirus 29 ( tai forest ebola virus nucleoprotein marburg equivalent to 0 . 7 mg / 108 micrograms ). - the other ingredients are chicken embryo fibroblast cells . this vaccine contains trace residues of gentamicin , sodium chloride , trometamol , water for injections and hydrochloric acid ( for ph adjustment ). what this medicine looks like and contents of the pack this medicine is a suspension for injection in a single - dose glass vial with a rubber stopper and yellow cap . each pack contains
bondronat contains the active substance ibandronic acid . this belongs to a group of medicines called bisphosphonates . it is used to treat breast cancer that has spread to your bones ( called ' bone ametastases '). it helps to prevent your bones from breaking ( fractures ) and other bone problems that may need surgery or radiotherapy bondonat can be used if you have a raised calcium level in your blood due to a tumour that has been lost from your bones or if your bones are weaker .
do not take bondronat if you are allergic to ibandronic acid or any of the other ingredients of this medicine ( listed in section 6 ). if you have low levels of calcium in your blood . warnings and precautions talk to your doctor , pharmacist or nurse before taking this medicine if you : have a side effect called osteonecrosis of the jaw ( onj ). onj is a serious form of bone damage in the jaw . your doctor may decide to reduce your dose or stop treatment . if you think you may have onj , tell your doctor . this is a painful condition that can be difficult to treat
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . your doctor will determine the type of cancer you have and will give you an infusion into your vein . you will have regular blood tests while you are being treated with bondronat . the dose of this medicine depends on your illness . if you have breast cancer that has spread to your bones , it may take 3 - 4 weeks before you are given an infusion in your vein , which may take up to 15 minutes . this is because of a raised calcium level in your blood . the recommended dose is 1
like all medicines , this medicine can cause side effects , although not everybody gets them . tell your doctor straight away if you notice any of the following serious side effects you may need urgent medical treatment : rare ( may affect up to 1 in 1 , 000 people ): persistent eye pain or inflammation new pain or weakness or discomfort in your thigh , hip or groin . unusual fracture of the thigh bone . very rare ( might affect more than 1 in 10 , 000 persons ): pain or sore in your mouth or jaw . severe jaw problems ( necrosis ( dead bone tissue ) in the jaw bone . ear pain or discharge from the ear .
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the vial label after exp . this medicine does not require any special storage conditions . after dilution the infusion solution should be used immediately . if not used immediately , in - use storage times and conditions prior to use are the responsibility of the user and would normally not be longer than 24 hours at 2 - 8 unless dilution has taken place in controlled and validated aseptic conditions . your healthcare professional will ensure that this medicine is used correctly and not thrown away .
what bondronat contains - the active substance is ibandronic acid . each ml of solution contains 2 mg ibondronic acid ( as a concentrate for solution for infusion ). - the other ingredients are : sodium monohydrate , sodium chloride , acetic acid , sodium acetate , water and water for injections . what bondsronat looks like and contents of the pack this medicine is a clear , colourless solution . it is supplied in a pack containing 1 or 2 vials with a bromobutyl rubber stopper .
what zeposia is and what it is used for it is a medicine that belongs to a group of medicines that affect the number of white blood cells called lymphocytes . what zepOSia is used in the treatment of patients with relapsing remitting multiple sclerosis ( rrms ) is a type of active disease that affects the nerves of the brain and spinal cord . symptoms include numbness , difficulty in walking and problems with vision and balance . relapses remittingmultiple sclerosis is characterised by attacks on the nerve cells . the symptoms usually disappear within a few days or for periods of time . some problems may
do not take zeposia if you are allergic to zanimod or any of the other ingredients of this medicine ( listed in section 6 ) if you have a severely weakened immune system ( e . g . a heart attack , angina , stroke , mini - stroke or transient ischemic attack ). warnings and precautions talk to your doctor , pharmacist or nurse before you are given tia if : you have severe heart failure within the last 6 months you have irregular or abnormal heartbeats ( arrhythmia ) your heart is not working properly after treatment you have or have had severe infection such as hepatitis ,
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much to take your doctor will work out the dose of zeposia you need based on your heart rate . you will be given a ' treatment initiation pack ' for the first 4 weeks . the recommended dose is 0 . 23 mg ozanimod once a day . this will be taken as 1 capsule in the morning and 4 capsules in the evening . after 4 weeks , your doctor may increase your dose to a ' maintenance pack ' with orange capsules ( 0 . 92 mg ozimod ).
like all medicines , this medicine can cause side effects , although not everybody gets them . serious side effects tell your doctor straight away if you notice any of the following side effects : very common ( may affect more than 1 in 10 people ): slow heart rate urinary tract infection ( increase in blood pressure in adults and children over 1 year of age ) uncommon ( might affect up to 1 in 100 people ): allergic reaction . the signs may include a rash . other side effects include : side effects that may occur with zeposia are listed below : common : may affect less than 1in 10 people : infections of the nose or nost
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the blister after exp . store below 25 . store in the original package in order to protect from moisture . this medicine does not require any special temperature storage conditions . if you notice any damage or signs of tampering to the pack , tell your pharmacist or nurse .
what zeposia contains - the active substance is ozanimod . each capsule contains 0 . 23 mg ( 0 . 25 mg ) ozanimog ( as hydrochloride ). each capsule of zeposeia 0 . 46 mg contains either 0 . 48 mg ( 1 . 088 mg ) or ozimod ( as hydrate ). - the other ingredients are microcrystalline cellulose , silica , colloidal anhydrous , croscarmellose sodium , magnesium stearate . - capsule shell of 0 . 03 mg : gelatin , titanium dioxide ( e171 ), yellow iron oxide ( e
the active substances of temybric ellipta are fluticasone furoate , umeclidinium bromide and vilanterol . fluticasmone furate belongs to a group of medicines called corticosteroids ( steroids ). umecylidinIUM bromine and vilterol belong to a class of medicines known as bronchodilators . what temybrexta is used for and how it is used temybric ellipta is indicated for the treatment of chronic obstructive pulmonary disease ( copd ). copd is a long - term
do not use temybric ellipta - if you are allergic to fluticasone furoate , umeclidinium , vilanterol or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before you are given this medicine . if you think any of these apply to you , tell your doctor or pharmacist before being given temybi ellipta . - if your doctor has told you that you have asthma . if any of this applies to you ( or you are not sure ), ask your doctor . warnings and
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much to use the recommended dose is one inhalation once a day . this medicine should be used within 24 hours of your last dose of temybric ellipta . if you have any further questions on the use of this medicine , ask your doctor , pharmacist or nurse . how long to use temchybric ellipta if you use more temybiellipta than you should contact your doctor right away if you experience symptoms of a sudden attack of breathlessness or wheez
like all medicines , this medicine can cause side effects , although not everybody gets them . immediate breathing difficulties if your breathing ( wheezing ) does not improve after taking this medicine , tell your doctor straight away . pneumonia ( infection of the lung caused by copd ) the most common side effect of temybric ellipta is symptoms of a lung infection such as fever , chills , increased mucus production , change in mucus colour , increased cough and increased breathing difficulties common side effects ( may affect up to 1 in 10 people ) are sore , raised patches in the mouth or throat caused by a fungal infection (
what temybric ellipta contains - the active substances are fluticasone furoate , umeclidinium bromide and vilanterol . each delivered dose contains 92 micrograms of flutic as a single dose , corresponding to a delivered dose of 65 microgram s of umeklidatiniumbromide , equivalent to a deliver dose of 55 microgramS of umclidinicium ( corresponding to an additional dose of 22 microgram / ml of vilterol ) and trifenatate . - the other ingredients are lactose monohydrate (
zinforo is an antibiotic medicine that contains the active substance ceftaroline fosamil . it belongs to a group of medicines called 'cephalosporin antibiotics '. zinforo helps to prevent infections of the skin and the tissues around the skin . it is used to treat an infection of the lungs called ' pneumonia ' in adults . your doctor will tell you how long you should continue to take it . you should not stop taking it unless your doctor has told you to . how zinfeno works your doctor may tell you to do so . zinnforo works by killing certain bacteria that cause
do not take zinforo if you are allergic to ceftaroline fosamil or any of the other ingredients of this medicine ( listed in section 6 ). if you think you may be allergic to othercephalosporin antibiotics . if you have had previous severe allergic reactions to other antibiotics ( such as penicillin or carbapenem ). warnings and precautions talk to your doctor , pharmacist or nurse before taking zin foro if any of these apply to you . you should tell your doctor if you : have kidney problems ( seizures or convulsions ). have any non - severe allergic reaction to
always use zinforo exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is 600 mg once a day for 12 weeks . your doctor may increase your dose to 600 mg every 8 weeks if you have some infections . the dose may be increased from 8 mg to 12 mg twice a day . it is given by a drip into a vein ( intravenously ) over a period of 5 to 60 minutes . if your doctor determines that the dose is too strong or too weak , you may receive an increased dose . the duration of treatment is 5 to 14 days
like all medicines , this medicine can cause side effects , although not everybody gets them . tell your doctor straight away if you notice any of the following side effects you may need urgent medical treatment : sudden swelling of your lips , face , throat or tongue , a severe rash , or swallowing or breathing problems . these could be signs of a severe allergic reaction ( anaphylaxis ). diarrhoea , stool , blood or mucus may be present . treatment with zinforo may be interrupted or stopped by medicines that slow bowel movement ( see section 1 ). a blood test called a ' coombs test ' will be performed to
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the blister after exp . store below 30 . store in the original package in order to protect from moisture . medicines should not be disposed of via wastewater or household waste . ask your pharmacist how to dispose of medicines no longer required . these measures will help to protect the environment .
what zinforo contains - the active substance is ceftaroline fosamil . - the other ingredients are arginine and water for injections ( see section 2 ). what zzinforo looks like and contents of the pack zinofo is a pale yellowish to light yellow powder for concentrate for solution for infusion in a vial . it is available in packs containing 10 vials .
pregabalin pfizer belongs to a group of medicines used to treat epilepsy , neuropathic pain and generalised anxiety disorder ( gad ) in adults . peripheral and central neurological pain pregabalin fizer is used for the treatment of long lasting pain caused by damage to the nerves . a variety of diseases can cause peripheral neurological pain , such as diabetes or shingles . pain sensations may be described as burning , throbbing , shooting , stabbing , sharp , cramping , aching , tingling , numbness , pins and needles . in addition , peripheral and peripheral neuropathy pain may also be associated with
do not take pregabalin pfizer : - if you are allergic to pregaabalin or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before taking any of these products . before you start taking pregagabalin pumpfizer , tell your doctor or pharmacist if you have symptoms suggestive of an allergic reaction . these symptoms include swelling of the face , lips , tongue , and throat and diffuse skin rash . if you experience any signs of these reactions you should contact your doctor immediately . during the marketing and administration of pre
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose of pregabalin pfizer for peripheral and central neuropathic pain , epilepsy and generalised anxiety disorder is 150 mg or 600 mg once a day . your doctor will tell you the dose to take . you should swallow the capsule whole with a glass of water . you can take the capsule with or without food . you may change the dose up to three times a day depending on how you respond to the medicine . the maximum daily dose that you should take is one tablet of pre
like all medicines , this medicine can cause side effects , although not everybody gets them . very common ( may affect more than 1 in 10 people ): dizziness , drowsiness , headache . common : may affect up to 1 in every 10 people : increased appetite , feeling of elation , confusion , disorientation , decrease in sexual interest , irritability , disturbance in attention , clumsiness , memory impairment , loss of memory , tremor , difficulty with speaking , tingling feeling , numbness , sedation , lethargy , insomnia , fatigue , feeling abnormal , blurred vision , double vision , vertigo ,
what pregabalin pfizer contains - the active substance is pregaabalin . each hard capsule contains 25 mg , 50 mg , 75 mg , 100 mg , 150 mg , 200 mg , 225 mg or 300 mg of preginabalin - the other ingredients are lactose monohydrate , maize starch , talc , gelatine , titanium dioxide ( e171 ), sodium laurilsulphate , anhydrous colloidal silica , black ink , shellac , black iron oxide ( e172 ), propylene glycol ( e1521 ), potassium hydroxide ). - the 75 mg and
xadago is a medicine that contains the active substance safinamide , which increases the levels of dopamine in the brain . this is a stimulant of the brain involved in movement . in parkinson ' s disease , the body does not respond normally to stimuli such as stimulation of the dopamine system . xadago can be used alone or in combination with levodopa or other medicines used to treat parkinson' s disease .
do not take xadago if you are allergic to safinamide or any of the other ingredients of this medicine ( listed in section 6 ). if you take the following medicines : monoamine oxidase ( mao ) inhibitors such as selegiline , rasagiline and moclobemide , phenelzine , isocarboxazid and tranylcypromine . these have not been studied during treatment for parkinson ' s disease or depression . pethidine ( a strong pain killer ) has been shown to increase the chance of experiencing an increase in your retina ( sensitive layers
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose of xadago is 50 mg or 100 mg taken by mouth once a day . your doctor will tell you how many tablets to take . if you have moderately reduced liver function , your doctor may prescribe a lower dose of 50 mg . if this applies to you , tell your doctor straight away . if your doctor thinks that the dose is too weak or too weak , talk to your doctor . if necessary , you may be asked to take a higher or lower dose . the usual dose of
like all medicines , this medicine can cause side effects , although not everybody gets them . hypertensive crisis : very high blood pressure may lead to collapse ( neuroleptic malignant syndrome ): confusion , sweating , muscle rigidity ( hyperthermia ), increase level of enzyme creatine kinase in your blood ( serotonin syndrome ), confusion , hypertension , muscle stiffness , hallucinations ( hypotension ). the following side effects have been reported with the use of parkinson ' s disease in combination with safinamide and levodopa . other medicines and xadago tell your doctor or pharmacist if you are taking , have recently taken or might take
what xadago contains - the active substance is safinamide . each tablet contains either 50 mg or 100 mg . - the other ingredients in the tablet core are : - tablet core : methansulfonate , microcrystalline cellulose , crospovidone type a , magnesium stearate , silica colloidal anhydrous - tablet coating : hypromellose , macrogol , titanium dioxide ( e171 ) and iron oxide red ( e172 ). what xADago looks like and contents of the pack xadagon 50 mg film - coated tablets of 7 mm diameter with metallic gl
zytiga is a medicine that contains the active substance abiraterone acetate . it is used to treat prostate cancer that has spread to other parts of the body . zytiga increases the levels of testosterone in your blood when you have prostate cancer . your doctor will test your blood to see if it is too high or too low for you to tolerate the medicine .
do not take zytiga if you are allergic to abiraterone acetate or any of the other ingredients of this medicine ( listed in section 6 ). if you think you may be pregnant . warnings and precautions talk to your doctor , pharmacist or nurse before taking this medicine if : you have severe liver damage . you have prostate cancer . this medicine should not be taken with this medicine . if any of these apply to you , tell your doctor or pharmacist before you take this medicine : if you have liver problems such as high blood pressure , heart failure or low blood potassium . if you know that you have low blood
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one tablet of 1 , 000 mg twice a day . swallow the tablet whole with a glass of water . this medicine can be taken with or without food . do not chew , crush or split the tablet . take the tablet by mouth . take zytiga at about the same time each day . if you take more tablets than you should if you accidentally take too many tablets , talk to a doctor or go to a hospital straight away . if possible , take your tablet with you .
like all medicines , this medicine can cause side effects , although not everybody gets them . stop taking zytiga and contact your doctor immediately if you experience : muscle weakness , muscle twitches , a pounding heart beat or palpitations . the level of potassium in your blood is low . your doctor will check your potassium regularly . other possible side effects include : very common ( may affect more than 1 in 10 people ): fluid in your legs or feet . low blood potassium ( seen in liver function test ). high blood pressure . urinary tract infection . diarrhoea . common ( might affect up to 1 in every 10 people ) high
what zytiga contains - the active substance is abiraterone acetate . each tablet contains nominally 250 mg abirate . - the other ingredients are : tablet core : microcrystalline cellulose , croscarmellose sodium , lactose monohydrate , magnesium stearate , povidone ( k32 ), colloidal anhydrous silica , sodium laurilsulfate . see section 2 for further information about some of the ingredients of this medicine ( see section 4 for important information on some of these ingredients ). what ztiga looks like and contents of the pack - zyt
hefiya contains the active substance adalimumab . it is a medicine used for the treatment of inflammatory diseases : polyarticular juvenile idiopathic arthritis , enthesitis - related arthritis , paediatric plaque psoriasis and paediatric crohn ' s disease . paediatric non - infectious uveitis . the active ingredient in hefiya , addalimumab , is a monoclonal antibody ( a type of protein that recognises and attaches to a specific target substance in the body ). the target of monoconal antibodies is a protein called tumour necrosis factor ( tnf
do not take hefiya - if your child is allergic to adalimumab or any of the other ingredients of this medicine ( listed in section 6 ). - if you have a severe infection , such as tuberculosis , sepsis ( blood poisoning ), or other opportunistic infections . warnings and precautions talk to your child ' s doctor , pharmacist or nurse before taking this medicine : - if he has a history of unusual infections or a weakened immune system . symptoms of infections may include fever , wounds , feeling tired , dental problems . - if the child has moderate or severe heart failure or a serious heart condition . allergic reaction
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the usual dose is one 40 mg tablet once a day . your doctor will tell you how many tablets to take . the dose may be increased or decreased depending on your response to the medicine . for polyarticular juvenile idiopathic arthritis age and body weight the usual starting dose is 2 tablets of 30 mg twice a day ( equivalent to 40 mg ) for 2 years of age and weighing 10 kg or more . thereafter , your doctor may increase your dose to 30 mg two times a day or to
like all medicines , this medicine can cause side effects , although not everybody gets them . most side effects are mild to moderate . however , some may be serious and require treatment . tell your doctor straight away if you notice any of the following side effects ( see section 4 of this leaflet ): - after the last hefiya injection - allergic reaction - heart failure - severe rash , hives , swollen face , hands , feet - trouble breathing or swallowing - shortness of breath - swelling of the feet - signs and symptoms of infection such as fever , feeling sick , wounds , dental problems , burning on urination , feeling weak
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the label and carton after exp . store in a refrigerator ( 2 8 ). do not freeze . keep the pre - filled syringe in the outer carton in order to protect from light . after first opening , the product may be stored at room temperature ( up to 25 ) for a maximum period of 14 days . once removed from the refrigerator for room temperature storage , you may use your pre - fitted syringe for a single period of up to 14 days without the need for any special storage
what hefiya contains - the active substance is adalimumab . each pre - filled syringe contains 20 mg of addalimumab in 0 . 4 ml solution . - the other ingredients are adipic acid , citric acid monohydrate , sodium chloride , mannitol ( e421 ), polysorbate 80 , hydrochloric acid and sodium hydroxide and water for injections . see section 2 for further information about some of the ingredients . what hefaya looks like and contents of the pack hafiya 20 mg solution for injection ( injection ) is a clear to slightly opalescent , colour
the active substance of ritemvia is rituximab , a type of protein called a " monoclonal antibody ". it attaches to a specific type of white blood cell called " b - lymphocyte " ( b lymphocyte ). when a person attaches to b lymphocytes , the cell ' s immune system ( the body ' s natural defence system ) will attack and destroy the cell . this is known as " non - hodgkin ' s lymphoma ". this is a disease of the lymph tissue that affects the immune system . it affects a certain type of a white blood type called b- lymphocytes
do not take ritemvia - if you are allergic to rituximab , other proteins that contain the active substance , or any of the other ingredients of this medicine ( listed in section 6 ). if you have a severe active infection with a weak immune system . if you suffer from severe heart failure or severe uncontrolled heart disease . warnings and precautions talk to your doctor , pharmacist or nurse before taking this medicine . children and adolescents do not give this medicine to children under 6 years of age because it has not been studied in this age group . this is because it is not known if it is safe or effective in this
your doctor will decide how much ritemvia you will receive and how often you will need this treatment . always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . if you have any side effects , talk to your doctor , pharmacist or nurse before you are given ritvia . it is given as a drip ( intravenous infusion ) into a vein . medicines given before each ritemvia administration you will be given rizervia in combination with other medicines ( pre - medication ) to reduce the risk of side effects during your treatment . for non -
like all medicines , this medicine can cause side effects , although not everybody gets them . most side effects are mild to moderate . however , some may be serious and require treatment . some of these reactions have been fatal . infusion reactions during the first 24 hours of the infusion , fever , chills , shivering , pain at the infusion site , blisters , itching , sickness , nausea , tiredness , headache , breathing difficulties , blood pressure raised , wheezing , throat discomfort , tongue or throat swelling , itchy , runny nose , vomiting , flushing , palpitations , heart attack , low number of platelets
what ritemvia contains - the active substance is rituximab . each ml of concentrate contains 100 mg of ritudimab ( as besilate ). each 10 ml vial contains 10 mg / ml ( 23 . 5 mg ) ritukimab in each ml . - the other ingredients are sodium chloride , tri - sodium citrate dihydrate , polysorbate 80 and water for injections ( see section 2 for further information on some of the ingredients of this medicine ). what it looks like and contents of the pack this medicine is a clear , colourless solution for infusion in a glass
capecitabine teva belongs to a group of medicines called " cytostatic medicines ", which stop the growth and spread of cancer cells . capecitabrine teva is a type of medicine known as a cytokostatic medicine . it is an active anti - cancer medicine that can be used in the treatment of certain types of colon , rectal , gastric , or breast cancers . the use of capecitabe teva has not been investigated in patients with advanced stage of colon cancer . after complete removal of the tumour by surgery it is recommended that you continue to receive chemotherapy while you are being treated with cape
do not take capecitabine teva if you : - are allergic to cape citabine or any of the other ingredients of this medicine ( listed in section 6 ) - have an allergy or reaction to this medicine - have severe reactions to fluoropyrimidine therapy ( a group of anticancer medicines containing fluorouracil ) - are pregnant - have low levels of white cells or platelets in the blood ( leucopenia , neutropenia , thrombocytopenia ) - suffer from severe liver or kidney problems - have problems with the enzyme dihydropyrimidine dehydrogenase (
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . capecitabine should only be prescribed by a doctor experienced in the use of anticancer medicines . your doctor will prescribe you a dose and treatment regimen that is right for you . the dose of cape citabine teva is based on your body surface area ( height and weight ). the usual dose for adults is 1250 mg / m2 of body surface surface taken twice a day . this means that you have a body weight of 64 kg and height of 1 . 64 mbq . you
like all medicines , this medicine can cause side effects , although not everybody gets them . stop taking capecitabine teva and contact your doctor immediately if you get any of these symptoms : diarrhoea : if you have an increase of 4 or more bowel movements . if you vomit more than once in a 24 - hour period , or if you lose your appetite . stomatitis : pain , redness , swelling or sores in your mouth and / or throat ( hand or foot ). skin - reaction : pain and swelling , including redness and tingling of hands and /or feet fever with a temperature
what capecitabine teva contains - the active substance is capecabine . each film - coated tablet contains 150 milligrams ( mbq ) capectabine ( as talc ). - each tablet contains 500 milligram ( mpa ). - the other ingredients are : tablet core : lactose , microcrystalline cellulose , hypromellose ( e464 ), croscarmellose sodium , magnesium stearate , macrogol 400 , talc ( e553b ). tablet coating : hypromellaose , titanium dioxide ( e171 ), yellow iron oxide ( e172
silodosin recordati is a medicine that belongs to a group of medicines called alpha1a - adrenoreceptor blockers . it is used for the treatment of prostate , bladder and urethra . it helps to maintain a smooth muscle in these tissues . it also helps to reduce your symptoms . your doctor will tell you how long you should continue to take silodosan recordati . silodosein recordi is used to treat the urinary symptoms associated with benign enlargement of the prostate ( prostatic hyperplasia ), such as difficulty in starting to pass water and a feeling of not completely emptying the bladder
do not use silodosin recordati - if you are allergic to siliodosin or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before using this medicine . before eye surgery if you experience cloudiness of the lens during cataract surgery , your doctor will examine your eye 26 before you start to use the medicine . if you notice a loss of muscle tone in the iris ( the coloured part of the eye ) during a surgery , you should take appropriate precautions . medicine and surgical techniques should not be used in combination with sil
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much to take the recommended dose of silodosin recordati is 8 mg once a day . if you have kidney problems or moderate kidney problems , your doctor may prescribe a lower dose . take this dose at the same time each day . swallow the capsule whole with a glass of water . do not chew or crush the capsule . you can take the tablet with or without food . you may find it easier to take it at any time during the day or at night . try to take your tablet
like all medicines , this medicine can cause side effects , although not everybody gets them . allergic reactions swelling of the face or throat , difficulty in breathing , feeling faint , itchy skin and hives ( the most common side effect of silodosin recordati ) dizziness . dizziness may be associated with dizziness and occasionally fainting . if you feel weak or dizzy , tell your doctor straight away . the symptoms may include dizziness or faints . if any of the above apply to you ( or you are not sure ), talk to your doctor or pharmacist before you are given this medicine . if
what silodosin recordati contains - the active substance is silosin . each capsule contains 8 mg of silodosein . - the other ingredients are : capsule content : silodusin 8 mg : mannitol ( e421 ), magnesium stearate , sodium laurilsulfate , gelatin , titanium dioxide ( e171 ). capsule shell : white , opaque , hard gelatin capsules , with " sda " debossed on one side and " gsi " on the other side . capsule size : 4 mg ( 4 . 5 mm ) silodnosin : mannaitol ( i421
kinzalmono belongs to a class of medicines known as angiotensin ii receptor antagonists . angiotENSin ii is a substance produced in the body which causes your blood vessels to narrow , thus increasing your blood pressure . kinzalono blocks the effect of angiotenin ii so that the blood vessels relax , and your blood blood pressure is lowered . this is called essential hypertension ( high blood pressure ). what is essential hypertension ? the highblood pressure is not caused by any other condition . high bloodpressure can damage blood vessels in several organs , which can lead to heart attack , heart or kidney failure
do not take kinzalmono if you are allergic to telmisartan or any of the other ingredients of this medicine ( listed in section 6 ). if this applies to you ( or you are not sure ), talk to your doctor , pharmacist or nurse before taking this medicine . warnings and precautions 3 if you think you may be pregnant , ask your doctor or pharmacist for advice before taking kinzdalmono ( see pregnancy section ). if you have severe liver problems such as cholestasis or biliary obstruction ( problems with drainage of the bile from the liver and gall bladder ) or any other severe
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose of kinzalmono is one tablet a day . the tablets should be swallowed whole with some water . do not chew or break the tablet as this may affect the way the medicine works . you should swallow the tablet whole with a glass of water . if you have any further questions on the use of this medicine , ask your doctor , pharmacist or nurse .
like all medicines , this medicine can cause side effects , although not everybody gets them . some side effects may be serious and need immediate medical attention : sepsis ( blood poisoning ) is a severe infection with whole - body inflammatory response that can cause rapid swelling of the skin and mucosa ( angioedema ). these side effects are rare ( may affect up to 1 in 1 , 000 people ). other side effects of kinzalmono common side effects ( affects more than 1 user in 10 ): low blood pressure ( hypotension ) cardiovascular events uncommon side effects : uncommon ( affects 1 to 100 users in 100 ): urinary
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the blister after exp . this medicine does not require any special temperature storage conditions . keep your medicine bottle tightly closed in order to protect from moisture . once your kinzalmono tablet has been removed from the blister , do not throw away any medicines via wastewater . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what kinzalmono contains - the active substance is telmisartan . each tablet contains 20 mg telmisantan . - the other ingredients are povidone , meglumine , sodium hydroxide , sorbitol , magnesium stearate . what kinzonmono looks like and contents of the pack kinzalamono 20 mg tablets are white to off - white , round , flat , biconvex tablets debossed with " gsi " on one side and " 20 " on the other side of the tablet in black ink on the white side of tablet . kin
afstyla is a human clotting ( coagulation ) factor viii product . it contains the active substance lonoctocog alfa . afstylfa is used to treat and prevent bleeding episodes in patients with haemophilia a ( inborn factor v iii deficiency ). factor v viii is essential for blood clotting . it helps to clot the blood . patients with an increased tendency to bleed have been shown to have higher levels of factor iii in their blood than in patients of all ages . in patients who have not been previously treated with factor iii , and who do not have enough factor v
do not use afstyla - if you have ever had an allergic reaction to any of the ingredients in this medicine ( listed in section 6 ). if you are allergic to hamster proteins . 46 warnings and precautions talk to your doctor , pharmacist or nurse before you are given this medicine . the dose and frequency of administration of the dose you receive is based on the batch number and the results of your treatment diary . do not stop using the product unless your doctor has told you to . do tell your doctor if you think you may be allergic ( hypersensitivity ) reactions to any ingredient in the medicine or to any other ingredients
your treatment will be overseen by a doctor experienced in the treatment of blood clotting disorders . always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the dose of afstyla you receive will depend on the duration of treatment , the severity of your disease the site and the bleeding your clinical condition . reconstitution and administration general instructions the powder and the solvent ( liquid ) should be used in aseptic conditions . the solvent should be clear and colourless to slightly opalescent . the solution should be injected into the eye . do not use the
like all medicines , afstyla can cause side effects , although not everybody gets them . symptoms of allergic reactions allergic reactions may include the following symptoms : hives generalised urticaria ( itchy rash , tightness of the chest , difficulty in breathing , wheezing ), low blood pressure and dizziness ( anaphylaxis ). bleeding has been reported in patients treated with factor viii medicines with inhibitor antibodies ( see section 2 " warnings and precautions "). common side effects ( may affect up to 1 in 10 people ) previous treatment with factor iii ( more than 150 days of treatment ) uncommon side effects (> 1
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the vial label after exp . store in a refrigerator ( 2 8 ). do not freeze . keep the afstyla powder in the outer carton in order to protect from light . after reconstitution , the reconstituted product should be used immediately . if not used immediately , in - use storage times and conditions prior to use are the responsibility of the user and would normally not be longer than 8 hours at 2 - 8 unless dilution has taken place
what afstyla contains the active substance is lonoctocog alfa . each vial contains 250 micrograms ( 2 . 5 mg ). each ml of solution for injection contains 100 microgram of lonoectocog aluminiuma . after reconstitution with 2. 5 mg and injections the solution is clear and colourless . the other ingredients are ( see section 2 ). 200 microgram s ( 3 . 0 mg ) loroctocag alfa ( 10 . 0 milligrams ) 1000 microgram ( 5 . 5 millilitres ) injections the suspension is clear , colourless and colour
what praxbind is and what it is used for the active substance in this medicine , idarucizumab , is a recombal agent of dabigatran ( pradaxa ). it is a blood thinner medicine used to prevent blood clot formation . what is used ? what is called " rapid trap dabgatran "? what is the name of the medicine used for ? what are the benefits of using this medicine ? if you are given more medicine than you should you may be at increased risk of being given too much medicine . if you have any further questions on the use of this product , ask
do not take praxbind if you are allergic to idarucizumab or any of the other ingredients of this medicine ( listed in section 6 ). if you have a genetic disease called hereditary fructose intolerance ( hfld ). if this applies to you , do not take the substance sorbitol . warnings and precautions talk to your doctor or pharmacist before taking this medicine . serious adverse reactions have been reported with this medicine in patients taking dabigatran . other medicines may increase the risk of blood clots . dabigATran is a substance that is naturally present in the body and helps to prevent blood cl
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much to use the recommended dose is 5 mg ( 2 . 5 mg ) dabigatran once a day . this medicine will be given to you in a hospital or clinic under the supervision of a doctor experienced in the treatment of blood clot formation . your doctor will decide how long you should be treated . if you have any further questions on the use of this medicine , ask your doctor , pharmacist or nurse .
like all medicines , this medicine can cause side effects , although not everybody gets them . reporting of side effects if you get any side effects talk to your doctor or pharmacist . this includes any possible side effects not listed in this leaflet . you can also report side effects directly via the national reporting system listed in appendix v . by reporting side effects you can help provide more information on the safety of this medicine .
what praxbind contains - the active substance is idarucizumab . - the other ingredients are sodium acetate trihydrate , acetic acid , sorbitol ( e420 ), polysorbate 20 and water for injections . what Praxbind looks like and contents of the pack the hard , clear , colourless to slightly opalescent , slightly yellow solution in a butyl rubber stopper and an aluminium cap .
temomedac contains a medicine called temozolomide . this medicine is an antitumour agent . temomedac is used to treat adults with certain types of brain tumours : - newly - diagnosed glioblastoma multiforme ( gli ) temomedic will be given together with radiotherapy ( concomitant phase of treatment ) and monotherapy phase oftreatment ( phase 3 ). - malignant glioma : - gliotherapy with or without radiotherapy . - anaplastic astrocytoma ( sastrocyticoma ). temormac will be used in combination with
do not take temomedac if you are allergic to temozolomide or any of the other ingredients of this medicine ( listed in section 6 ). if you have had an allergic reaction to dacarbazine ( an anticancer medicine sometimes called dtic ). signs of allergic reaction may include feeling itchy , breathlessness or wheezing , swelling of the face , lips , tongue or throat . if blood cells are severely reduced ( myelosuppression ), your white blood cell count and platelet count may decrease . these blood cells help you in fighting infection and are important for proper blood clotting . temomed
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . dose and duration of treatment your doctor will work out your dose of temomedac based on your height and weight . this is especially important if you have a recurrent tumour that has not responded to chemotherapy treatment in the past and you are taking other medicines ( anti - emetics ) that are not suitable for you . your doctor may decide to reduce your dose , or temporarily stop your treatment , if you experience nausea or vomiting . patients with newly - diagnosed glioblastoma multiforme the duration
like all medicines , this medicine can cause side effects , although not everybody gets them . if you have a severe allergic ( hypersensitive ) reaction , including hives , wheezing or other breathing difficulty , uncontrolled bleeding , seizures , convulsions , fever , chills and severe headache , stop temomedac treatment and tell your doctor straight away . there may be a reduction in certain kinds of blood cells , which may result in increased bruising or bleeding , anaemia ( reduced number of red blood cells ), fever and reduced resistance to infections . the reduction in blood cell counts may be due to aplastic anaemia . your
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the blister after exp . this medicine does not require any special storage conditions . after first opening , the capsules should be used within 30 days . if you notice any change in the appearance of the capsules , do not throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what temomedac contains - the active substance is temozolomide . each tablet contains 5 mg of temozolsomide ( as mesilate ). each tablet of temomedic 20 mg contains 20 mg temozlomide in each tablet . - the other ingredients are : tablet core ( e464b ) temogac 100 mg : 100 micrograms temozoleomide per tablet . temomedoc 140 mg : 140 milligrams temozolateomide is excreted in water for injections . - tablet shell ( including printing ink ). - capsule shell ( containing printing ink ) tem
cialis is a treatment for adult men with erectile dysfunction . this is when a man cannot get , or keep a hard , erect penis suitable for sexual activity . cialis helps to provide a hard erect penis in men who are unable to get , keep or keep an erection when they are sexually stimulated . the medicine contains the active substance tadalafil , which belongs to a group of medicines called phosphodiesterase type 5 inhibitors ( pfms ). ciali works by helping to relax the blood vessels in your penis . this helps your penis to work better and allows you to maintain erectile function .
do not take cialis if you are allergic to tadalafil or any of the other ingredients of this medicine ( listed in section 6 ) if you have been treated with organic nitrate or nitric oxide donors such as amyl nitrite or medicines (" nitrates ") used to treat angina pectoris (" chest pain "). warnings and precautions talk to your doctor , pharmacist or nurse before you are given this medicine if any of these apply to you ( or you are not sure ), ask your doctor or pharmacist for advice before taking nitrate . if you suffer from serious heart disease or have recently
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . cialis tablets are for oral use . swallow the tablets whole with a glass of water . the tablets can be taken with or without food . the recommended starting dose is 5 mg twice a day . your doctor may increase your dose to 2 . 5 mg once a day depending on how you respond to the medicine . if you have any further questions on the use of this medicine , ask your doctor , pharmacist or nurse . how much to take the usual dose is one tablet a day , with or
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects may happen with the medicine : allergic reactions including rashes ( frequency not known ) and chest pain have been reported in patients taking nitrates . the frequency is not known ( frequency cannot be estimated from the available data ). priapsim may cause a prolonged and possibly painful erection . stop taking cialis and get an erection straight away ( see section 4 " warnings and precautions "). contact your doctor immediately if you experience sudden loss of vision . this is of no frequency . other side effects very common ( may affect more than
what cialis contains - the active substance is tadalafil . each 2 . 5 mg film - coated tablet contains a tablet ( tablet ) called " talafil ". - the other ingredients are : tablet core : lactose monohydrate ( see section 2 under ' important information about some of the ingredients '), croscarmellose sodium , hydroxypropylcellulose , microcrystalline cellulose , sodium laurilsulfate , magnesium stearate . film - coating : cellulose ( e460i ) ( e464i ) and hypromellose , triacetin ,
enyglid is an oral antidiabetic medicine containing repaglinide , which helps your pancreas make better use of insulin when your blood sugar is high ( glucose ). type 2 diabetes is a disease in which your body does not make enough insulin to control the sugar in your blood or where your body is not able to use the insulin it produces effectively . enyglide is used to treat type 2 diabetic in adults . treatment is usually started with diet and exercise and weight reduction . your doctor may also increase your dose of metformin if necessary . you should continue to follow your doctor ' s advice on
do not take enyglid : if you are allergic to repaglinide or any of the other ingredients of this medicine ( listed in section 6 ). if you have type 1 diabetes . if the acid level in your blood is too low . if you suffer from diabetic ketoacidosis ( see section 4 ). warnings and precautions talk to your doctor , pharmacist or nurse before you are given this medicine if : you have a severe liver disease . you are taking gemfibrozil ( a medicine used to lower increased fat levels ). you have liver problems . you have moderate liver 28 disease . see section 2
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one 0 . 5 mg tablet once a day . swallow the tablet whole with a glass of water . you can take enyglid with or without food . the usual starting dose is 30 mg twice a day for 4 weeks . your doctor may increase your dose to 30 mg every 16 weeks depending on your response to the medicine . if your blood sugar is too low , you may experience a hypo . do not take a double dose to make up for a forgotten tablet . if
like all medicines , this medicine can cause side effects , although not everybody gets them . hypoglycaemia the most common side effect of enyglid ( may affect up to 1 in 10 people ) is hypoglycasemic reactions . these are generally mild / moderate . however , in some cases , they may be severe and need immediate medical attention . if this happens you may require medical attention or be admitted to a hospital straight away ( see section " warnings and precautions "). if this occurs , you should contact your doctor immediately . if you experience any of the following symptoms : swelling , difficulty in breathing , rapid heartbeat ,
what enyglid contains - the active substance is repaglinide . each tablet contains 0 . 5 mg , 1 mg or 2 mg repagginide . - the other ingredients are microcrystalline cellulose , calcium hydrogen phosphate , anhydrous , croscarmellose sodium , povidone k25 , glycerol , magnesium stearate , meglumine , poloxamer , yellow iron oxide ( e172 ) ( see section 1 under " important information about some of the ingredients "). - the film - coating is yellow ( e1203 ) and contains red iron oxide
azacitidine mylan is an anti - cancer agent . azacitrix mylan works by inhibiting the growth and spread of cancer cells . what is azcitidine yourlan used for ? the name of the medicine is erythromycin . it is a white to off - white , round tablet that is engraved with the company logo on one side of the tablet and the company symbol on the other side . what it is used for the treatment of patients with a stem cell transplantation is used to treat : higher - risk myelodysplastic syndromes ( mds ) chronic my
do not take azacitidine mylan - if you are allergic to azapitidine or any of the other ingredients of this medicine ( listed in section 6 ). - if your doctor has told you that you have advanced liver cancer . warnings and precautions talk to your doctor , pharmacist or nurse before taking this medicine if : you have decreased counts of platelets , red or white blood cells . you suffer from kidney disease . you have liver disease . if you have a heart condition known as heart attack or lung disease . your doctor may ask you to have blood test periodically during treatment . if this happens , your doctor will
before starting azacitidine mylan , you will be given another medicine to prevent nausea and vomiting . the recommended dose is 75 mg once a day . your doctor will tell you how many tablets of this medicine you need to take . the dose will depend on your height and weight . your dose will be adjusted by your doctor . you will usually be given one tablet once a week for 3 weeks before starting this " treatment cycle " ( cycle 4 to 6 ). this medicine is injected under the skin ( subcutaneously ) on the skin of the thigh , tummy or upper arm . if you have any further questions on the
like all medicines , this medicine can cause side effects , although not everybody gets them . tell your doctor straight away if you notice any of the following serious side effects : drowsiness , shaking , jaundice , abdominal bloating and easy bruising . these could be symptoms of liver failure . swelling of the legs and feet , back pain , reduced passing of water , increased thirst , rapid pulse , dizziness , nausea , vomiting , reduced appetite , confusion , restlessness and fatigue . these may be signs or symptoms of kidney failure . a fever may be a sign of an infection . low levels of white blood cells . chest pain
keep this medicine out of the sight and reach of children . do not use azacitidine mylan after the expiry date which is stated on the vial label and the carton after exp . store in a refrigerator ( 2 - 8 ). do not freeze . keep the vials in the outer carton in order to protect from light . after reconstitution , the reconstituted product should be used immediately . if not used immediately , in - use storage times and conditions prior to use are the responsibility of the user and would normally not be longer than 1 hour at 2 to 8 . if the azac
what azacitidine mylan contains - the active substance is azapitidine . one vial of powder contains 100 mg of azacinidine . after reconstitution , 4 ml of water for injections is sufficient . the reconstituted suspension contains 25 mg / ml ( 0 . 5 %) azaciticidine . - the other ingredient is mannitol ( e421 ). see section 2 for further information about some of the ingredients . what azacituidine melan looks like and contents of the pack azacitonidine myl is a white powder supplied in a glass vial containing 100 mg
duotrav eye drop solution contains a combination of two active substances , travoprost and timolol in one drop . travostrost is a prostaglandin analogue , which is used to measure pressure in the eye and to reduce the amount of fluid inside the eye that is too high due to pressure within the eye . duotraveye drops are used to reduce high pressure in your eye due to an illness called glaucoma .
do not take duotrav if you are allergic to travoprost , prostaglandins , timolol , beta blockers or any of the other ingredients of this medicine ( listed in section 6 ). if you have respiratory problems such as asthma , severe chronic obstructive bronchitis , severe lung disease , wheeziness , difficulty in breathing , long - standing cough , breathing problems , severe hay fever , a slow heartbeat , heart failure ( a disorder of heart rhythm ), or if your eye becomes cloudy . if any of these apply to you , tell your doctor . warnings and precautions talk to your doctor before taking du
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one drop in each eye twice a day . do not use duotrav in both eyes at the same time each day . you may need to change the dose to make sure it works for you and your family . do this every day until your doctor tells you otherwise . if you have any further questions on the use of this medicine , ask your doctor , pharmacist or nurse . how much to use the recommended drops are 1 , 2 , 3 , 4 drops in a bottle .
like all medicines , this medicine can cause side effects , although not everybody gets them . stop using duotrav and see a doctor straight away if you notice any of the effects listed below . very common side effects ( may affect more than 1 in 10 people ) effects of the eye eye redness . this is a common side effect that may affect up to 1 in every 10 people . the effect may be increased if the eye surface inflammation is not treated . signs and symptoms include eye pain , blurred vision , abnormal vision , dry eye , itchy eye and eye discomfort . signs or symptoms may include eye irritation , burning and st
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the blister after exp . store below 30 . store in the original package in order to protect from moisture . once opened , duotrav should be used within 4 weeks to prevent infections .
what duotrav contains - the active substances are travoprost and timolol . each vial contains 40 mg of tritonavir . - the other ingredients are propylene glycol , polyoxyethylene hydrogenated castor oil ( 40 mg / ml ), boric acid , sodium chloride , sodium hydroxide , hydrochloric acid , purified water ( e . g . sodiumhydroxide ) and / or water for injections ( see section 2 ). - the acidity levels are also increased ( ph levels ). what duotra looks like and contents of the pack duotrave is a liquid
nplate ' s active ingredient is romiplostim . it is a protein that helps to control low platelet counts in the immune ( idiopathic ) thrombocytopenic purpura ( itp ). itp is a disease in which your body ' s immune system does not produce enough platelets . platelets are important in the blood to prevent blood clots from forming . if you have any of the following conditions , your doctor may want to monitor you more closely , or to reduce the dose of nplate : very lowplatelet counts may lead to bruising or serious bleeding ( see section 1
do not take nplate if you are allergic to romiplostim or any of the other ingredients of this medicine ( listed in section 6 ). if you think you may be allergic , ask your doctor for advice . warnings and precautions talk to your doctor or pharmacist before taking nplate : if you have a low blood platelet count ( thrombocytopenia ). nplate may lower your platelet counts , which may increase the chances of blood clots forming . if you suffer from blood clotting or liver problems . if any of these apply to you ( or you are not sure ), tell your doctor .
always use nplate exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . adults and adolescents ( aged 1 to 17 years ) the recommended dose of nplate is one injection once a week . nplate should be injected every three weeks . your doctor will check your platelet counts regularly . you will also have regular blood samples taken to measure the number of your platelets and the amount of platelet count in your blood . this will help your doctor determine the correct dose for you . the dose you receive will depend on your age and body weight . if you use more nplate
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects have been reported with itp : very common ( may affect more than 1 in 10 people ): headache , allergic reaction , upper respiratory tract infection ( very common ) common : dizziness , tingling , or numbness of the hands or feet ( paraesthesia ) migraine , redness or the skin ( flushing ), blood clot in a lung artery ( pulmonary embolism ) nausea , diarrhoea , abdominal pain , indigestion ( dyspepsia ), constipation , itching of theskin ( pr
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the blister after exp . this medicine does not require any special storage conditions . store in a refrigerator ( 2 - 8 ). do not freeze . after first opening , the product should be used within 30 days .
what nplate contains - the active substance is romiplostim . nplate 125 mg powder for solution for injection : each vial contains 230 micrograms of romplostim ( as 125 mg ). each ml of solution contains 125 microgram of romoplostim in a deliverable amount of 0 . 25 ml solution . each single - dose vial provides either 125 or 300 microgram ( as 375 microgram ) of romemplostim per vial . each two - dose ampoule provides either 250 or 500 microgram (" nplate 500 mg ") romiplustim in the three - dose
this medicine contains an active substance called glycopyrronium bromide , which belongs to a group of medicines called bronchodilators . what tovanor breezhaler is used for this medicine is used to treat breathing difficulties in adults with a lung disease called chronic obstructive pulmonary disease ( copd ). copd causes the muscles around the airways to tighten , making breathing difficult . this medicine works by tightening these muscles in the lungs , making it easier for air to get in and out of the lungs . using this medicine to treat copd reduces the amount of air that gets into your lungs . this
do not use tovanor breezhaler - if you are allergic to glycopyrronium bromide or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before using this medicine if you : - have kidney problems - have an eye problem called narrow - angle glaucoma - have difficulty passing urine . your doctor may decide to reduce your dose or stop treatment . if you think any of these apply to you , tell your doctor or pharmacist immediately . - have tightness of the chest , coughing , wheezing or
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much tovanor breezhaler to use the recommended dose of this medicine is one inhalation every 24 hours . your doctor will tell you how many capsules to use each day . the maximum recommended dose is one 75 mg inhalation per day . this medicine should not be used in combination with another inhaler and capsules ( in blisters ). the medicine should be inhaled through inhalation powder . the capsules should be swallowed whole with water . do not chew , crush or break the capsules .
what tovanor breezhaler contains - the active substance is glycopyrronium bromide . each hard capsule contains 63 micrograms ( 23 . 5 microgram ) glycoprroniumbromide and 50 microgram ( 25 . 3 microgram ). - each delivered dose of glycopyronium is delivered into the mouthpiece of the inhaler delivering a delivered delivered dose ( equivalent to 44 microgram / ml ). - the other ingredients in the inhalation powder are lactose monohydrate , magnesium stearate and water for injections ( see section 2 ). what tovanOR breez
adasuve contains the active substance loxapine and belongs to a group of medicines called antipsychotics . it works by stimulating the brain to produce dopamine and serotonin , which are involved in calming effects and relieving aggressive behaviour . adasuve is used to treat acute symptoms of mild - to - moderate agitation in adults with schizophrenia and bipolar disorder . these are diseases characterised by symptoms such as : ( schizophrenia ) hearing , mistaken beliefs , incoherent speech and behaviour , emotional flatness , depressed , guilty , anxious or tense . ( bipolar disorder ) feeling " high ", having excessive amounts of energy , needing much less sleep
do not take adasuve : - if you are allergic to loxapine or any of the other ingredients of adasve ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before you are given adsasuve if you : - have lung problems like asthma , chronic obstructive pulmonary disease ( copd ), narrowing of the airways ( bronchospasm ), wheeze , cough , chest tightness and shortness of breath 25 - have had neuroleptic malignant syndrome ( nms ), which has been reported with symptoms of antipsychotic medicines . these symptoms include
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is 9 . 1 mg twice a day . your doctor may increase your dose every 2 weeks to 4 . 5 mg depending on your condition . always take adasuve with food , preferably with a glass of water . do not chew , crush or split the tablets . you can also take it with or without food . it is important that you take the tablet with a meal or between meals at the same time each day to help you remember to take it . if you take more adasu
like all medicines , this medicine can cause side effects , although not everybody gets them . tell your doctor straight away if you notice any of the following serious side effects : - any breathing symptoms such as wheezing , cough , shortness of breath , chest tightness , irritating your airways ( asthma or copd ). - light - headedness or fainting . these may be signs that your blood pressure is getting too high . - worsening agitation , confusion , fever and muscle stiffness . these could be signs of a severe condition called neuroleptic malignant syndrome . other side effects include : very common ( may affect more
keep this medicine out of the sight and reach of children . do not use adasuve after the expiry date which is stated on the carton and the blister after exp . this medicine does not require any special storage conditions . store in a refrigerator ( 2 - 8 ). do not freeze . keep the blister in the outer carton in order to protect from light . if you notice any visible sign of physical damage , do not throw away any medicines via wastewater . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what adasuve contains - the active substance is loxapine . each single - dose inhaler contains 5 mg of loxepine . after dilution , each delivered dose delivers a delivered dose of 4 . 5 mg ( 25 micrograms ) in each ml of solution . - the other ingredient is lactose ( lactose ) ( see section 2 ). what adasuves looks like and contents of the pack adsasuve is a white to off - white plastic inhaler with " lh5 " debossed on one side . each inhaler is packed in a sealed foil pouch . adasuvet
azacitidine betapharm contains the active substance azacitine . it is an anti - cancer agent , which belongs to a group of medicines called cytokines . what azasitidinebetapharm looks like and contents of the pack the active ingredient in azacitonidine betabarm is a white to off - white , round , biconvex type of protein . it has been given to you by your doctor or nurse as an injection before a stem cell transplantation in adult patients with higher - risk myelodysplastic syndromes ( mds ) and chronic myelomonocy
do not take azacitidine betapharm - if you are allergic to azapitidine or any of the other ingredients of this medicine ( listed in section 6 ). - if your doctor has told you that you have advanced liver cancer . warnings and precautions talk to your doctor , pharmacist or nurse before taking this medicine if : you have decreased counts of platelets , red or white blood cells . you have kidney disease . your doctor may ask you to have blood tests before and during treatment . you are not sure if any of these applies to you . if you have been previously diagnosed with a heart condition called heart attack
before starting azacitidine betapharm , you will be given another medicine to prevent nausea and vomiting . the recommended dose is 75 mg once a day . your doctor will tell you how many tablets of this medicine you need to take . the dose will depend on your height and weight . you will usually be given one tablet of azaccitidinebetapharm every 3 weeks during this " treatment cycle " ( cycle 4 to 6 ). this medicine is given by injection under the skin ( subcutaneously ) on the skin of the thigh , tummy or upper arm . if you have any further questions on the use of
like all medicines , this medicine can cause side effects , although not everybody gets them . tell your doctor straight away if you notice any of the following serious side effects : drowsiness , shaking , jaundice , abdominal bloating and easy bruising . these may be symptoms of liver failure . swelling of the legs and feet , back pain , reduced passing of water , increased thirst , rapid pulse , dizziness , nausea , vomiting , reduced appetite , confusion , restlessness and fatigue . these could be signs or symptoms of kidney failure . a fever may be a sign of an infection . low levels of white blood cells . chest pain
keep this medicine out of the sight and reach of children . do not use azacitidine betapharm after the expiry date which is stated on the vial label and the carton after exp . store in a refrigerator ( 2 - 8 ). do not freeze . keep the vials in the outer carton in order to protect from light . store below 45 . after reconstitution , the azaconidinebetapharm suspension must be used immediately . if not used immediately , in - use storage times and conditions prior to use are the responsibility of the user and would normally not be longer than 8 hours at 2
what azacitidine betapharm contains - the active substance is azapitidine . each vial contains 100 mg of azacinidine . after reconstitution with 4 ml of water for injections , the reconstituted suspension contains 25 mg / ml azaccitidine . - the other ingredient is mannitol ( e421 ). see section " important information about some of the ingredients " in this leaflet for further information on some of these ingredients . see " other ingredients " below for more information on the contents of this medicine ( see section 4 ). - the solvent for solution for injection is water for
the active substance of cerdelga is eliglustat . it is used for the long term treatment of gaucher disease type 1 in adults . gaucher diseases type 1 is inherited condition in which a substance called glucosylceramide is not removed from the body . this substance is mainly produced by the spleen , liver and bones . when used in combination with another medicine called dexamethasone , it can also be produced by your body . your doctor will test your affected organs to see how well this medicine works . if you have any further questions on the use of this medicine , ask your doctor or pharmacist
do not take cerdelga if you are allergic to eliglustat or any of the other ingredients of this medicine ( listed in section 6 ). if you have been previously treated with medicines called moderate cyp2d6 inhibitors ( e . g . quinidine , terbinafine , 31 ) or with moderatecyp3a inhibitors such as erythromycin or itraconazole . these medicines are used to improve your body ' s ability to use its own blood . warnings and precautions talk to your doctor or pharmacist before you are given the medicine , if any of these apply to you .
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much to take the recommended dose is one tablet of metaboliser twice a day . your doctor will tell you how many tablets to take each day . the dose will depend on how much metaboliser you are taking . swallow the tablets with a glass of water . if you take more cerdelga than you should if you accidentally take more tablets than you were told to , talk to a doctor or go to a hospital straight away . you may experience dizziness , loss of balance and slow heart rate .
like all medicines , this medicine can cause side effects , although not everybody gets them . very common ( may affect more than 1 in 10 people ): headache , dizziness , change in taste ( dysgeusia ), palpitations , throat irritation , heartburn ( dyspepsia ), feeling sick ( nausea ), diarrhoea constipation , abdominal pain , stomach ache ( upper abdominal pain ) acid reflux disease ( gastrooesophageal reflux diseases ) bloating ( abdominal distension ) inflammation of the stomach ( gastritis ) 34 difficulty swallowing ( dysphagia ) vomiting , dry mouth gas ( flat
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the outer carton and on the sleeve after exp . this medicine does not require any special storage conditions . store in the original package in order to protect from moisture .
what cerdelga contains - the active substance is eliglustat . each hard capsule contains 84 mg of eliglustit . - the other ingredients are : capsule content : microcrystalline cellulose , lactose monohydrate ( see section 2 under ' important information about lactose '), hypromellose , glycerol dibehenate . capsule shell : gelatin , potassium aluminium silicate , titanium dioxide ( e171 ), yellow iron oxide ( e172 ), indigotine ( e132 ). printing ink : shellac , black iron oxide , propylene glycol and ammonia solution ( e1520 ). what cer
the active substance in zoledronic acid hospira is zoledoracid , which belongs to a group of substances called bisphosphonates . zoledron acid works by attaching itself to the bone and slowing down the rate of bone change . it is used to prevent bone complications , e . g . fractures , in adult patients with bone metastases ( a type of cancer that affects the primary site of the bone ). it works by reducing the amount of calcium in the blood in these patients . this is known as tumour - induced hypercalcaemia ( tih ).
follow carefully all instructions given to you by your doctor , pharmacist or nurse . your doctor will carry out blood tests before and during treatment with zoledronic acid hospira and regularly during treatment . if you are not sure , talk to your doctor or pharmacist before you are given this medicine . warnings and precautions talk to the nuclear medicine doctor or nurse before you receive this medicine , if you : - are allergic ( hypersensitive ) to any of the active substances in this medicine ( listed in section 6 ). - are breast - feeding . - are intolerant to any other medicine that contains zolingronic acid ( such as another
zoledronic acid hospira will be given to you by a doctor or nurse who is experienced in the use of bisphosphonates intravenously ( into a vein ). ' iv ' administration is recommended in order to reduce the risk of dehydration . how much zoledronic acidic hospira is given the recommended dose is 4 mg per kilogram body weight . if you have a kidney problem , your doctor may decide to lower your dose . if your kidney problem is not well controlled , your dose may be reduced . how often zolingronic acidospira is used in patients with a history of bone complications ( such as bone
like all medicines , zoledronic acid hospira can cause side effects , although not everybody gets them . the following side effects have been reported : common ( may affect up to 1 in 10 people ): severe kidney impairment ( shown in blood tests ) low level of calcium in the blood uncommon ( may effect up to one in 100 people ): pain in the mouth , teeth and / or jaw , swelling or non - healing sores inside the mouth and jaw discharge , numbness or a feeling of heaviness or loosening of a tooth . these may be signs of bone damage in the jaw ( osteonecrosis ). if you
your doctor , pharmacist or nurse knows how to store zoledronic acid hospira properly .
what zoledronic acid hospira contains - the active substance is zedronic acid . one vial of zoledic acid contains 4 mg zoledron acid . - the other ingredients are : monohydrate , mannitol , sodium citrate and water for injections . what zolingronic acidospira looks like and contents of the pack zoledidronic acid hospira is supplied as a liquid concentrate for solution for infusion (' sterile concentrate '). each pack contains 4 ml of concentrate . not all pack sizes may be marketed .
varuby contains the active substance rolapitant . it is used to treat adults with cancer feeling sick ( nauseous ) or being sick ( vomiting ) at the start of cancer treatment chemotherapy . when chemotherapy is given , nerve cells in the brain start growing out of control . this can lead to vomiting . if you feel sick ( vomit ) or are sick ( being sick ) at any time during treatment with varuby , these nerve cells help to control nausea and vomiting .
do not take varuby if you are allergic to rolapitant or any of the other ingredients of this medicine ( listed in section 6 ). if you take an herbal medicine called st john ' s wort ( hypericum performatum ) for depression and difficulty sleeping ( see section 2 " warnings and precautions "). if you have taken this medicine for more than 27 days . if you suffer from severe liver or kidney problems . if any of these apply to you , tell your doctor before taking this medicine . if your doctor has told you to stop taking certain medicines ( e . g . rifampicin , used
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one 180 mg tablet once a day for up to 90 days . swallow the tablet whole with a glass of water . you can take varuby with or without food . take the tablet at least 2 hours before your chemotherapy cycle . your doctor may change your dose or interrupt your dose depending on how you respond to chemotherapy . if you experience sickness or if you feel sickness after taking this medicine , you should contact your doctor immediately . you may be given chemotherapy at the start of another chemotherapy
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects have been reported with varuby : very rare ( may affect more than 1 in 1 , 000 people ): symptoms of an allergic reaction may include sudden shortness of breath , swelling of the lips or tongue , change in taste or swelling of skin or tissue , sudden rash , fever and faster heartbeats . tell your doctor immediately and receive appropriate treatment . other side effects may include : very common : may affect up to 1 in 10 people : headache , constipation , feeling tired uncommon : may affects up to1 in
what varuby contains - the active substance is rolapitant . each tablet contains 90 mg rolapitant . - the other ingredients are : tablet core : lactose monohydrate ( see section 2 under ' varubsy contains lactose '), pregelatinised starch , microcrystalline cellulose , povidone ( k - 30 ), croscarmellose sodium , colloidal silicon dioxide , magnesium stearate . film - coating : polyvinyl alcohol , titanium dioxide ( e171 ), macrogol , polysorbate 80 . tablet coat : blue 100 mg film - coated tablet
what enerzair breezhaler is the active substance in this medicine is indacaterol - glycopyrronium - mometasone furoate ellipticodilators ellipticudilators are used to relax the muscles in the lungs , making it easier for air to get in and out of the lungs . e . g . in adults and children , it belongs to a group of medicines called corticosteroids . steroids are used in adults to reduce the swelling and irritation ( inflammation ) in the small airways in the lung , which can lead to breathing problems and makes it harder for air
do not use enerzair breezhaler if you are allergic to indacaterol , glycopyrronium , mometasone furoate or any of the other ingredients of this medicine ( listed in section 6 ). if you think you may be allergic , ask your doctor for advice . warnings and precautions talk to your doctor or pharmacist before using this medicine if you : - have heart problems - have an irregular or fast heartbeat - have thyroid gland problems or diabetes - have high blood sugar - have seizures - have severe kidney problems , have severe liver problems or have low level of potassium in your blood -
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much to use the recommended dose is one inhaler twice a day . the medicine should be inhaled once a day at about the same time each day . you should inhale enerzair breezhaler every day until your asthma has gone away or your symptoms are controlled by your doctor . how to use and when to inhale the medicine you need to use it is provided in this pack . you will find an inhaler and capsules that contain the medicine . the inhaler contains the medicine
like all medicines , this medicine can cause side effects , although not everybody gets them . some side effects may be serious . stop using enerzair breezhaler and see a doctor straight away if you notice any of the following : very common ( may affect more than 1 in 10 people ): difficulty breathing or swallowing , swelling of the tongue , lips or face , skin rash , itching and hives ( signs of allergic reaction ). other side effects other possible side effects include the following side effects : common : may affect up to 1 in every 10 people : sore throat , runny nose , sudden difficulty breathing , feeling of tight
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the blister after exp . this medicine does not require any special temperature storage conditions . store in the original package in order to protect from light . the capsules should be used within one month after first opening . store the capsules in a refrigerator ( 2 8 ). do not throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what enerzair breezhaler contains - the active substances are indacaterol ( as acetate ), glycopyrronium ( as bromide ) and mometasone furoate . each capsule contains 150 micrograms of the active substance , as well as : 63 microgram ( as ethyl ) of the other ingredients , aspartate glycopyroniumbromide ( 50 microgram ) of each capsule , as part hydrolysis of the two ingredients . each delivered dose ( dose ) contains 160 microgram of the three active substances . - the dose that leaves the mouth
clopidogrel acino pharma gmbh contains the active ingredient clopridogrel which belongs to a group of medicines called antiplatelet medicinal products . platelets ( so - called thrombocytes ) are very small structures , which clump together during blood clotting . by reducing the amount of this clumping in the blood and reducing the chances of blood clots forming ( a process known as thrombo - occlusion ) it helps to prevent the formation of a dangerous blood clump ( also known as atherothrombosis ), which can lead to atheroarthromb
do not take clopidogrel acino pharma gmbh - if you are allergic ( hypersensitive ) to clopridogrel or any of the other ingredients of this medicine ( listed in section 6 ). if you have a medical condition that is currently causing bleeding such as a stomach ulcer or bleeding within the brain . if you suffer from severe liver disease . if any of these apply to you ( or you are in any doubt at all ), talk to your doctor or pharmacist before taking the tablet . warnings and precautions talk to the doctor , pharmacist , or nurse before taking clopidoogrel
always take clopidogrel acino pharma gmbh exactly as your doctor has told you . you should check with your doctor or pharmacist if you are not sure . the usual starting dose is one 75 mg tablet once a day . your doctor may increase your dose to one tablet once daily depending on your condition and on the severity of bleeding you experience . if you have any further questions on the use of this product , ask your doctor , pharmacist or nurse .
like all medicines , clopidogrel acino pharma gmbh can cause side effects , although not everybody gets them . the following side effects have been reported : very common ( affects more than 1 user in 10 ) uncommon ( affects 1 to 10 users in 100 ) rare ( affects less than 1 users in 1 , 000 ) not known ( frequency cannot be estimated from the available data ): rare decrease of some blood cells ( signs of liver problems ) yellowing of the skin and / or the whites of the eyes ( jaundice ), bleeding mainly under the skin ( red pinpoint dots ), confusion ( see section 2
store in the original blister in order to protect from moisture . keep out of the reach and sight of children . do not use clopidogrel acino pharma gmbh after the expiry date which is stated on the carton and on the blister after exp . this medicinal product does not require any special temperature storage conditions . keep the tablet bottle tightly closed in order for it to reach room temperature ( not above 25 ). do not throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help to protect the environment .
what clopidogrel acino pharma gmbh contains - the active substance is clopridogrel ( as mesilate ). each tablet contains 75 mg of clopidaogrel . - the other ingredients are : tablet core : macrogol 6000 cellulose , microcrystalline ( e460 ) crospovidone type a castor oil ( type a ) hydrogenated film - coating : macromol 6000 ethylcellulose ( e462 ) titanium dioxide ( e171 ) 171 what clopidiogrelacino pharma gmbhl looks like and contents of the
delstrigo is used to treat hiv (' human immunodeficiency virus ') infection in adults . it is used in combination with medicines called ' antiretroviral medicines '. the active substances in delstrigo are doravirine , a non - nucleoside reverse transcriptase inhibitor ( nnrti ), lamivudine , which is also a neosinophiline ( also known as " nrti ) and tenofovir disoproxil , which are all known as ' nucleoside analogue reverse transcriptase inhibitor ' ( nri ). del
do not take delstrigo : - if you are allergic to doravirine , lamivudine , tenofovir disoproxil or any of the other ingredients of this medicine ( listed in section 6 . warnings and precautions talk to your doctor , pharmacist , or nurse before taking delstigo . take the following medicines : carbamazepine ( e . g . oxcarbazepine , phenobarbital , phenytoin ( medicines to prevent seizure ) rifampicin and rifapentine ( medicines used to treat tuberculosis ) st . john ' s w
always take delstrigo exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is a complete regimen of a single tablet once a day to treat hiv infection ( 1 tablet a day ). your doctor may change your dose of certain medicines ( e . g . doravirine ) or other medicines that you are taking at the same time . this medicine swallow the tablet whole with a glass of water . you can take this medicine with or without food . if you have any further questions on the use of this medicine , ask your doctor , pharmacist or
like all medicines , this medicine can cause side effects , although not everybody gets them . stop taking this medicine and tell your doctor straight away if you notice any of the following : very common ( may affect more than 1 in 10 people ): abnormal dreams difficulty in sleeping ( insomnia ) headache dizziness sleepiness cough nasal symptoms feeling sick ( nausea ) diarrhoea stomach pain vomiting wind ( flatulence ) hair loss rash muscle symptoms pain ( stiffness ) feeling tired fever blood tests showing increased levels in liver enzymes uncommon ( might affect up to 1 in 100 people ): nightmares , depression , anxiety , irritability , confusion , suicidal thoughts 45 trouble
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the bottle and the carton after " exp ". this medicine does not require any special temperature storage conditions . keep the bottle tightly closed in order to protect from moisture . the bottle should not be re - opened .
what delstrigo contains the active substance is doravirine . each tablet contains 300 mg of lamivudine ( equivalent to 245 mg ). the other ingredients are tenofovir disoproxil ( as fumarate ), croscarmellose sodium e468 , hypromellose acetate succinate , magnesium stearate , microcrystalline cellulose e460 , silica , colloidal anhydrous , sodium stearyl fidarate . a coating material containing carnauba wax e903 . the printing ink contains : - the tablet core contains : â the tablet coating contains
spravato contains the active substance esketamine . it belongs to a group of medicines called anti - depressants . this medicine helps to control your depression and reduces the symptoms of depression such as feeling sad , anxious , worthless , sleeping difficulties , change in appetite , loss of interest in favourite activities and feeling of being slowed down . spravato can be used alone or in combination with another antidepressant ( see section 2 , " antidepressant medicines ").
do not take spravato if you are allergic to esketamine or any of the other ingredients of ketamine ( listed in section 6 ). if you have had an aneurysm ( a weak spot in a blood vessel wall that bulges out ) or bleeding in the brain . if you recently had a heart attack . within 6 weeks of starting treatment . if this happens , you may experience a temporary increase in blood pressure . serious complications in these conditions may occur . if any of these apply to you , tell your doctor or pharmacist before you are given this medicine . warnings and precautions talk to your doctor before taking
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the spravato nasal spray is for oral use only . the nasal spray device should be used within 1 hour . use in children and adolescents the recommended dose is 2 to 3 nasal spray devices per day . this means that you should use at least one spray device per day for at least 4 hours . you should not use more than 4 sprays per day , unless instructed by your doctor . if you have any further questions on the use of this medicine , ask your doctor , pharmacist or nurse .
like all medicines , this medicine can cause side effects , although not everybody gets them . tell your doctor straight away if you notice any of the following side effects : very common ( may affect more than 1 in 10 people ): feeling disconnected , feelings and things around you feeling dizzy headache change in sense of taste feeling sleepy decreased feeling or sensitivity of the mouth area spinning sensation ( vertigo ) vomiting nausea very common : may affect up to 1 in every 10 people : feeling extremely happy ( euphoria ), feeling agitated , feeling anxious , eyes or ears , sense of touch are deceived or mimicked , irritable panic attacks , change
what spravato contains - the active substance is esketamine . one ml of each nasal spray device contains esketam hydrochloride equivalent to 28 mg esketa . - the other ingredients are citric acid monohydrate disodium edetate sodium hydroxide ( for ph adjustment ) water and water for injections . see section 2 for further information about some of the ingredients of this medicine ( see section 4 ). what spraveato looks like and contents of the pack spravatos is a nasal spray solution . this medicine is a clear , colourless solution supplied in a single - use nasal spray unit . sp
zelboraf is an anticancer medicine that contains the active substance vemurafenib . it is used to treat adult patients with melanoma that has spread to other parts of the body or cannot be removed by surgery . this type of cancer has a change ( mutation ) in a gene responsible for the growth of melanoma . zelinboraf targets proteins that are involved in the growth and spread of your cancer .
do not use zelboraf - if you are allergic to vemurafenib or any of the other ingredients of this medicine ( listed in section 6 ). symptoms of allergic reactions may include swelling of the face , lips or tongue , difficulty breathing , rash and fainting sensation . if any of these apply to you , tell your doctor or pharmacist . warnings and precautions talk to your doctor , pharmacist or nurse before you are given this medicine . allergic reactions if allergic reactions occur while you are being treated , or after you have been treated with any other medicine , please contact your doctor immediately . if you experience any
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one 4 mg tablet once a day for up to 8 weeks . if you take more than 4 tablets a day , your doctor may reduce your dose to 4 tablets per day , depending on the severity of side effects and how you respond to your treatment . taking zelboraf if you experience vomiting , take it as soon as you remember and then take your next tablet at its usual time . do not take more tablets than your doctor tells you to . take the tablet at the same
like all medicines , zelboraf can cause side effects , although not everybody gets them . serious allergic reactions such as swelling of the face , lips or tongue difficulty breathing rash fainting sensation have been reported in patients treated with the combination of the two active substances , zelfboraf and radiation treatment . tell your doctor immediately if you experience any of the following symptoms : skin rash , blistering , peeling , discoloration of the skin shortness of breath , a cough , fever or chills ( pneumonitis ) difficulty or pain when swallowing , chest pain , heartburn or acid reflux ( esoph
your doctor , pharmacist or nurse knows how to store zelboraf properly . these measures will help to protect the environment .
what zelboraf contains - the active substance is vemurafenib . each film - coated tablet contains 240 mg of vemurabenib ( as a co - precipitate of valsartan ). - the other ingredients are : tablet core : hypromellose acetate succinate , colloidal anhydrous silica , croscarmellose sodium , hydroxypropyl cellulose , magnesium stearate film - coating : iron oxide ( e172 ), macrogol 3350 , polyvinyl alcohol , talc and titanium dioxide ( e171 ). printing ink : shellac . what
duoplavin contains clopidogrel and acetylsalicylic acid ( saa ) and belongs to a group of medicines called antiplatelet medicinal products . platelets are very small structures in the blood , which clump together during blood clotting . by preventing this clumping , blood vessels relax and blood can be formed . by reducing the number of these thinning layers , antiplatelets medicinal products reduce the chances of blood clots forming ( a process called atherothrombosis ). by lowering the amount of a thin layer of blood that can form ( asa ) in hardened arteries , at
do not take duoplavin if you are allergic to clopidogrel , acetylsalicylic acid ( arsa ) or any of the other ingredients of this medicine ( listed in section 6 ). if you think you may be allergic to other products called non - steroidal anti - inflammatory products . if you have painful and / or inflammatory conditions of muscles or joints ( for example , a medical condition called asthma , nasal discharge , runny nose , polyps ( a type of growth in the nose ) or if you currently have a risk of bleeding such as a stomach ulcer or bleeding within the brain .
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much to take the recommended dose of duoplavin is one tablet a day . take your medicine at the same time each day . do not take more than your doctor tells you to . if you have a heart attack , take the tablet as soon as you remember and then take your next tablet at the usual time . if more than one tablet has been taken , contact your doctor , pharmacist or your nearest hospital emergency department because of the increased risk of bleeding . how long to take duop
like all medicines , this medicine can cause side effects , although not everybody gets them . contact your doctor immediately if you experience : - fever , signs of infection or extreme tiredness . these may be due to rare decrease of some blood cells . - signs of liver problems such as yellowing of the skin or the whites of the eyes ( jaundice ), bleeding which appears under the skin as red pinpoint dots and / or confusion ( see section 2 ' warnings and precautions '). - swelling in the mouth or skin disorders such as rashes and itching , blisters of theskin . these could be the signs of an allergic reaction
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the blister after exp . store below 25 . store in the original package in order to protect from moisture . this medicine does not require any special temperature storage conditions . if you notice any visible sign of deterioration , do not throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help to protect the environment .
duoplavin 75 mg film - coated tablets 46 the active substances are clopidogrel and acetylsalicylic acid ( arsa ). each 75 mg tablet contains clopridogrel ( as hydrogen sulphate ). the other ingredients are : 75 mg : the active substance is clopin ( as hydroxypropylcellulose ). the ingredients are mannitol ( e421 ), macrogol 6000 , microcrystalline cellulose ( e460 ), low substituted hydroxy propylcellularose ( type a ), maize starch , hydrogenated castor oil ( see section 2 ' duop
simbrinza contains two active substances called brinzolamide and brimonidine tartrate . brin zolamide belongs to a group of medicines known as carbonic anhydrase inhibitors . brimidine titrate is a substance produced in the body that binds to receptors in the blood called alpha - 2 adrenergic receptor agonists . this results in an increase in pressure within the eye . simbrinz is used in the eyes of children and adolescents ( aged 18 years and older ) to treat eye conditions such as glaucoma , ocular hypertension and high pressure on the surface of the eyes .
do not take simbrinza if you are allergic to brinzolamide , brimonidine tartrate or any of the other ingredients of this medicine ( listed in section 6 ) if you think you may be allergic to sulphonamides ( a group of medicines used to treat diabetes and infections ), diuretics ( water tablets ) or a monoamine oxidase ( mao ) inhibitors ( medicines used in the treatment of depression or parkinson ' s disease ). if you take certain antidepressants , please tell your doctor before taking any antidepressant medicines . if you have severe kidney problems or have too much acidity in your
always use this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . simbrinza should be used in both eyes and in the eyes . wash your hands thoroughly with soap and water ( see section 1 , " simberza contains sodium " and " water for injections " and section 2 ). remove the cap and snap collar from the bottle . hold the medicine between your fingers . tilt your head back . pull down the eyelid with a clean finger until there is a ' pocket ' between the eyeball and the eye . gently squeeze the drop
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects may happen with this medicine : if you have a reaction to the medicine ( frequency not known ): signs of an allergic reaction may include severe skin reactions , rash , redness or itching all over your body , eyes trouble breathing , chest pain , irregular heart beat , tell your doctor immediately extreme tiredness or dizziness . other side effects that have been reported with simbrinza in combination with other medicines called brinzolamide or brimonidine : common side effects ( may affect up to 1 in 10 people )
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the bottle and the carton after " exp ". this medicine does not require any special storage conditions . store in a refrigerator ( 2 - 8 ). do not freeze . keep the bottle tightly closed in order to protect from light . after first opening , use within 4 hours to prevent infections . if you use more simbrinza than you should a new bottle should be used immediately . if not used immediately , in - use storage times and conditions prior to use are the responsibility of the user and would
what simbrinza contains - the active substances are brinzolamide and brimonidine tartrate . each ml of suspension contains 10 mg of brin zolamide ( corresponding to 2 mg of bimonidine titrate equivalent to 1 . 3 mg / ml ) of bromonidine . - the other ingredients are benzalkonium chloride ( see section 2 under ' important information about some of the ingredients of the suspension '). - the ingredients in the suspension are propylene glycol , carbomer 974p , boric acid , mannitol , sodium chloride , tyloxapol , hydro
what filgrastim ratiopharm is and what it is used for the treatment of cancer in adults , adolescents and children is a combination of two active substances , filgrasterim and a protein called escherichia coli . it is a natural protein produced by biotechnology in the body called granulocyte - colony stimulating factor ( gsffr ). filgrasteim works by encouraging the bone marrow to produce new blood cells . more blood cells are needed than white cells . white cells are important as they help your body fight infection . what is the use of filgraspim ratisopharm ? fil
you must not be given filgrastim ratiopharm : if you are allergic ( hypersensitive ) to peanut or soya or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before you are given this medicine . if you have ever had a cough , fever or difficulty breathing , as this may be a symptom of a pulmonary disorder . tell your doctor straight away if you notice any of these side effects . sickle cell disease 57 if you get left upper abdominal pain ( pain at the tip of your shoulder ) as this could be a
filgrastim ratiopharm will be given to you by a doctor or nurse who is experienced in the care of patients who are not able to take the medicine . your doctor will explain to you how to take and when you can take it . how much filgrasterim ratiopharm you will receive filgrasteim ritimopharm treatment in combination with chemotherapy . the usual starting dose is 0 . 5 mg per kilogram body weight once daily for up to 60 days , followed by 30 days of rest . your treatment will last approximately 14 days . some disease types may be more severe than others
you must not be given filgrastim ratiopharm : if you have sickle cell disease 57 if you get left upper abdominal pain or pain at the tip of your shoulder . if you suffer from a spleen disorder ( see section 4 . possible side effects ). your doctor will do regular blood tests before and during treatment with filgrasteim ratisopharm to check the number of neutrophils ( a type of white blood cells ) in your blood . your doctor may also check your blood at regular intervals during treatment . children and adolescents this medicine is not recommended for use in children or adolescents . other medicines
keep out of the reach and sight of children . do not use filgrastim ratiopharm after the expiry date which is stated on the carton and on the blister after exp . store in a refrigerator ( 2 8 ). do not freeze . filgrasteim ratisopharm should not be used if the solution is cloudy or contains particles . medicines should not throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help to protect the environment .
what filgrastim ratiopharm contains - the active substance is filgrasterim . each ml of solution for infusion contains 60 mg of filgrasim . - the other ingredients are water for injections ( see section 2 . filgrasteim ratisopharm with sodium hydroxide , glacial acetic acid , sorbitol ( e420 ), polysorbate 80 ( e433 ). - the concentrate for solution for injections is a clear , colourless to pale yellow solution . the ingredient sphincter is contained in a clear glass vial ( 0 . 8 ml ) with filgr
what riluzole zentiva is and what it is used for the active substance in this medicine is called rilanuzole . it belongs to a group of substances called cytokines , which are involved in the nervous system and play an important role in controlling body movements and movements . what rilsuzole ventiva looks like and contents of the pack riluxole zertiva is used to treat amyotrophic lateral sclerosis ( mds ) in adult patients with motor neurone disease . mds affects the nerve cells responsible for sending signals to the muscles , causing weakness , muscle waste and paralysis . m
do not take riluzole zentiva if you are allergic to rilizole or any of the other ingredients of this medicine ( listed in section 6 ). if you have any liver disease or increased blood levels of some enzymes of the liver called transaminases . if you think you may be pregnant or are planning to have a baby , ask your doctor for advice before taking this medicine . warnings and precautions talk to your doctor , pharmacist or nurse before taking any of these medicines : if you get yellowing of your skin or the whites of your eyes ( jaundice ), itching , feeling sick or being sick
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one tablet once a day . the tablets should be taken by mouth at least 12 hours apart . if you take more riluzole zentiva than you should contact your doctor , pharmacist or your nearest hospital emergency department immediately . take the tablet pack with you . do not take a double dose to make up for a forgotten dose . you can take the tablets with or without food . it is important that you carry on taking this medicine for as long as prescribed by your doctor
like all medicines , this medicine can cause side effects , although not everybody gets them . contact your doctor immediately if you experience : fever ( increase in temperature ) during treatment with riluzole zentiva . this may be due to a decrease in the number of white blood cells . your doctor will take a blood sample to check for these changes . if you notice any of the following symptoms : yellowing of your skin or the whites of your eyes ( jaundice ), itching , feeling sick or being sick . these may be signs of liver disease ( hepatitis ). your doctor may do regular blood tests while you are taking r
what riluzole zentiva contains - the active substance is rilanuzole . - the other ingredients are : tablet core : anhydrous dibasic calcium phosphate , micro crystalline cellulose ( e460i ), an hydrous colloidal silica , magnesium stearate . tablet coating : croscarmellose sodium , hypromellose , macrogol 6000 , titanium dioxide ( e171 ). not all the ingredients in the tablet core may be present in the solution or may be harmful to other people . do not shake the tablet vigorously as this may affect its action . what ril
emgality contains the active substance galcanezumab . this is a medicine that blocks the activity of a protein called calcitonin gene ( cgrp ). migraine is a condition in which the body does not produce enough of the protein . increased levels of crgrp can lead to migraine . emgality is used to treat migraine in adults , adolescents and children aged 4 years and older . migraines have been reported in these patients , but the frequency of migraine headache has not been estimated from the available data . your doctor has recommended that emegality be used every day to improve your quality of life
do not take emgality if you are allergic to galcanezumab or any of the other ingredients of this medicine ( listed in section 6 ). if you have a serious cardiovascular disease warnings and precautions talk to your doctor , pharmacist or nurse before taking this medicine , as serious cardiovascular diseases can be life - threatening and can be fatal . allergic reactions emegality may cause serious allergic reactions . these reactions may occur within 40 minutes of a serious allergic reaction . if such signs occur , tell your doctor straight away as you may be at increased risk of side effects ( see section 4 . possible side effects ). children and
always use emgality exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is 240 mg once daily . your doctor will decide how many days you need to take emgally . emegality is injected under your skin ( subcutaneous injection ). your doctor may decide to change the dose depending on your response and response to your emgonality injection . after proper training , you should receive the 240 mg dose as soon as possible . do not take a double dose to make up for a forgotten dose . if you have any further questions on the use of
like all medicines , this medicine can cause side effects , although not everybody gets them . serious side effects allergic reactions to emgality may include rash and itching . serious allergic reactions ( rare , may affect up to 1 in 1 , 000 people ): difficulty breathing or swallowing , low blood pressure , dizziness or light - headedness , swelling of the neck , face , mouth , lips , tongue or throat , severe itching of the skin , with a red rash and raised bumps . other side effects tell your doctor or pharmacist if you notice any of the following : very common side effects ( may affect more than 1 in 10 people
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the blister after exp . store in a refrigerator ( 2 - 8 ). do not freeze . after first opening , the product may be stored for up to 7 days at room temperature ( up to 30 ) before being used . this medicine does not require any special temperature storage conditions .
what emgality contains - the active substance is galcanezumab . each pre - filled pen contains 120 mg of galcanesumab in 1 ml of solution . - the other ingredients are l - histidine , l- histidine hydrochloride monohydrate , polysorbate 80 , sodium chloride and water for injections . what emgonality looks like and contents of the pack emgalis is presented as a solution for injection in a clear glass syringe . the solution is colourless to slightly yellow . the syringe is supplied in single - dose pen of 1 ml , 2 ml or 3
defitelio is a medicine that contains the active substance defibrotide . it is used to treat a condition called hepatic veno - occlusive disease ( hepatic ) in which the blood vessels in the liver become damaged and clogged with blood clots . it has been given to you by your doctor or nurse in combination with medicines you have received prior to a stem cell transplantation . your doctor will test for the presence of a substance in the blood and will decide if defibroide is suitable for you . if you have any further questions on the use of this medicine , ask your doctor ,
do not use defitelio if you are allergic to defibrotide or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before using this medicine if : you have a history of blood clots ( tissue plasminogen activator warnings ) you are taking medicine to prevent bleeding ( for example , if you have heavy bleeding after a blood transfusion or surgery ) you have problems with blood circulation or a constant blood pressure ( see section 1 ) you take other medicines to prevent blood clotting ( e . g . acetylsalicy
the treatment with defitelio will be started by a doctor who is experienced in the use of stem cells transplantation . it will be given by infusion into one of your veins ( known as an ' intravenous infusion ') or drip . the duration of this treatment is 21 days . if your symptoms do not improve after this 21 day period , your doctor may decide to reduce your dose . if you have any further questions on the use or use of this medicine , ask your doctor or pharmacist . children and adolescents do not give this medicine to children under 18 years of age because there is no experience in this age group
like all medicines , defitelio can cause side effects , although not everybody gets them . if you get any of the side effects listed below , stop taking the medicine and contact your doctor immediately . very common ( may affect more than 1 in 10 people ): low blood pressure common : may affect up to 1 in every 10 people bleeding in general bleeding including the nose bleeding in the brain bleeding from the gut vomiting blood bleeding from one or more of the lungs bleeding from blood in the urine or the mouth bleeding from any part of the skin coagulopathy ( disturbance in blood clotting ) nausea vomiting diarrhoea rash itching
keep this medicine out of the sight and reach of children . do not use defitelio after the expiry date which is stated on the outer carton and on the vial label after exp . this medicine does not require any special storage conditions . the infusion storage should be completed within 24 hours of dilution . if not used immediately , in - use storage times and conditions prior to use are the responsibility of the user and would normally not be longer than 2 hours at 2 - 8 unless dilution has taken place in controlled and validated aseptic conditions . if you notice that the solution is cloudy or contains particles ,
what defitelio contains - the active substance is defibrotide . each ml of 2 . 5 ml solution contains 200 mg of defibrojectide . - the other ingredients are sodium citrate dihydrate , hydrochloric acid and sodium hydroxide ( for ph - adjustment ) and water for injections ( see section 2 " defitelsio contains sodium "). - the solvent for solution for infusion is a clear , colourless to pale yellow solution . each 10 ml vial contains 2. 5 mg of concentrate .
daklinza contains the active ingredient daclatasvir . hepatitis c is an infectious disease that affects the liver caused by the hepatitis c virus . this medicine is used to treat adults with hepatitis c when the body is unable to eliminate the virus from its blood . daklinz is used in combination with other medicines to treat hepatitis c infection . the other medicines that you will be given are : - tablets that contain the active substance daplinza . - medicines that lower the amount of the virus in your blood . - tablets which increase the number of hepatitis c cells in your body . these include those that are
do not take daklinza - if you are allergic to daclatasvir or any of the other ingredients of this medicine ( listed in section 6 ) - if your doctor has told you to take a tablet by mouth with or without food . if you take the following medicines : phenytoin , carbamazepine , oxcarbazepine and phenobarbital ( used to prevent epileptic seizures ) rifampicin , rifabutin and rifapentine ( antibiotics to treat tuberculosis ) dexamethasone ( a steroid used to treat allergic and inflammatory diseases )
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose of daklinza is one 60 mg tablet once a day . do not chew , crush or chew the tablet as this may have an unpleasant taste . your doctor will tell you how long you should continue to take this type of medicine . some other medicines may be more suitable for you . if you have any questions about how long to continue with this , ask your doctor , pharmacist , or nurse . how much to take your doctor may prescribe other medicines to treat hepatitis c infection .
like all medicines , this medicine can cause side effects , although not everybody gets them . daklinza in combination with sofosbuvir and ribavirin has been associated with the following side effects : very common ( may affect more than 1 in 10 people ): headache fatigue common : may affect up to 1 in every 10 people : difficulty sleeping dizziness migraine nausea ( feeling sick ) diarrhoea abdominal pain joint pain aching or tender muscles have been reported in patients treated with either of the two active substances ( dakhlinza alone or in combination of sofosebuvir or ribavir ). other side
what daklinza contains - the active substance is daclatasvir . each film - coated tablet contains 30 mg or 60 mg of daclaasvir ( as dihydrochloride ). - the other ingredients are : tablet core : anhydrous lactose , microcrystalline cellulose , croscarmellose sodium , silicon dioxide , magnesium stearate , hypromellose , titanium dioxide ( e171 ), macrogol 400 , indigo carmine aluminum lake ( e132 ), yellow iron oxide ( e172 ) and 51 film - coating : daklineza 30 mg film
proquad is a vaccine to protect against measles , mumps , rubella and chickenpox ( varicella ) viruses . when a person is given the vaccine , the immune system ( the body ' s natural defence system ) will produce its own protection ( antibodies ) against the diseases that cause them . in mumps and rubella , it can be given to individuals who are already infected with varicellis viruses . the antibodies help to prevent diseases caused by these viruses . proquad is given to adults and adolescents from 9 years of age and older . it is given in national vaccination schedules . measles is caused by
do not receive proquad if you are allergic to any varicella vaccine , measles , mumps or rubella vaccine , or any of the other ingredients of this vaccine ( listed in section 6 ) if you have a blood disorder ( a type of cancer that affects the immune system ) if treatment with medications that suppress your immune system ( e . g . low - dose corticosteroid therapy , asthma or replacement therapy ) if your child has a weakened immune system or a disease ( including aids ) with congenital or hereditary immunodeficiency ( immune competence ) if he / she has active untreated tuberculosis . if your
proquad is given by injection into a muscle ( subcutaneously ) under the skin ( usually in the thigh or upper arm ). injections will be given into the muscle of the thigh area or into the upper arm . if you have a blood clotting disorder due to low levels of platelets , the vaccine should not be given under your skin , as this may increase the risk of bleeding from the muscle . proquad will be injected into a blood vessel . the recommended dose of proquad is 9 micrograms per injection . children and adolescents from 9 to 12 years of age there is no experience with chickenpox or measles .
like all vaccines and medicines , this vaccine can cause side effects , although not everybody gets them . allergic reactions ( hives ) these reactions may cause difficulty in breathing or swallowing . if you experience signs of an allergic reaction , contact your doctor immediately . other side effects that have been reported with proquad include : very common ( may affect more than 1 in 100 people ): seizures ( fits ) with a fever . rare ( likely to affect up to 1 in 1 , 000 people ): bronchiolitis ( difficulty breathing , cough , unsteadiness with walking ). other possible side effects of proquad are listed below . very common :
what proquad contains - the active substances are : measles virus1 , edmonston strain , 3 . 00 mg mumps virus1 ( jeryllynnâ¢ level b ) strain , 4 . 30 mg rubella virus2 , strain 3 .00 mg varicella virus3 , merck strain ( 3 . 99 mg mrc ) - the other ingredients are : powder sucrose , hydrolysed gelatin , urea , sodium chloride , sorbitol ( e420 ), monosodium glutamate , sodium phosphate , sodium bicarbonate , potassium phosphate , potassium chloride 199 and hanks ' salts ( mem , ne
jylamvo is an anticancer medicine used to prevent unwanted reactions from occurring . it is an immunosuppressive agent . it acts as an anti - inflammatory effect jylimvo is used for the treatment of rheumatic and skin diseases : active rheumatoid arthritis with polyarthritic forms in the joints severe juvenile idiopathic arthritis ( jia ) in children and adolescents ( 3 years of age and older ) who have not been previously treated with non - steroidal anti -inflammatory drugs ( nsaids ) and who have inadequate o severe or disabling psoriasis . treatment is usually started with
do not use jylamvo if you are allergic to methotrexate or any of the other ingredients of this medicine ( listed in section 6 ). if you have a severe kidney impairment or a liver impairment . if you suffer from blood disorders ( e . g . bone marrow hypoplasia , leukopenia , thrombocytopenia , significant anaemia ). if 34 you have or have ever had a weakened immune system , a serious infection such as tuberculosis or hiv , ulcers in the stomach or intestines , an inflammation of the mucous membrane of the mouth or mouth ulcers . if
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . jylamvo can cause severe side effects , sometimes leading to even death . the treatment should be initiated under the supervision of a doctor experienced in the treatment of rheumatoid arthritis , severe juvenile idiopathic arthritis and severe psoriasis . if you have severe psoriatic arthritis , your doctor may recommend that you start jylimvo as a long - term treatment . your doctor will decide whether you should continue to use the medicine for rheumatic and skin diseases such as j
like all medicines , this medicine can cause side effects , although not everybody gets them . contact your doctor immediately if you experience : wheeziness , difficulty in breathing , swelling of the eyelids , face or lips , rash and itching all over your whole body . other possible side effects include breathing problems , feeling of illness , dry , irritating cough , shortness of breath , difficulty or breathing , chest pain ( fever ), spitting or coughing blood , serious peeling or blistering of the skin unusual bleeding ( vomiting blood ), bruising nose bleeds nausea , vomiting , abdominal discomfort severe diarrhoea mouth ulcers , black or tarry
keep this medicine out of the sight and reach of children . do not use the medicine after the expiry date which is stated on the carton and on the vial label after exp . the expiration date refers to the last day of that month . store below 25 . store in the original package in order to protect from light . the medicine should be used immediately after dilution . accidental spillage may occur within 3 hours . any unused medicine or waste material should be disposed of in accordance with local requirements for cytotoxic products .
what jylamvo contains - the active substance is methotrexate . each ml of solution contains 2 mg of methotroxybenzoate . - the other ingredients are macrogol 400 mg , glycerol , orange flavour , sucralose , ethyl parahydroxybenzzoate ( e218 ), sodium methyl parahydroxybenze ( e219 ), citric acid , tri - sodium citrate , purified water ( see section 2 " jylimvo contains ethyl parahydroxybenzoates and sodium methyl parahhydroxy benzoate "), and water for injections
this medicine contains the active substance glycopyrronium bromide , which belongs to a group of medicines called bronchodilators . this medicine is used to treat breathing difficulties in adults with a lung disease called chronic obstructive pulmonary disease ( copd ). in copd , the muscles around the airways tighten , making breathing difficult . using this medicine helps to stop this tightening of these muscles in the lungs , making it easier for air to get in and out of the lungs . your doctor has prescribed this medicine to help reduce the effects of copd on your everyday life .
do not use enurev breezhaler : if you are allergic to glycopyrronium bromide or any of the other ingredients of this medicine ( listed in section 6 ). if you suffer from kidney problems . if you have an eye problem called narrow - angle glaucoma ( difficulty passing urine ). if any of these apply to you ( or you are not sure ), talk to your doctor or pharmacist before using this medicine . tell your doctor immediately if you experience tightness of the chest , coughing , wheezing or breathlessness . these may be signs of bronchospasm ( difficulties in
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much to use the recommended dose is one inhalation once a day . this medicine can be used for up to 24 hours at room temperature ( up to 75 ). do not change the dose unless your doctor tells you to . do not use more than the recommended dosage of this medicine . how to inhale this medicine use an inhaler and capsules ( in blisters ). inhale the medicine using inhalation powder . the capsules should be swallowed whole with water . use the inhaler provided in this pack
like all medicines , this medicine can cause side effects , although not everybody gets them . some side effects may be serious : very common ( may affect more than 1 in 100 people ) irregular heart beat high level of blood sugar ( hyperglycaemia ) typical symptoms are excessive thirst or hunger ( frequent urination ) rash , itching , hives , difficulty breathing or swallowing dizziness allergic reaction swelling mainly of the tongue , lips , face or throat ( angioedema ) if any of the side effects gets serious , stop taking enurev breezhaler and tell your doctor straight away . other side effects include some side
what enurev breezhaler contains - the active substance is glycopyrronium bromide . each hard capsule contains 63 micrograms of glycoprroniumbromide ( equivalent to 50 microgram glycopyronium ). - the delivered dose is delivered into the mouthpiece of the inhaler . each delivered dose delivers 44 microgram ( 3 . 5 microgram ) per kilogram of body weight . - the other ingredients in the inhalation powder are lactose monohydrate and magnesium stearate ( see section 2 under ' enuringv breezy inhaler contains lactose ').
riximyo contains the active substance " rituximab ". this is a type of protein called a " monoclonal antibody ". it sticks to a specific target in a certain type of white blood cell called " b - lymphocyte ". by sticking to the target of the protein , riximyo slows down the rate at which the cell dies . this is called " growth inhibition ". your doctor will test your body ' s immune system to see if it is working properly . this will depend on how well your body is working and on how your body responds to the treatment . your doctor may decide to give you
do not use riximyo - if you are allergic to rituximab , other proteins , or any of the other ingredients of this medicine ( listed in section 6 ). if you have a severe active infection at the moment . if you suffer from a weak immune system . warnings and precautions talk to your doctor , pharmacist or nurse before you are given this medicine if : you have severe heart failure or severe uncontrolled heart disease . you have granulomatosis , polyangiitis , microscopic polyangaiitis or pemphigus vulgaris . if any of these apply to you , tell your
your doctor will give you riximyo under the supervision of a doctor experienced in the use of this treatment . always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . if you have any side effects , talk to your doctor , pharmacist or nurse before you are given this medicine . how and when to use your doctor will decide on the dose you need and how often you need to use it . it is very important that you are able to use rximyo as a drip ( intra - venous infusion ) into a vein . medicines given before
like all medicines , this medicine can cause side effects , although not everybody gets them . most side effects are mild to moderate . however , some may be serious and require treatment . some of these reactions have been fatal . infusion reactions during the first 24 hours of the infusion , fever , chills , shivering , pain at the infusion site , blisters , itching , sickness , nausea , tiredness , headache , breathing difficulties , blood pressure raised , wheezing , throat discomfort , tongue or throat swelling , itchy , runny nose , vomiting , flushing , palpitations , heart attack , low number of platelets
what riximyo contains - the active substance is rituximab . each 10 ml vial contains 100 mg of ritukimab ( 10 mg / ml ). each 50 ml vials contains 500 mg ritudimab in 10 ml of solution . - the other ingredients are sodium citrate , polysorbate 80 , sodium chloride , sodium hydroxide and hydrochloric acid ( see section 2 " important information about some of the ingredients ") and solvent for solution for infusion . - in 2 ml glass vials , each pack contains 3 vials . pack sizes of 1 and 2
topotecan actavis is a medicine that contains the active substance topotecaan . it is used to treat adult patients with the following conditions : - small cell lung cancer that has come back after chemotherapy - advanced cervical cancer that cannot be treated with surgery or radiotherapy . in this case topotecen actavis treatment is combined with medicines containing cisplatin .
do not take topotecan actavis - if you are allergic to topoteecan or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before you are given this medicine : - if your blood cell counts are too low . your doctor may decide to lower your dose or stop you from taking toprotecanactavis if you have any kidney problems . if you think any of these apply to you , tell your doctor or pharmacist as soon as possible . do not stop taking toptopecan actingavis unless your doctor tells you
the dose of topotecan actavis you receive will depend on the disease being treated and on the results of blood tests carried out before and during treatment . the usual dose of treatment for adults small cell lung cancer is 1 . 5 mg per square metre of body surface area for the first 5 days of this treatment cycle . for cervical cancer , your doctor may increase your dose to 0 . 75 mg / m2 of bodysurface area once every 3 days during thistreatment cycle . if you have cervical cancer that has not responded to another anticancer medicines ( such as cisplatin ), your doctor will reduce your dose of cis
like all medicines , this medicine can cause side effects , although not everybody gets them . serious side effects stop taking topotecan actavis and tell your doctor straight away if you notice any of the following serious sideeffects : infections very common ( may affect more than 1 in 10 people ): fever . your general condition may include local symptoms such as sore throat , burning sensation , severe stomach pain , fever , diarrhoea and bowel inflammation ( neutropenic colitis ). your doctor may reduce the dose you receive or temporarily stop your treatment with topotecaanactavis , temporarily reducing your ability to fight infections . lung inflammation
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the outer carton and on the vial label after exp . store in a refrigerator ( 2 8 ). do not freeze . the drug product solution should be used immediately after reconstitution and dilution chemical and physical in - use stability has been demonstrated for 24 hours at room temperature ( up to 25 ) and at 2 to 8 oc . from a microbiological point of view , the product should be administered immediately after dilution . if not used immediately , in - used storage times and conditions
what topotecan actavis contains - the active substance is topofecan . each 1 ml ampoule contains 4 mg topotan ( as hydrochloride ). after reconstitution with 1 ml of water for injection , 1 mg / ml ( 0 . 5 %) topotecaan is also contained in the ampoules . - the other ingredients are mannitol ( e421 ), tartaric acid , hydrochloric acid and sodium hydroxide ( see section 2 under ' contents of the pack '), grey bromobutylic stopper and aluminium seals with plastic flip - off
the active substance of rivastigmine hexal is rivustigmine . rivestigmine belongs to a class of substances called cholinesterase inhibitors . in patients with alzheimer ' s dementia or dementia due to parkinson ' s disease , certain nerve cells die in the brain , resulting in low levels of the neurotransmitter acetylcholine ( a substance that allows nerve cells to communicate with each other ). by blocking the activity of these enzymes , the medicine allows the levels to be increased in the blood ( acetylCHoline is a substance produced in the body ), helping to reduce the
do not take rivastigmine hexal - if you are allergic to rivastaigmine or any of the other ingredients of this medicine ( listed in section 6 ). if you have had a previous skin reaction ( allergic contact dermatitis ). warnings and precautions talk to your doctor , pharmacist or nurse before you are given the medicine . if you think any of these apply to you ( or you are not sure ), ask your doctor or pharmacist for advice before being given the product . you should not be given the active substance in rivostigminehexal if you : have irregular or slow heartbeat , have
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . dosage and duration of treatment your doctor will tell you how many tablets of rivastigmine hexal you should take . treatment usually starts with a low dose . depending on how you respond to treatment , the highest dose may be 6 . 0 mg per kg of body weight . you should continue taking this medicine until your doctor tells you otherwise . if you have any further questions on the use of this medicine , ask your doctor , pharmacist or nurse . how long to take take your medicine every day
like all medicines , this medicine can cause side effects , although not everybody gets them . tell your doctor straight away if you notice any of the following side effects . your doctor may change the dose of your medicine or stop it altogether . the side effects listed below may affect more than 1 in 10 people . feeling dizzy loss of appetite stomach problems such as feeling sick ( nausea ) or being sick ( vomiting ) diarrhoea common ( may affect up to 1 in every 10 people ) anxiety sweating headache heartburn weight loss stomach pain feeling agitated feeling tired or weak generally feeling unwell trembling or feeling confused decreased appetite nightmares uncommon ( may
keep this medicine out of the sight and reach of children . do not use rivastigmine hexal after the expiry date which is stated on the carton and blister after exp . store below 30 . store in the original package in order to protect from moisture .
what rivastigmine hexal contains 64 - the active substance is rivetigmine hydrogen tartrate . - the other ingredients are : hypromellose , magnesium stearate , microcrystalline cellulose , colloidal anhydrous silica , gelatin , yellow iron oxide red iron oxide ( e172 ), titanium dioxide ( e171 ) and shellac . each vial contains 1 . 5 mg / ml of solution for injection . - each rivasta hexal 2 . 5 milligram / 0 . 5 micrograms / ml is coated with white to off - white powder . -
cabometyx is a cancer medicine that contains the active substance cabozantinib . it is used to treat adult patients with kidney cancer ( renal cell carcinoma ) or liver cancer that has not responded to a specific anticancer medicine containing sorafenib . cabometyx has been shown to increase the activity of proteins called receptor tyrosine kinases ( rtyks ), which are involved in the formation of new blood vessels . by binding to these proteins , the medicine can increase the number of high amounts in cancer cells that can be grown and given back to you . if you have any questions about how cab
do not take cabometyx 45 if you are allergic to cabozantinib or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before taking cabometyx : if you have high blood pressure , have had an aneurysm ( enlargement or weakening of a blood vessel wall ) or have a tear in or around a blood valve wall , have diarrhoea , have recently had significant bleeding from surgery ( including within the last month ) or had surgical procedures ( including dental surgery ) if you suffer from inflammatory bowel disease ( including
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one tablet once a day . this medicine is for oral use . swallow the tablet whole with a glass of water . you can take cabometyx with or without food . your doctor may increase your dose depending on your response to your treatment and on whether you experience serious side effects . duration of treatment your doctor will tell you how long you should continue taking cabometx . the usual starting dose is 60 mg cabomety twice a day for 2 weeks . cabometrix may be
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects may happen with cabometyx and other medicines : tell your doctor straight away if your side effects become severe or uncontrollable . if you notice any of the following serious side effects you may need urgent medical treatment : symptoms include pain in the abdomen ( nausea and feeling sick ), vomiting , constipation and fever , as these may be signs of a gastrointestinal perforation ( a hole in the stomach or intestine ). if you experience any of these , you should contact your doctor immediately . severe or unpredictable bleeding . symptoms include vomiting blood
what cabometyx contains - the active substances are cabozantinib ( s ) and malate . each tablet contains either 20 mg cabozatinib or malate ( as monate ). each tablet provides a dose of 20 mg of cabozutinib in each tablet . - the other ingredients are : tablet core : cabobometyx 40 mg : cabozentinib_( s )- malate - each tablet delivers 40 mg caboxantinab in each tablets . - tablet coating : cabostyx 60 mg : cobozantinnib (s ) - malate 60 mg
pemetrexed hospira is a medicine used in the treatment of cancer . it is used in adult patients whose doctor has decided to give them a different type of medicine called pemetrexED hospira ( cisplatin , another anti - cancer medicine ). it is also used for treatment of malignant pleural mesothelioma ( a form of cancer that affects the lining of the lung ) when no prior chemotherapy has been available or has not been able to be safely treated . petrexedospira will be given to you in combination with cisplin for the initial treatment of lung cancer . pemet
do not use pemetrexed hospira : - if you are allergic ( hypersensitive ) to any of the other ingredients of pemetreed ( listed in section 6 ) or to peanut or soya ( see section " pregnancy , breast - feeding and fertility "). warnings and precautions talk to your doctor , pharmacist or nurse before using treatment . before you are given this medicine , tell your doctor if you have recently received or are about to receive a vaccine against yellow fever . your doctor may decide to delay or stop your treatment while you are being treated with pemrexedospira . if you develop problems with
the recommended dose of pemetrexed hospira is 500 mg for every square metre of your body ' s surface area . this means that your height and weight are measured in square meters ( mÂ² ) of the body . your doctor will work out the right dose for you based on this body surface area and will adjust your dose depending on your response to treatment and on your blood cell counts . the doctor or nurse will also have to check your blood and weight regularly during treatment . the infusion will last approximately 9 minutes . sodium chloride solution will be mixed before it is given to you . you will receive a single infusion of p
like all medicines , this medicine can cause side effects , although not everybody gets them . tell your doctor straight away if you notice any of the following : fever or signs of infection ( with a temperature of 38Âºc or greater ). sweating . this may be a sign of infection . if you have less white blood cells than normal , which may indicate infection ( sepsis ). this may indicate death . chest pain with a fast heart rate . pain , redness , swelling or sores in your mouth . allergic reaction ( including skin rash , burning , prickling sensation and fever ). skin reactions may be severe and could lead to
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the vial label after exp . this medicine does not require any special storage conditions . reconstituted and infusion solution : the product should be used immediately . if not used immediately , in - use storage times and conditions prior to use are the responsibility of the user and would normally not be longer than 24 hours at 2Âºc - 8Âºc unless dilution has taken place in controlled and validated aseptic conditions . in the case of parenteral medicines
what pemetrexed hospira contains - the active substance is pemetreepentahydrate . one vial contains 100 mg or 100 mg of pemrexed ( as pemetereed disodium hemipentahhydrate ). one ampoule contains 500 mg or 500 micrograms of pemetreonep edema . each ampoules contains 1 , 000 iu ( 2300 iu / ml ). - the other ingredient ( s ) ( excipients ) ( e . g ., water for injections ) ( see section 2 ) ( for further information on pemetretted
the active substances of ganfort are bimatoprost and timolol . they work together to reduce pressure in the eye . bimAToprost belongs to a group of medicines called prostamides . it works by interfering with a prostaglandin analogue ( analogue ) that is used in the treatment of glaucoma .
do not use ganfort eye drops if you are allergic to bimatoprost , timolol , beta - blockers or any of the other ingredients of this medicine ( listed in section 6 ). if you have respiratory problems such as asthma , severe chronic obstructive bronchitis or severe lung disease . if you experience wheeziness , difficulty in breathing or long - standing cough . warnings and precautions talk to your doctor or pharmacist before using this medicine if you suffer from coronary heart disease ( symptoms include chest pain , tightness , breathlessness , choking , heart failure , low blood pressure 44 ), disturbances of heart rate
always use ganfort exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one drop in the eye once a day . treatment should be started as soon as possible . keep the bottle tightly closed in order to protect from moisture . do not put the bottle close to your neck . 5 . gently squeeze the bottle . 1 . wash your hands . tilt your head back . 2 . pull down your eyelid . this will open a small pocket . 3 . put your eye back in place . continue treatment as usual . 4 . close the lid of your eye
like all medicines , ganfort can cause side effects , although not everybody gets them . stop using the drops and see a doctor straight away if you notice any of the following serious side effects . ganedfort ( multi - dose or single - dose ) can cause very common side effects ( may affect more than 1 in 10 people ) the eye redness is usually mild to moderate . the following side effects have also been reported in patients who have received the combination of the two doses : common side effect : may affect up to 1 in 9 people 100 the eye burning , itching , stinging , irritation of the conjunctiva
keep this medicine out of the sight and reach of children . do not use ganfort after the expiry date which is stated on the carton and on the label after exp . store in a refrigerator ( 2 - 8 ). do not freeze . keep the vial in the outer carton in order to protect from light . if you notice that the solution is discoloured , do not throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help to protect the environment .
what ganfort contains - the active substance is bimatoprost . each vial contains 0 . 3 mg of timolol ( corresponding to 5 mg / ml of timbolol maleate ) in 6 . 8 ml of solution . - the other ingredients are benzalkonium chloride ( a preservative ), sodium chloride , sodium phosphate dibasic heptahydrate , citric acid monohydrate , purified water , hydrochloric acid and sodium hydroxide . what gansfort looks like and contents of the pack the clear , colourless to slightly yellow solution for injection in the eye is
gefitinib mylan contains the active substance gefitinib . this protein is produced by biotechnology in cancer cells and is very similar to a natural protein produced by your own immune system ( the body ' s natural defences ) but it can also be used for the treatment of non - small cell lung cancer . this cancer is a disease in which malignant ( cancer ) cells form in the tissues of the lung .
do not take gefitinib mylan - if you are allergic to gefitoninib or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before you take this medicine if you : - have or have had any other lung problems . some lung problems can be serious and need immediate medical attention . your doctor may want to monitor you more closely while you are being treated with this medicine . if you think any of these apply to you , tell your doctor or pharmacist before you are given the medicine . - have problems with your liver
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is 250 mg antacids taken once a day on an empty stomach ( see section 2 , " gefitinib mylan contains lactose "). if you have trouble swallowing the tablets , you can take them with or without food . do not split , crush or split the tablets . if you take any other liquids , contact your doctor for advice . the maximum recommended daily dose is 20 mg . take the tablets at the same time each day . you should swallow the tablets whole
like all medicines , this medicine can cause side effects , although not everybody gets them . tell your doctor straight away if you notice any of the following serious side effects you may need urgent medical treatment : allergic reaction with symptoms such as swollen face , lips , tongue or throat , difficulty to swallow , hives , nettle rash , difficulty breathing , serious breathlessness , sudden worsening breathlessness with a cough or fever . these may be signs of an inflammation of the lungs called ' interstitial lung disease ' ( i . e . uncommon , may affect up to 1 in 100 people ). gefitinib may cause severe skin reactions
what gefitinib mylan contains - the active substance is gefinib . each film - coated tablet contains 250 mg of gefginib . - the other ingredients are : tablet core : lactose monohydrate , microcrystalline cellulose , crospovidone ( type a ), povidoone ( k30 ), sodium laurilsulfate , magnesium stearate . tablet coating : polyvinyl alcohol , macrogol 4000 , titanium dioxide ( e171 ), red iron oxide ( e172 ), yellow iron oxide red ( e 172 ). what gefitoninib melan
the active substance of reblozyl is luspatercept . it is used to treat myelodysplastic syndromes ( mds ). mds is a group of many different blood and bone marrow disorders in which red blood cells become abnormal . signs and symptoms include a low red blood cell count ( anaemia ) and a lack of red blood vessel transfusions ( see section 2 ). your doctor may decide to give your first dose of the new medicine . your doctor will decide how long you should be treated with rebloxyl . anaemia in mds can be caused by the lack or lack of
do not take reblozyl if you are allergic to luspatercept or any of the other ingredients of this medicine ( listed in section 6 ). if you think you may be pregnant or are planning to have a pregnancy , ask your doctor for advice before taking this medicine . if you have thalassaemia ( your spleen removed ) or have had a blood clot during hormone replacement therapy or after a previous blood clot . if any of these apply to you , tell your doctor or pharmacist . preventive measures should be taken in case of medicines that may increase the risk of a blood clot . high blood pressure
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . your doctor will carry out blood tests before and during treatment with reblozyl . how much to use the recommended dose is one injection under the skin ( subcutaneously ). the injections should be given over a period of at least 1 . 0 hours . the usual dose is based on your body weight . this dose may be adjusted by your doctor depending on your blood pressure . use in children and adolescents use in adults with myelodysplastic syndromes the maximum single dose is 1 .
like all medicines , this medicine can cause side effects , although not everybody gets them . serious side effects : difficulty in walking or speaking , dizziness , loss of balance and coordination , numbness or paralysis in the face , leg or arm , which may be symptoms of a stroke , blood clots swelling in the area around the eyes , face , lips , mouth or tongue throat allergic reactions , rashes 36 reporting of side effects if you get any side effects talk to your doctor or pharmacist . this includes any possible side effects not listed in this leaflet . you can also report side effects directly via the national reporting system listed
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the vial label and carton after exp . store in a refrigerator ( 2 8 ). do not freeze . after reconstitution , reblozyl may be stored at room temperature ( up to 8 ) for up to 24 hours at 2 8 . any unused medicinal product or waste material should be disposed of in accordance with local requirements .
what reblozyl contains - the active substance is luspatercept . each ml of solution contains 25 mg or 75 mg of luspaterscept . after reconstitution with eachml of solution , each ml contains either 50 mg or 100 mg luspatecept . - the other ingredients are excipients , citric acid monohydrate , sodium citrate 80 , sucrose , hydrochloric acid ( for ph adjustment ), sodium hydroxide ( to adjust ph adjustment ) and water for injections ( see section 2 under " important information about some of the ingredients of rebl ozyl "). what rebl
fotivda contains the active substance tivozanib . it is a protein kinase inhibitor , which is similar to a natural protein in the body . tiv ozanib works by stopping the growth of the cancer by stopping cancer cells from growing and attaching to new blood vessels . if you have advanced kidney cancer , you may be given other treatments ( alpha or interleukin - 2 ) to treat your disease .
do not take fotivda if you are allergic to tivozanib or any of the other ingredients of this medicine ( listed in section 6 ). if you have a problem with your st . john ' s wort ( hypericum perforatum ), a herbal remedy used for depression and anxiety . warnings and precautions talk to your doctor or pharmacist before you are given this medicine if you : - have high blood pressure . your doctor will check your blood pressure regularly . - are taking a medicine that lowers your blood blood pressure , such as a medicine . you should tell your doctor if any of these apply to you
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much to take the recommended dose of fotivda is 1340 mg twice a day ( 21 mg and 7 mg ). you will take 1 capsule of capsules once a day for 4 weeks . your doctor will tell you how many capsules to take . if you take too many capsules , you may experience unacceptable side effects . if severe side effects occur , your doctor may reduce your dose or stop fotovda therapy . the recommended daily dose of the medicine is fotvda 890 mg
like all medicines , this medicine can cause side effects , although not everybody gets them . serious side effects high blood pressure is a very common side effect ( may affect more than 1 in 10 people ). tell your doctor immediately if you experience any of the following symptoms : severe headaches , blurred vision , shortness of breath , changes in your mental state ( e . g . feeling anxious , confused or disorientated ). your doctor may want to monitor your blood pressure more closely while you are taking fotivda . you may need to take a medicine to control your high blood blood pressure . if you take more than the recommended dose
what fotivda contains - the active substance is tivozanib . each hard capsule contains 890 mg of tiv ozanib ( as tivzanib hydrochloride monohydrate ). - the other ingredients are : capsule content : 890 micrograms ( tibb ), mannitol ( e421 ), magnesium stearate , gelatin , titanium dioxide ( e171 ), indigo carmine ( e132 ), yellow iron oxide ( e172 ) and propylene glycol ( for strong ammonia solution ). capsule shell : titanium dioxide , tartrazine aluminium lake , shellac , propylene
stribild contains two active substances : elvitegravir ( an antiretroviral medicine known as an integrase inhibitor cobicistat , a booster ( pharmacokinetic enhancer ) of the activity of the immune system ( the body ' s natural defences ) of elvitabine ( an antitroviral medication known as a nucleoside reverse transcriptase inhibitor ( nrti ) tenofovir disoproxil ( an antiviral medicine called a nucleotide reverse transcriptase inhibitor ) stribild is given as a single tablet regimen for the treatment of human immunodef
do not take stribild : - if you are allergic to elvitegravir , cobicistat , emtricitabine , tenofovir , ten ofovir disoproxil or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before taking this medicine . during treatment , your doctor may change the dose of any medicine that contains ten of ovir disaproxil . this will depend on your kidney function and whether you are taking any of these medicines : - alfuzosin ( used
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . adults and adolescents 12 to less than 18 years of age 35 the recommended dose is one tablet taken by mouth once a day . swallow the tablet whole with a glass of water . you can take your medicine with or without food . your doctor may change the dose of the tablet depending on how you respond to the treatment . if you take medicines containing oral supplements ( such as antacids , laxatives containing minerals , magnesium , aluminium , calcium , iron , zinc ), take the tablet at least 4 hours
during hiv therapy there may be an increase in weight and in levels of blood lipids and glucose . this is partly linked to restored health and life style , and in the case of bloodlipids sometimes to the hiv medicines themselves . your doctor will test for these changes . like all medicines , this medicine can cause side effects , although not everybody gets them . if you have hiv infection , you may get unwanted effects from stribild . these effects are usually mild to moderate and of a short duration . however , some hiv disease itself can cause serious side effects . tell your doctor immediately if you experience any of
what stribild contains - the active substances are elvitegravir , cobicistat , emtricitabine and tenofovir disoproxil . each stribil film - coated tablet contains 150 micrograms of the two active substances , respectively , of each of them . each tablet of elvitesgravira , 150 milligrams of both of them , as well as of each other , of which each of the three active substances is either 150 mg of either of them ( as besilate ) of the four active substances ), of which both are revolvers ,
zyprexa contains the active substance olanzapine . zyprexa belongs to a group of medicines called antipsychotics and is used to treat the following conditions : schizophrenia , a disease with symptoms such as hearing , seeing or sensing things which are not there , mistaken beliefs , unusual suspiciousness , and becoming withdrawn . people with this disease may also feel depressed , anxious or tense . moderate to severe manic episodes , a condition with symptoms of excitement or euphoria , which has been reported in some patients taking zyprixa . it has been shown to prevent recurrence of these symptoms in patients with bipolar disorder whose
do not take zyprexa if you are allergic ( hypersensitive ) to olanzapine or any of the other ingredients of this medicine ( listed in section 6 ). signs of an allergic reaction may include a rash , itching , a swollen face , swollen lips and shortness of breath . if you have eye problems such as certain kinds of glaucoma ( increased pressure in the eye ). if any of these apply to you , tell your doctor or pharmacist . warnings and precautions talk to your doctor , pharmacist or nurse before you are given zyprixa : if you suffer from dementia . serious side
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . zyprexa tablets should be taken with or without food . you should swallow the tablets whole with a glass of water . the dose may be increased to a maximum of 5 mg or 20 mg once a day depending on your symptoms . swallow the tablet whole with some water . do not chew or crush the tablets . zzyprexa can be taken in combination with or with food . take your zypxa tablets at the same time each day . you can take your tablets at any time of
like all medicines , this medicine can cause side effects , although not everybody gets them . unusual movement ( a common side effect that may affect up to 1 in 10 people ) mainly of the face or tongue . this may be a sign of blood clots in the veins . this side effect is uncommon ( affects 1 in 100 people ) in the legs . symptoms include swelling , pain , and redness in the leg which may travel through blood vessels to the lungs causing chest pain and difficulty in breathing . if you notice any of these symptoms seek medical advice immediately . fever , faster breathing , sweating , muscle stiffness and drowsiness or
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . zyprexa will be stored by the healthcare professionals at the hospital or clinic . these measures will help to protect the environment .
what zyprexa contains - the active substance is olanzapine . - each yzyprexa tablet contains 2 . 5 mg or 5 mg , 7 . 5mg , 10 mg , 15 mg , or 20 mg . - the other ingredients of your zypoxa tablet pack are lactose monohydrate , hyprolose , crospovidone , microcrystalline cellulose , magnesium stearate , hypromellose , titanium dioxide ( e171 ), carnauba wax . the different zypxa tablet strengths are marked with the following symbols : - zy
what prolia is prolia contains the active substance denosumab , which is a protein ( monoclonal antibody ) that is similar to another protein found in the body . it is used to prevent bone loss in adult patients with osteoporosis when treatment with prolia has failed . prolia helps to make bone stronger by reducing the amount of oestrogen in the bone . this helps to prevent bones from becoming thin and fragile . what osteoorosis is and what it is caused by osteoarthritis the body does not make enough of a hormone called testosterone ( also called glucocorticoids
do not use prolia if you have low calcium levels in the blood ( hypocalcaemia ) if you are allergic to denosumab or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before using prolia . if you develop a skin infection with symptoms such as a swollen , red area of skin on the leg that feels hot and tender ( cellulitis ) and symptoms of fever . if any of these symptoms indicate an allergy to latex , please remove the needle from the pre - filled syringe and use a derivative of latex . if
always use prolia exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one pre - filled syringe of 60 ml given every 6 weeks as a single injection under the skin ( subcutaneous ) in the thighs , abdomen or upper arm . you can inject prolia with or without stickers . your doctor will tell you if you need calcium and vitamin d supplements . if you have any further questions on the use of prolia , ask your doctor , pharmacist or nurse . how much prolia to use and how often to use it the usual dose of
like all medicines , this medicine can cause side effects , although not everybody gets them . stop taking prolia and see a doctor straight away if you notice any of the following skin infections ( cellulitis ). these symptoms may be due to prolia : - swollen , red area of skin , usually in the leg , which feels hot and tender . - symptoms may include fever . - prolia may cause pain in the mouth and / or jaw , swelling or non - healing of sores in the jaw , discharge , numbness , feeling of heaviness or loosening of a tooth . these may be signs of bone damage in the
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the outer carton and on the label of your pre - filled syringe after exp . store in a refrigerator ( 2 8 ). do not freeze . after first opening of the pen , you may remove prolia from the refrigerator and keep it at room temperature ( not above 25 ) for a single period of up to three months . after this period , the injection may be stored at 25 for a maximum period of not more than 30 days . your healthcare professional will throw away any medicines that are no
what prolia contains - the active substance is denosumab . each ml of solution contains 1 mg or 60 mg of denosumaab ( 60 mg ). - the other ingredients are acetic acid , glacial , sodium hydroxide , sorbitol ( e420 ), polysorbate 20 and water for injections . what prolia looks like and contents of the pack prolia is a clear to slightly yellow solution for injection in a pre - filled syringe with a needle guard .
aimirix is a vaccine for use in adults , adolescents and children from 1 to 15 years of age . it is used to treat two diseases : hepatitis a and hepatitis b : infection with the hepatitis a virus , which causes the liver to become swollen and inflamed with the virus . the virus can be found in faeces , serum or saliva . symptoms usually occur 3 to 6 weeks after infection . if you feel sick , have a fever , aches and pains , get very tired , dark urine , palefaeces or yellowish skin or eyes ( jaundice ). the severity and type of symptoms can vary
you must not be given ambirix if you are allergic to any of the active substances or any other ingredients of this vaccine ( listed in section 6 ). signs of an allergic reaction may include itchy skin rash , shortness of breath , and swelling of your face or tongue . if you have signs of such a reaction , tell your doctor or nurse straight away . you should not receive any vaccine for hepatitis a or hepatitis b diseases . a severe infection with a high temperature should not be a reason to receive the vaccine . a minor infection such as a cold should be avoided . if any of these apply to you ( or you
your doctor or nurse will give you ambirix as an injection into a muscle ( usually in the upper arm ). your doctor will decide how many injections you need and how often you need to have them . the recommended dose is one injection per month . the injection will usually be given into the thigh muscle . your doctor may decide to give you a total of two injections . the injections should be given within 12 months . if you miss an injection , make another one as soon as possible . the second injection may be given between 6 and 12 months after the first injection . you may need extra doses to make up for future booster d
like all medicines , this vaccine can cause side effects , although not everybody gets them . serious side effects tell your doctor straight away if you notice any of the following side effects you may need urgent medical treatment : allergic and anaphylactic reactions . the signs may include a rash , itchy , blistering , swelling of the eyes and face , difficulty in breathing or swallowing , a sudden drop in blood pressure and loss of consciousness . other side effects reported in clinical trials with ambirix were : common ( may affect up to 1 in 10 people ): headache loss of appetite feeling tired irritable pain or redness where the injection
what ambirix contains 26 the active substance is hepatitis a virus . each 1 ml pre - filled syringe contains 720 micrograms of elisa units . the other ingredients are hepatitis b surface antigen ( mrc ), human diploid , mrc , cells , aluminium hydroxide ( hydrated in 0 . 05 ml ), saccharomyces cerevisiae , aluminium phosphate ( 0 . 4 ml ) and sodium chloride and water for injections . what ambiraix looks like and contents of the pack suspension for injection is a white , slightly milky liquid , supplied in a glass vial containing 1 ml of amb
besero is a meningococcal group b vaccine . bexsero is given to adults , adolescents and children from 2 years of age with disease caused by the neisseria meningitidis group b bacteria . these bacteria help to prevent infections ( such as meningitis , inflammation of the brain and spinal cord ) and sepsis ( blood poisoning ). the vaccine works by helping to prevent the disease from returning .
do not use bexsero - if you are allergic to the active substance or any of the other ingredients of this vaccine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist , or nurse before you are vaccinated . if you have a severe infection with a high temperature ( over 38 ). vaccination should be postponed until you have recovered from a minor infection such as a cold . if any of these apply to you ( or you are not sure ), your doctor may postpone the vaccination until you return to your regular schedule . if your doctor has told you that you have haemophilia or any other problem
always use bexsero exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one injection ( 5 ml ) in the muscle of the thigh or upper arm . the first two injections will be given at least 2 months apart . the interval between injections should not exceed 1 month . if you have the impression that the effect of the vaccine is too strong or too weak , talk to your doctor . your doctor may give you an additional injection ( booster ). the first injection should be given between 2 and 3 months . if this effect is too weak or weak ,
like all vaccines , this vaccine can cause side effects , although not everybody gets them . stop using bexsero and tell your doctor straight away if you notice any of the following serious side effects : very common ( may affect more than 1 in 10 people ): pain / tenderness at the injection site , redness of the skin at the site of injection , swelling of theskin at the place of injection site hardness at the area of injection injection site the following side effects have been reported with this vaccine : common : may affect up to 1 in every 10 people : fever , loss of appetite , tenderness on the injectionsite
what bexsero contains - the active substances are recombinant neisseria meningitidis group b nhba fusion protein ( 1 , 2 , 3 , 50 micrograms ) and recombinant nisseria manningitidis ( group b noada protein ). - the other ingredients are : - the following ingredients are excipients : - each vial contains either 1 mg , 2 mg or 3 mg of nhhba . - the reconstituted product is a clear , colourless to pale yellow solution for injection in outermembrane vials ( called omv ). - neiss
nitisinone mdk contains the active substance nitisinONE . this medicine is used to treat a rare disease called hereditary tyrosinemia in adults , adolescents and children aged 1 year and above . because of this disease your body does not produce enough of the amino acid tyrosine ( amino acids are substances that are naturally present in the body ) as a result of the harmful substances in this medicine . by reducing the amount of tyrorosine in your body , it helps to lower the levels of the damaging substances in the blood . your doctor has prescribed this medicine to help to reduce the level of tyros
do not take nitisinone mdk - if you are allergic to any of the active substances in this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before taking this medicine . pregnancy , breast - feeding and fertility you must tell your doctor or pharmacist if you have had or might have had a problem with your eyes during or after nitis inone treatment . if you develop red eyes or if your eyes get darker , tell your physician immediately . your doctor may recommend an eye examination . eye problems may be due to inadequate dietary control . see section 4 for more information .
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . treatment with this medicine will be started by a doctor who is experienced in the treatment of the disease ( hereditary tyrosinemia type 1 ). the recommended starting dose is 1 mg for every kg of body weight . this dose may be increased to 20 mg for this patient population . swallow the capsules whole with a small amount of water or formula diet . if you take more nitisinone mdk than you should if you accidentally take too many capsules , contact a doctor or the nearest hospital straight away .
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the blister after exp . this medicine does not require any special storage conditions . after first opening : store in a refrigerator ( 2 8 ). do not freeze . store in the original package in order to protect from light . after opening : nitisinone mdk may be stored for a maximum of 2 weeks at a temperature not above 25 .
what nitisinone mdk contains - the active substance is nisinone . each hard capsule contains either a single or two doses of nitis inone . the first hard capsule is 2 mg . the second capsule is 10 mg . - the other ingredients are : - tablet core : nitisinnone . - capsule shell : 5 mg . each capsule contains 5 mg nitis . - printing ink : shellac glaze ( e1520 ) and ink : white to off - white powder . - hard capsules : 15 . 7 mm hard gelatin capsules imprinted with " nitis " on one side and "
the name of the medicine is docetaxel accord . the active substance in this medicinal product is docepaxel ( 123 mg / ml ). it belongs to a group of medicines called " anti - cancer medicines " ( taxoids ) and is used in the treatment of breast cancer , lung cancer and non - small cell lung cancer . the other ingredients are prostate cancer , gastric cancer and head and neck cancer . in advanced breast cancer the active substances in docetaaxel are doxorubicin , trastuzumab and capecitabine . in early breast cancer with or without lymph node involvement
do not use docetaxel accord - if you are allergic ( hypersensitive ) to docepaxel or to any of the other ingredients of this medicine ( listed in section 6 ) if you have a low number of white blood cells if you suffer from a severe liver disease . warnings and precautions before you are given this medicine , your doctor will ask you to have blood tests to check that you have enough blood cells and sufficient liver function to be treated . if any of these apply to you ( or you are not sure ), talk to your doctor , pharmacist or nurse before being given docetxel accord . white
docetaxel accord will be given to you by a doctor or nurse . the dose will depend on your weight and your general condition . your doctor will calculate your body surface area in square meters ( mÂ² ) and will determine the dose you should receive . method and route of administration dexamethasone accord is given as an infusion into one of your veins . the infusion will last approximately one hour . frequency of administration you will receive your infusion once every 3 weeks , depending on the results of your blood tests and on the general condition of your body . your dose may be adjusted by your doctor if you receive docet
like all medicines , this medicine can cause side effects , although not everybody gets them . your doctor will discuss these with you and will explain the potential risks and benefits of your treatment . the following adverse reactions have been reported with docetaxel accord : decrease in the number of red blood cells and white blood cells ( alopecia ), nausea , vomiting , sores in the mouth , diarrhoea and tiredness . the frequency of adverse events listed below has not been estimated from the available data . if you have been treated with any other chemotherapeutic agents during the infusion , please inform your doctor . allergic reactions
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the vial label after exp . store in a refrigerator ( 2 - 8 ). do not freeze . keep the container in the outer carton in order to protect from light . after dilution of the medicine , the infusion bag should be used within 6 hours ( up to 25 hours ) prior to infusion . the infusion solution should be stored in non - pvc bags for 48 hours ( 2 to 8 ). if not used immediately , in - use storage times and conditions prior
what docetaxel accord concentrate for solution for infusion contains 20 mg film - coated tablets ( see section 2 " docel accord contains sodium "). each vial of 1 ml concentrate delivers 20 mg of docelaxel . each 4 ml ml of concentrate contains 80 mg docel. each 8 ml ampoule of 160 ml of solution for injection contains 160mg docel . the other ingredients in the concentrate are polysorbate 80 , ethanol anhydrous ( see also section 2 under " docellaccord contains ethanol "), citric acidanhydrous and water for injections ( see below " docet
intuniv contains the active substance guanfacine . this medicine belongs to a group of medicines that stimulate the brain to produce its own dopamine ( neurotransmitters ). this medicine is used to treat impulsive , hyperactive behaviours ( also called ' attention deficit hyperactivity disorder ') in adults with adhd when current stimulant medication is not controlling adhd symptoms . the medicine is also used as a treatment programme for psychological therapy , educational therapy and social therapy . intuniv is used in adults 38 years of age and older who have adhd and whose condition has not responded to the medicine or is not adequately controlled by
do not take intuniv if you are allergic to guanfacine or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before taking this medicine if you have low or high blood pressure . heart problems tell your doctor straight away if you think you may have heart problems . you have ever fainted or have recently had thoughts or feelings of suicide or any other psychiatric conditions ( withdrawal symptoms ). you have increased heart rate . you are also at high risk of high bloodpressure . if any of these apply to you ( or you are not sure ),
your treatment will be started by a doctor who is experienced in the treatment of adolescent behavioural disorders . always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one tablet once a day . your doctor will work out the right dose for you based on your child ' s age and weight . the dose will depend on your response to your treatment and on how well your child responds to it . the usual starting dose is 1 tablet per day . this will be gradually increased over the course of 1 to 3 weeks . depending on how you respond to treatment
like all medicines , this medicine can cause side effects , although not everybody gets them . if you feel unwell , stop taking your medicine and seek medical advice straight away . serious side effects tell your doctor straight away if you notice any of the following side effects : feeling drowsy , feeling dizzy ( hypotension ), slow heart beat ( bradycardia ), feeling faint , loss of concentration ( syncope ), a serious withdrawal side effect with high blood pressure . symptoms may include headaches , feeling confused , nervousness , agitation and tremors ( hypertensive encephalopathy ). if any of these side effects occur , tell your
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the blister pack after exp . this medicine does not require any special storage conditions . the tablets should be used within one month after first opening . blister pack : do not throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what intuniv contains - the active substance is guanfacine hydrochloride . 1 mg : each prolonged - release tablet contains 1 mg guanFacine ( see section 2 ). 2 mg : one prolonged -release tablet contains 2 mg guinfacine . 3 mg : two prolonged - releases : one long - lasting tablet contains 3 mg ( 3 mg of guanfuine ). 4 mg : four prolonged - releasing tablets contain 4 mg guenfacine ( as long as the doctor continues to prescribe it ). - the other ingredients are hypromellose 2208 , methacrylic acid - ethyl ac
ecalta contains the active substance anidulafungin . ecalta is used in adults , adolescents and children from the age of 18 years to treat adults with a type of fungal infection that affects the blood or other internal organs called invasive candidiasis . the infection is caused by fungal cells called candida ( echinocandins ). these medicines are used to treat serious fungal infections caused by problems with the fungal cell walls that can be life - threatening and can be fatal . your doctor will test for these conditions before you start using ecalda . if you have any questions about how ec
do not use ecalta - if you are allergic to anidulafungin , other echinocandins , caspofungin acetate or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before you are given this medicine . your doctor may need to monitor your liver function . if you have liver problems , your treatment may be interrupted or you may be given anaesthetics . if any of these apply to you ( or you are not sure ), your doctor will monitor your condition during and after your treatment with ecalt
the treatment will be given to you by a doctor or nurse . the usual starting dose is 200 mg or 100 mg given once a week . the recommended dose is 1 mg per kg body weight . children and adolescents ( aged 1 to 18 years ) the dose is 3 . 0 mg , 200 mg , 1 . 5 mg and 100 mg . the doctor will work out the patient ' s weight . ecalta is given as a slow infusion ( a drip into a vein ) over a period of 1 to 3 hours . the loading dose will depend on how well the infusion is working for the patient . your doctor will calculate the
like all medicines , this medicine can cause side effects , although not everybody gets them . tell your doctor straight away if you notice any of the following serious side effects : - threatening allergic reactions , including difficulty breathing or wheezing or an existing rash . ecalta may cause serious effects such as convulsion ( seizure ), flushing , rash , pruritis , itching , hot flush , hives , sudden contraction of the muscles , wheezed or coughing , difficulty of breathing other side effects very common side effects ( may affect more than 1 in 10 people ): low blood potassium ( hypokalaemia ), diarrhoea
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the vial label after exp . store in a refrigerator ( 2 8 ). do not freeze . the reconstituted solution should be used within 24 hours . the infusion solution may be stored at room temperature ( up to 25 ) for up to 48 hours . if not used immediately , in - use storage times and conditions prior to use are the responsibility of the user and would normally not be longer than 48 hours at 2 - 8 unless dilution has taken place in controlled
what ecalta contains - the active substance is anidulafungin . each vial of powder contains 100 mg of an idulafugin . - the other ingredients are mannitol , polysorbate 80 , tartaric acid , sodium hydroxide , hydrochloric acid and 30 micrograms / ml ( 0 . 5 %) solution for injection in a vial ( see section 2 ). what ecaltas looks like and contents of the pack ecaltfa is supplied as a box containing 1 vial containing 100 mg concentrate for solution for infusion . the powder is white to off
adynovi contains the active substance rurioctocog alfa pegol , which is a substitute for pegylated human coagulation factor viii ( hcvviii ). the hcnvviii is produced by recombinant dna technology in the laboratory and is very similar to factor vix produced naturally in the blood . it helps to form clots and stop bleedings in patients with haemophilia a and b . adynovi is used for the treatment and prevention of bleeding in adults and adolescents 12 years of age and older and in children and adolescents of all ages . haem
do not use adynovi if you are allergic to rurioctocog alfa pegol or octocog aluminium or any of the other ingredients of this medicine ( listed in section 6 ). if you think you may be allergic , ask your doctor for advice . warnings and precautions talk to your doctor , pharmacist or nurse before using adsynovi : if you have ever had an anaphylactic reaction ( a severe , sudden allergic reaction to any substance that is present in adsellovi ). allergic reactions may include rash , 95 hives , wheals , generalised itching , swelling of lips and tongue ,
treatment with adynovi will be started by a doctor who is experienced in the treatment of haemophilia a . your doctor will decide on the most appropriate dose for you . the dose you receive will depend on your condition and on the type of bleeding you are at risk of bleeding . if you have the impression that the effect of the replacement therapy is too strong or too weak , talk to your doctor or pharmacist . the recommended dose is one tablet once a day . your physician may decide that adynov is a life - long treatment . always use this medicine exactly as your doctor has told you . check with your
like all medicines , this medicine can cause side effects , although not everybody gets them . sudden allergic reactions ( anaphylactic ) may occur after the injection . early symptoms of allergic reactions may include rash , hives , wheals , generalised itching , swelling of lips and tongue , difficulty in breathing , wheezing , tightness in the chest , feeling of being unwell , dizziness and loss of consciousness . if you experience severe symptoms of this type , you should immediately contact your doctor or seek emergency treatment . previous treatment with factor viii ( more than 150 days of treatment ) inhibitor antibodies ( see section 2 )
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and vial label after exp . store in a refrigerator ( 2 8 ). do not freeze . keep the vial in the outer carton in order to protect from light . the powder vial may be stored at room temperature ( up to 30 ) for a maximum period of 3 months . this medicine expires after 3 months and should be used within 3 months after first opening . if not used immediately , in - use storage times and conditions prior to use are the responsibility of the user
what adynovi contains the active substance is rurioctocog alfa pegol ( pegylated human coagulation factor viii produced by recombinant dna technology ). each powder vial contains nominally 250 , 500 , 1000 or 2000 iu of the active ingredient in ruriolocog alpha pegol . the solvent vial provides 5 ml of sterilised water for injections . the other ingredients are mannitol , trehalose dihydrate , histidine , glutathion , sodium chloride , calcium chloride diydrate , tris ( hydroxymethyl ) aminometh
rekovelle contains follitropin delta , a follicle stimulating hormone . it belongs to a group of hormones called gonadotropins . gonadsotropins play an important role in female fertility and are involved in assisted reproduction programs ( i . e . in vitro fertilisation ( ivf ) and intracytoplasmic sperm injection . they work by helping the ovaries produce many egg sacs .
do not use this medicine if any of the above applies to you . if you are not sure , talk to your doctor , pharmacist or nurse before using rekovelle . warnings and precautions you should tell your doctor if : you have your fertility problems . you are allergic to follicle stimulating hormone ( fsh ). you have enlarged ovaries or cysts on your ovaries . you have polycystic ovarian disease ( bleeding from the vagina at an early menopause ) or malformations of the sexual organs ( see section " pregnancy , breast - feeding and fertility "). you have fibroids of the uterus
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the rekovelle dose will be given to you by your doctor during your first treatment cycle . your doctor will prescribe a type of anti - mÃ¼llerian hormone that stimulates your ovaries to produce stimulation with gonadotropins . the dose is based on your blood weight and will be calculated from a blood sample taken within the last 12 months . the duration of treatment will depend on your body weight and how well you respond to treatment . if you have any further questions on the use of this
like all medicines , this medicine can cause side effects , although not everybody gets them . serious side effects caused by hormones ( infertility ) this medicine may cause a high level of activity in the ovaries ( ovarian hyperstimulation syndrome ). symptoms include pain , discomfort , swelling of the abdomen , nausea , vomiting , diarrhoea , weight gain and difficulty breathing . if you experience any of these symptoms , stop taking rekovelle and contact your doctor straight away . a side effect that may affect up to 1 in 10 people is headache . nausea ( the frequency cannot be estimated from the available data ) ovarian hyper stimulation syndrome ( pelvic
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the vial label after exp . store in a refrigerator ( 2 - 8 ). do not freeze . rekovelle may be stored at room temperature ( up to 25 ) for a single period of up to 3 months . after this period , the product should be used within 3 months or disposed of . if not used within 28 days , it should be discarded . after the treatment any unused solution should be disposed of in accordance with local requirements . medicines should not be disposed
what rekovelle contains - the active substance is follitropin delta . each multidose cartridge contains 12 million units of the active substances . each millilitre of solution contains 0 . 36 millilitres of solution ( equivalent to 33 . 3 micrograms of follnitropin delta in each ml of solution ). - the other ingredients ( excipients ) are phenol , polysorbate 20 , l - methionine , sodium sulphate decahydrate , disodium phosphate dodecahydrates , concentrated phosphoric acid , sodium hydroxide and water for injections . what
the active substances of revinty ellipta are fluticasone furoate and vilanterol . each inhalation contains either one of the following active substances : - the active substances are : - ellipta 92 micrograms of vilterol per inhalation each 22 inhalation dose is : one inhalation ( two inhalations ), one tablet ( three inhalations , one tablet ) and one other tablet ( four tablets ) ( two tablets ) each day . the other ingredient is : - aeronazole ( a type of medicine used to treat asthma ) - aerobellasone 184 microgram
do not take revinty ellipta - if you are allergic to fluticasone furoate , vilanterol or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before taking ellipta . ellipta has been shown to increase the risk of liver disease . the following side effects have been reported with ellipta in patients with moderate or severe liver disease : the lower strength of ellipta 92 / 22 mg / ml may be associated with heart problems , high blood pressure , tuberculosis ( tb ) of the lung , or any long
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much revinty ellipta to use asthma the usual dose for asthma is one inhalation of fluticasone furoate ( 22 mg vilanterol ) once a day . if you have severe asthma , your doctor may give you the higher strength inhalation ( two inhalations each day ) of flitantasonefuroate 22 mg ( 24 mg vilterol ). how much to use in copd the usual starting dose for copd is three inhalations of fl
like all medicines , this medicine can cause side effects , although not everybody gets them . allergic reactions allergic reactions to ellipta are rare ( may affect up to 1 in 1 , 000 people ). if you experience any of the following symptoms while taking ellipta , stop taking this medicine and contact your doctor immediately : skin rash , hives , redness swelling mainly of the face and mouth ( angioedema ), feeling very wheezy , coughing , difficulty in breathing , feeling weak or light headed , collapse or loss of consciousness . immediate breathing difficulties immediate breathing problems stop taking revinty ellipta and get medical help immediately if
what revinty ellipta contains the active substances are fluticasone furoate and vilanterol . each inhalation delivers 92 micrograms of flutic asonefuroate ( corresponding to 22 microlitres per inhalation ) and vilterol ( as trifenatate ). each 184 microlitre inhalation provides 184 microgramms of the active substance ( correspondingto 184 micrometrespera ) and of the other ingredients ( listed in section 6 ). the dose is based on the body weight of the inhaler . the two active substances in the inhalation are : lact
atripla contains three active substances that are used to treat human immunodeficiency virus ( hiv ) infection : efavirenz , a non - nucleoside reverse transcriptase inhibitor ( nnrti ), emtricitabine , a nucleosidermal necrolysis ( nrti ) and tenofovir , both of which are also known as a nucleotide reverse transcriptase inhibitor . these active substances are used in combination with antiretroviral medicines to change the way the body works by interfering with the activity of an enzyme ( reverse transcriptases ) that
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one tablet taken by mouth once a day . atripla should be taken on an empty stomach at least 1 hour before or 2 hours after food . some side effects ( such as dizziness and drowsiness ) may be serious . if you take more tablets than you should if you accidentally take too many tablets , talk to a doctor or go to the nearest hospital straight away . take the tablet pack with you so that you can easily describe what you have taken . you can
during hiv therapy there may be an increase in weight and in levels of blood lipids and glucose . this is partly linked to restored health and life style , and in the case of bloodlipids sometimes to the hiv medicines themselves . your doctor will test for these changes . like all medicines , this medicine can cause side effects , although not everybody gets them . serious side effects lactic acidosis ( excess lacticacid in the blood ) is rare ( may affect up to 1 in 1 , 000 people ). if you experience any of the following serious side effect , stop taking atripla and contact your doctor immediately
what atripla contains - the active substances are efavirenz , emtricitabine and tenofovir disoproxil . each atrippla film - coated tablet contains 600 mg of eflavirenz ( 200 mg of the active substance ) and emptricitubine ( 245 mg of ten ofovirdisoproxel ( as fumarate ). - the other ingredients are croscarmellose sodium , hyprolose , magnesium stearate , microcrystalline cellulose , sodium laurilsulfate ( see section 2 " at
orgalutran contains the active substance ganirelix . it belongs to a group of medicines known as anti - gonadotrophin . it is a synthetic version of the natural gonadodotrophicin releasing hormone ( gnrh ), which is produced by biotechnology in the laboratory . when the natural gnrh regulates the release of gonadsotrophins , follicle stimulating hormone ( fh ) is released from the follicle and stimulates the growth of follicles in the ovaries . follicles are small round sacs that contain the egg cells and release the immature egg cells in the sacs .
do not use orgalutran if you are allergic to ganirelix or any of the other ingredients of this medicine ( listed in section 6 ). if you think you may be hypersensitive ( hypersensitive ) to gonadotrophin releasing hormone ( gnrh ) or to a gnrh analogue . if you have a moderate or severe kidney or liver disease . warnings and precautions talk to your doctor , pharmacist or nurse before you are given this medicine . you may experience allergic reactions ( generalised , hives , urticaria ), swelling of the face , lips tongue and / or throat , difficulty in breathing
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . orgalutran will be given to you by a doctor or nurse who is experienced in the treatment of assisted reproduction techniques ( i . e . in vitro fertilisation ( ivf ), ovarian stimulation , follicle stimulating hormone ( corifollitropin ) on day 2 or day 3 of each treatment cycle . you will be injected with a different injection site . your doctor will tell you how many injections you need and how often you need to use it . the recommended dose is one injection under the
like all medicines , this medicine can cause side effects , although not everybody gets them . a side effect that may affect more than 1 in 10 people is local skin reactions ( redness and swelling ). the local reaction usually disappears after a few days . see section 4 for more information . uncommon ( may affect up to 1 in 100 people ) is headache , nausea , malaise . very rare ( frequency cannot be estimated from the available data ) is allergic reactions ( rash facial swelling with difficulty breathing ( dyspnoea ) swelling of face , lips , tongue , and / or throat with difficulty in breathing or swallowing ( angio
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the syringe label after exp . store in a refrigerator ( 2 - 8 ). syringes should be clear , liquid - free solutions . store below 30Âºc .
what orgalutran contains - the active substance is ganirelix . each vial contains 0 . 5 ml of acetic acid . - the other ingredients are mannitol ( e421 ) and water for injections ( see section 2 ). - the ph - 1 is sodium hydroxide ( e524 ) which is used to adjust the dose and to increase the amount of acic acid that can be absorbed by the body . see section 4 for further information on the effects of this product on the body and on the quality of the solution . - after subcutaneous administration , the needle must be replaced .
what blitzima is blitzima contains the active substance " rituximab ". this is a type of protein called a " monoclonal antibody ". it sticks to a specific target in a certain type of white blood cell called " b - lymphocyte ". how blitzima works blitzima can be used to treat : a ) non - hodgkin ' s lymphoma ( a disease of the lymph tissue that affects the immune system ) in adults . b ) an increase in the number of an abnormal type of a type called " a - lymphocytes ". blitzima may be used in combination with other medicines called
do not use blitzima - if you are allergic to rituximab , other proteins that are made by recombinant dna technology , or any of the other ingredients of this medicine ( listed in section 6 ). - if your child has a severe active infection , a weak immune system , severe heart failure or severe uncontrolled heart disease . warnings and precautions talk to your doctor , pharmacist or nurse before using blitzima if you have : - granulomatosis , polyangiitis , microscopic polyagiitis or pemphigus vulgaris ( see section " other medicines and blitzima "). -
your treatment with blitzima will be overseen by a doctor who is experienced in the use of this treatment . always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . if you experience any side effects , stop using blitzima and contact your doctor straight away . you will be given a drip ( intravenous infusion ) of medicines before each blitzima administration . your doctor may decide to give you blitzima together with other medicines ( pre - medication ) to reduce the risk of side effects . your treatment will be repeated every three weeks . non - hodgkin '
like all medicines , this medicine can cause side effects , although not everybody gets them . most side effects are mild to moderate . however , some may be serious and require treatment . some of these reactions have been fatal . infusion reactions during the first 24 hours of the infusion , fever , chills , shivering , pain at the infusion site , blisters , itching , sickness , nausea , tiredness , headache , breathing difficulties , blood pressure raised , wheezing , throat discomfort , tongue or throat swelling , itchy , runny nose , vomiting , flushing , palpitations , heart attack , low number of platelets
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the outer carton and the vial label after exp . store in the original package in order to protect from light . after first opening : store in a refrigerator ( 2 - 8 ). do not freeze . keep the container tightly closed in order for the product to reach room temperature ( 20 - 25 ) and to protect it from light and moisture . the product should be used immediately after dilution . if not used immediately , in - use storage times and conditions prior to use are the responsibility of the
what blitzima contains - the active substance is rituximab . each ml of solution contains 10 mg or 100 mg of the active substances . - the other ingredients are : powder for concentrate for solution for infusion ( 10 mg , 50 mg or 500 mg of ritukimab in 10 ml ), sodium chloride , tri - sodium citrate dihydrate , polysorbate 80 and water for injections . what blitzima looks like and contents of the pack blitzima is a clear , colourless solution for injection or infusion . it is available in 2 strengths : 50 mg and 1 ml . not all pack sizes
roactemra contains the active substance toilizumab , a monoclonal antibody ( a type of protein that recognises and attaches to a specific target in the body ). it blocks the activity of a protein called interleukin - 6 , which is involved in causing the inflammation in your body . when used in combination with roactenra , you may experience symptoms such as pain and swelling in your joints . roactemera reduces the damage to the cartilage and bone in the joints caused by the disease . roactorra is used in adult patients with moderate to severe active rheumatoid
do not use roactemra if you are allergic to tocilizumab or any of the other ingredients of this medicine ( listed in section 6 ). if you have an active , severe infection . warnings and precautions talk to your doctor , pharmacist or nurse before the infusion with roactema . if you experience allergic reactions such as chest tightness , wheezing , severe dizziness , light - headedness , swelling of the lips or skin rash , stop the infusion and contact your doctor immediately . infections tell your doctor or pharmacist immediately if you feel unwell while being treated or when you are being treated with
always use roactemra exactly as your doctor has told you . you should check with your doctor or nurse if you are not sure . the intravenous infusion will be given over a period of time . your doctor will decide how long you should receive the treatment . the usual starting dose of roctemra is 8 mg per kg body weight . this is given every 4 weeks . the recommended starting dose for adults and children aged 8 years and older is 30 mg every 8 weeks . depending on your body weight , your doctor may decide to increase your dose or stop the treatment altogether . the maximum recommended dose for children aged 30
like all medicines , roactemra can cause side effects , although not everybody gets them . the following side effects have been reported in clinical trials ( see section 3 under " warnings and precautions "): if you are given more than the recommended dose , you may experience the following serious side effects : common ( may affect up to 1 in 10 people ): allergic reactions , including difficulty with breathing , chest tightness , light - headedness , rash , itching , hives , swelling of the lips , tongue or face . serious infections , including fever and chills , especially in the mouth and skin blisters . stomach ache signs
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the outer carton and the vial label after exp . this medicine does not require any special storage conditions .
what roactemra contains - the active substance is tocilizumab . each vial of 4 ml contains 80 mg of tociluzumab ( 20 mg / ml ). each 10 ml vial contains 200 mg of aldosterone ( e219 ). - the other ingredients ( excipients ) are : powder for concentrate for solution for infusion ( see section 2 ), sucrose , polysorbate 80 , disodium phosphate dodecahydrate , sodium dihydrogen phosphate dihydrate and water for injections in vial ( see also section 2 ). what roactemetra looks like and contents
onbrez breezhaler contains the active substance indacaterol which belongs to a group of medicines called bronchodilators . it works by relaxing the muscles in the walls of the small air passages in the lungs . onbrez bronz inhaler is used to treat breathing difficulties in adults with a lung disease called chronic obstructive pulmonary disease ( copd ). copd causes the muscles around the airways to relax , making breathing difficult . this medicine helps relax these muscles in your lungs , making it easier for air to get in and out of your lungs .
do not use onbrez breezhaler if you are allergic to indacaterol or any of the other ingredients of this medicine ( listed in section 6 ). if you have asthma . warnings and precautions talk to your doctor , pharmacist or nurse before using this medicine . if you think any of these apply to you , tell your doctor or pharmacist before you are given this medicine : heart problems , epilepsy , thyroid gland problems ( thyrotoxicosis ) or diabetes . if any of this applies to you ( or you are not sure ), consult your doctor immediately . you may experience tightness of the chest , coughing
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the usual dose is one 150 microgram capsule twice a day . your doctor may increase your dose to 300 micrograms once a day depending on how you respond to the treatment . you should use your inhaler at least 24 hours after you last inhaled it . onbrez breezhaler is supplied as an inhaler and capsules ( in blisters ) containing the medicine ( inhalation powder ) are provided in the pack . you can use the onbreez breez inhaler with or
what onbrez breezhaler contains - the active substance is indacaterol ( as indaconaterol maleate ). - the other ingredients are lactose and the capsule ( s ) contains gelatin . - the printing ink contains : - each one of the 300 micrograms capsules contains 300 milligrams of indiacaterol . the other ingredient ( s) is lactose , the capsule is composed of gelatin and - the ink contains an inhaler . capsules are provided in blisters . the capsules are supplied with a white powder . - each hard capsule contains : one hard capsule with 150 milligram
clopidogrel hcs is a combination of medicines called antiplatelet medicinal products . platelets ( so - called thrombocytes ) are very small structures in the blood , which clump together during blood clotting . by reducing the amount of this clumping , anti platelet medicinalproducts reduce the chances of blood clots forming ( a process known as atherothrombosis ) and reduce the risk of atheroarthrombotic events ( such as stroke , heart attack , or death ). you have been prescribed clopidoodrel hc to help prevent blood clotting and help prevent
do not take clopidogrel hcs - if you are allergic to clopilogrel or any of the other ingredients of this medicine ( listed in section 6 ). - have a medical condition that is currently causing bleeding such as a stomach ulcer or bleeding within the brain . - have severe liver disease . if any of these apply to you , tell your doctor or pharmacist . warnings and precautions take special care when you are taking clopridogrel clcs if you : - have an increased risk of bleeding ( e . g . a risk of internal bleeding ) - have previously had aomach ulcer
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose , including for patients with a condition called ' atrial fibrillation ' ( an irregular heartbeat ), is one 75 mg tablet of clopidogrel hcs per day to be taken orally with or without food , and at the same time each day . if you have experienced severe chest pain ( unstable angina or heart attack ), your doctor may prescribe a lower dose ( 300 mg ) of the same dose as usual . your doctor will decide how long you should continue to take cl
like all medicines , this medicine can cause side effects , although not everybody gets them . contact your doctor immediately if you experience : - fever , signs of infection or extreme tiredness . these may be due to rare decrease of some blood cells . - signs of liver problems such as yellowing of the skin and / or the eyes ( jaundice ), which may be associated with bleeding which appears under the skin as red pinpoint dots or confusion ( see section 2 ' warnings and precautions '). - swelling in the mouth or skin disorders such as rashes and itching , blisters of theskin . these could be the signs of an
what clopidogrel hcs contains - the active substance is clopridogrel . each film - coated tablet contains 75 mg of clopigrel ( as hydrochloride ). - the other ingredients ( excipients ) are ( see section 2 " clopidaogrel hexamethylene "): tablet core : microcrystalline cellulose , colloidal anhydrous silica , crospovidone ( type a ), macrogol 6000 and hydrogenated castor oil . tablet coating : polyvinyl alcohol , titanium dioxide ( e171 ), red iron oxide ( e172 ), yellow
fetcroja contains the active substance cefiderocol . it is an antibiotic medicine . it belongs to a group of antibiotics called cephalosporins . antibiotics are used to fight bacteria that cause infections . fetcroja is used to treat infections caused by bacteria that have not responded to other antibiotics .
do not use fetcroja if you are allergic to cefiderocol or any of the other ingredients of this medicine ( listed in section 6 ). if you think you may be allergic to other antibiotics , e . g . cephalosporins . if you have had a severe allergic reaction to certain antibiotics ( such as penicillins or carbapenems ) if you develop severe skin peeling and swelling of the hands , face , feet , lips , tongue or throat that may cause difficulty swallowing or breathing . warnings and precautions talk to your doctor , pharmacist or nurse before using fetcroj if you
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . fetcroja is given as an infusion ( a drip ) into a vein over a period of 3 to 2 hours . your doctor will decide how long you should be treated with this medicine . the dose you receive will depend on the type of infection you have and on the severity of your infection . if you have any pain during the fetroja infusion , your doctor may decide to give you a lower dose ( one drip into your vein ) if you suffer from kidney problems . patients with kidney problems should
like all medicines , this medicine can cause side effects , although not everybody gets them . serious side effects tell your doctor straight away if you notice any of the following side effects you may need urgent medical treatment : - severe allergic reaction - sudden swelling of your lips , face , throat or tongue - a severe rash or other severe skin reactions - difficulty swallowing or breathing - signs of this reaction may include diarrhoea , stools , blood or mucus . treatment with medicines that slow bowel movement may cause this reaction . other side effects include : common side effects ( may affect up to 1 in 10 people ) feeling sick ( nausea )
what fetcroja contains - the active substance is cefiderocol sulfate tosylate . each vial contains 1 mg of ccfiderocol . - the other ingredients are sucrose , sodium chloride and sodium hydroxide ( see section 2 ). what fetcroJA looks like and contents of the pack fetcroja is a white to off - white powder for concentrate for solution for infusion . each carton contains 10 vials . not all pack sizes may be marketed .
depocyte is used for the treatment of lymphomatous meningitis in adults and children aged 2 years and older . lymphomatinous maningitis is a condition in which tumour cells accumulate in the membranes of the brain and spinal cord . depocyte works by blocking the activity of these cells . by blocking their activity , depocyte is able to kill lymphoma tumour cell cells .
do not take depocyte if you are allergic to cytarabine or any of the other ingredients of this medicine ( listed in section 6 ). if you have a meningeal infection . warnings and precautions severe neurological side effects have been reported with depocyte . symptoms of the nervous system may include convulsions , pain , numbness , tingling , blindness and visual disturbances . if you experience any of these symptoms , stop taking any dexamethasone tablets and tell your doctor straight away . unwanted effects your doctor will monitor your side effects regularly to detect any new side effects . other medicines and depocyte tell your
treatment of cancer in the lumber sac will be overseen by a doctor who is experienced in the use of depocyte . depocyte will be prepared and given to you by a healthcare professional in a hospital or clinic under the supervision of a doctor with experience in the care of patients with advanced stage of cancer . your doctor will calculate the correct dose for you based on your weight and the type of cancer you have . each depocyte dose will be monitored by your doctor to detect any side effects . the recommended dose for depocyte is based on body surface area ( temperature 22 to 30 ). before withdrawing depocyte from the vial , you
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects may occur during your treatment with depocyte : very common side effects ( may affect more than 1 in 10 people ): very common : may affect up to 1 in 100 people : uncommon : may affects up to1 in 10 , 000 people : very rare : not known : frequency cannot be estimated from the available data . very common adverse events after the use of depocyte in combination with other chemotherapeutic agents ( see section 1 ). very common , may affect less than 1in 10 people : nausea , vomiting weakness ,
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the label and carton after exp . depocyte must be stored in a refrigerator ( 2 - 8 ). store in the original package in order to protect from light . after reconstitution , depocyte should be used within 4 hours . if depocyte is not used immediately , in - use storage times and conditions prior to use are the responsibility of the user and would normally not be longer than 24 hours at 2 to 8 , unless dilution has taken place in controlled and validated aseptic conditions
what depocyte contains - the active substance is cytarabine . each ml of solution for injection contains 10 mg cytarbine . one vial of 5 ml solution for injections contains 50 milligrams of cytarabeine . - the other ingredients are cholesterol , triolein , dioleoylphosphatidylcholine , dipalmitoylophosphATidylglycerol , sodium chloride and water for injections . what depocyte looks like and contents of the pack depocyte is a clear , colourless solution . it is supplied as an injection in a 5 ml glass v
the active substances in bemrist breezhaler are indacaterol and mometasone furoate . both of these active substances belong to a group of medicines called bronchodilators . they relax the muscles in the small airways in the lungs , making it easier for air to get in and out of the lungs . both belong to the class of medicines known as steroids . corticosteroids reduce the swelling and irritation ( inflammation ) in the smaller airways , which can lead to breathing problems and makes it harder for you to breathe effectively . when corticostromes are used to treat
do not take bemrist breezhaler if you are allergic to indacaterol , mometasone furoate or any of the other ingredients of this medicine ( listed in section 6 ). if you think you may be allergic , ask your doctor for advice . warnings and precautions talk to your doctor or pharmacist before taking belemrist breezezer : if you have heart problems , such as an irregular or fast heartbeat , thyroid gland problems , diabetes , high blood sugar , seizures , low level of potassium in your blood , severe liver problems , tuberculosis ( tb ) of the lung , or any long
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . bemrist breezhaler capsules should be swallowed whole with water . swallow the capsules whole with a glass of water . you can take the medicine with or without food . do not chew or crush the capsules . if your asthma does not improve or your symptoms get worse , talk to your doctor straight away . how much to use the recommended dose is one inhaler twice a day . you should use the inhaler once a day at the same time of the day . if you use more bem
like all medicines , this medicine can cause side effects , although not everybody gets them . some side effects may be serious . tell your doctor straight away if you notice any of the following : very common ( may affect more than 1 in 10 people ): difficulty breathing or swallowing , swelling of the tongue , lips , or face , skin rash , itching and hives ( signs of allergic reaction ). uncommon ( might affect up to 1 in 100 people ): swelling mainly around the tongue and lips , face and throat ( sign of angioedema ). other side effects other possible side effects the following side effects are listed below : common : may
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the blister and the carton after exp . the expiration date refers to the last day of that month . this medicine does not require any special temperature storage conditions . the capsules should be kept in the original blister in order to protect from light .
what bemrist breezhaler contains - the active substances are indacaterol ( as acetate ) and mometasone furoate . each inhaler contains 125 , 62 . 5 or 173 micrograms ( 3 . 5 mg ) of the active substance in each nostril . each inhale contains 150 mg of indacatorol ( 80 mg ) in each inhalation . - the other ingredients are : - in the mouthpiece of the inhaler : 125 microgram ( 6 . 0 mg ) indacataterol , 62. 5 mg , and in the inhalation : momet
the active substance of zyllt is clopidogrel . it belongs to a group of medicines called antiplatelet medicinal products . platelets are very small structures in the blood , which clump together during blood clotting . by preventing this clumping , antiplatelets medicinal products reduce the chances of blood clots forming ( a process called thrombosis ). zylltic is used to prevent blood clumps ( thrombi )forming in hardened blood vessels ( arteries ), a process known as atherothrombinosis , which can lead to atheroarthrombotic events ( such as stroke
do not take zyllt if you are allergic to clopidogrel or any of the other ingredients of this medicine ( listed in section 6 ). if you have a medical condition that is currently causing bleeding such as a stomach ulcer or bleeding within the brain . if you suffer from severe liver disease . if any of these apply to you ( or you are not sure ), talk to your doctor , pharmacist or nurse before you take zllt . warnings and precautions before you start taking zylltt , tell your doctor or pharmacist if : you have an increased risk of bleeding , such as : - a medical
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose for patients with a condition called ' atrial fibrillation ' ( an irregular heartbeat ) is one 75 mg tablet of zyllt per day to be taken orally with or without food . if you have experienced severe chest pain ( unstable angina or heart attack ), your doctor may prescribe a lower dose of 300 mg of zllt ( 1 tablet of 75 mg ) once at the start of treatment . this dose may be increased to 75 mg once a day depending on your response to
like all medicines , this medicine can cause side effects , although not everybody gets them . contact your doctor immediately if you experience : - fever , signs of infection or extreme tiredness . these may be due to rare decrease of some blood cells . - signs of liver problems such as yellowing of the skin or the whites of the eyes ( jaundice ). - bleeding which appears under the skin as red pinpoint dots and / or confusion ( see section 2 ' warnings and precautions '). - swelling in the mouth or skin disorders such as rashes and itching , blisters of theskin . these could be the signs of an allergic
what zyllt contains - the active substance is clopidogrel . each film - coated tablet contains 75 mg of clopridogrel ( as hydrogen sulphate ). - the other ingredients are : tablet core : lactose ( see section 2 under ' important information about lactose '), microcrystalline cellulose , pregelatinised maize starch , macrogol 6000 and hydrogenated castor oil in the tablet core and hypromellose ( e464 ), titanium dioxide ( e171 ), red iron oxide ( e172 ), talc and propylene glycol in the film - coating . what z
lamivudine teva contains the active substance , lamivudrine . lamivudaine tiva is used for the treatment of long term ( chronic ) hepatitis b infection in adults , adolescents and children aged 12 years and older who are not able to pass on their own virus ( hepatitis b ). the hepatitis b virus belongs to a group of medicines called nucleoside analogue reverse transcriptase inhibitors ( nrtis ). hepatitis b is a virus that infects the liver , and so is life - threatening . in patients with long term (" chronic " infection , liver damage is not prevented . your doctor has prescribed lamiv
you must not be given lamivudine teva - if you are allergic , or think you may be allergic , to any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions 28 talk to your doctor , pharmacist or nurse before you are given this medicine if you : - are breast - feeding ( see section 28 for more information on this ). - are taking other similar medicines which may increase the risk of serious side effects . - have liver disease , such as hepatitis c . - are overweight . your doctor may ask you to have blood tests before you start your medication . see section 4 for
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much to take your doctor lamivudine teva is used to treat your hepatitis b infection . your doctor will check whether your infection is getting worse and will treat your illness if necessary . take the tablet at the same time each day . do not chew or break the tablet as this may affect its action . you should swallow the tablet whole with a glass of water . if you cannot swallow the tablets whole , talk to your doctor . the recommended dose is one tablet once a day . lamiv
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects have been reported with lamivudine teva in clinical trials for other conditions linked to hepatitis b . if any of the side effects gets serious , stop taking the medicine and see a doctor straight away . the duration of therapy for hepatitis b is not known . other side effects reported during the post - marketing use of lamivudaine clinical trials were : tiredness , respiratory tract infections , throat discomfort , headache , stomach discomfort , pain , nausea , vomiting , diarrhoea , increases in liver enzymes , seen in tests
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the blister after exp . this medicine does not require any special storage conditions . lamivudine teva should not be disposed of via wastewater or household waste . ask your pharmacist how to dispose of medicines no longer required . these measures will help to protect the environment .
what lamivudine teva contains - the active substance is lamvudine . each film - coated tablet contains 100 mg of lamibrudine - the other ingredients are : tablet core : microcrystalline cellulose , sodium starch glycolate , magnesium stearate . tablet film - coating : hypromellose , titanium dioxide ( e171 ), macrogol , polysorbate 80 , iron oxide yellow ( e172 ) and iron oxide red ( e 172 ). tablet coat : shellac , talc ( e553b ), red ink ( e904b ), black ink ( type a
nespo ( an anti - anaemic ) is used to treat your anaemia . anaemia occurs when your blood does not contain enough red blood cells . the symptoms include fatigue , weakness and shortness of breath . it is caused by the lack of the natural hormone erythropoietin ( a substance produced by biotechnology in the body ) and the inability of your kidneys ( your bone marrow ) to produce enough redblood cells . darbepoetin alfa is used for the treatment of chronic renal failure ( symptomatic anaemia ) in adult patients with kidney failure . nespo reduces the amount
do not use nespo : if you have high blood pressure or are taking other medicines . if you think you may be allergic , ask your doctor or pharmacist for advice . warnings and precautions talk to your doctor , pharmacist or nurse before you are given neespo ( darbepoetin alfa ) or r - huepo . if any of the above applies to you ( or you are not sure ), please tell your doctor . children and adolescents do not give this medicine to children under the age of 18 years because it has not been studied in this age group . other medicines and nes
your doctor will carry out blood tests before and during treatment with nespo to check your haemoglobin level . the usual starting dose is 10 micrograms per kilogram of body weight . your doctor may increase your dose to a maximum of 10 microg / kg every 12 hours . the pre - filled syringe can be given into a vein ( intravenous ). if you have chronic renal failure , a single injection may be given under the skin or into an intravenous . if your anaemia does not respond to the medicine , your doctor will check your blood to make sure it is not too high or too low .
like all medicines , nespo can cause side effects , although not everybody gets them . the following side effects have been reported in clinical trials : 471 to 10 out of 100 patients high blood pressure ( hypertension ) fluid retention ( oedema ) uncommon ( to less than 1 in 100 patients ) blood clots ( thrombosis ) pain in the area injected rash and redness of the skin rare ( may affect up to 1 in 10 , 000 patients ) serious allergic reactions sudden life - threatening allergic reactions ( anaphylaxis ) swelling of the face , lips , mouth , tongue or throat that may cause difficulty
keep out of the reach and sight of children . do not use nespo after the expiry date which is stated on the carton and on the syringe label after exp . store in a refrigerator ( 2 - 8 ). do not freeze . keep your syringe in the outer carton in order to protect from light . after first opening : do not store above 30 and keep it at room temperature ( up to 7 ) for a single period of up to seven days . do this at the end of this seven - day period . keep the bottle tightly closed in order not to damage it . medicines should not be disposed
what nespo contains - the active substance is darbepoetin alfa . each ml of a pre - filled syringe contains 10 , 15 , 20 , 30 , 40 , 50 , 60 , 80 , 100 , 130 , 150 , 300 or 500 iu . - the other ingredients are sodium phosphate monobasic , sodium phosphate dibasic ( type a ), sodium chloride , polysorbate 80 and water for injections . what nespos looks like and contents of the pack the solution is clear , colourless to slightly pearly liquid and cloudy . each pack contains 1 or
macugen is a solution for the treatment of macular degeneration in adults . it contains the active substance pegaptanib . this medicine is used to prevent abnormal formation of new blood vessels in the eye . macugen is used in adults , adolescents and children of all ages . the treatment is intended for adults with macular dementia . in this disease , vision loss occurs due to damage to a part of the retina called the macula . macula is the thin layer between the two layers of the eye ( amd ). as a result , abnormal blood vessels grow in the retina ( macula ) and become larger . these new
do not use macugen if you are allergic to pegaptanib or any of the other ingredients of this medicine ( listed in section 6 ). if you have an active or suspected infection in your eye . warnings and precautions talk to your doctor , pharmacist or nurse before using macugen . if you think you may have an infection or bleeding in the eye , stop macugen injection and contact your doctor immediately . tell your doctor or nurse if you experience the following symptoms : eye pain , increased discomfort , worsening eye redness , blurred or decreased vision , increased sensitivity to light , or small particles in your vision . the injection may
how macugen is given macugen will be given to you by a doctor or nurse . it is given as a single injection into the back of the eye . the recommended dose is 6 to 9 ml . the injection will be injected into the vitreous part of your eye . your doctor will decide how much macugen you need and how often you need to be treated . macugen must not be used in combination with antibiotic eye drops . the doctor will clean your eye and give you some local anaesthetic ( numbing medicine ) to relieve any pain that you may have after the injection . if you are allergic to antibiotic eye
like all medicines , this medicine can cause side effects , although not everybody gets them . serious allergic reaction ( anaphylactic reaction ) angioedema of which symptoms include breathing difficulty , wheezing , swollen mouth , face , hands or feet , itching skin , fainting , rapid pulse , stomach cramps , nausea , vomiting and diarrhoea . the frequency of these side effects is not known . an infection in the internal portion of the eye has been reported in patients receiving macugen treatment . the symptoms are described in section 2 under " warnings and precautions " for these symptoms . other side effects very common (
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the blister after exp . this medicine does not require any special storage conditions . the medicine should be used immediately .
what macugen contains - the active substance is pegaptanib . each single dose pre - filled syringe contains 0 . 3 mg of pegaptenib in 90 ml of solution . - the other ingredients are : sodium chloride , monobasic sodium phosphate monohydrate , dibasicodium phosphate heptahydrate , sodium hydroxide , hydrochloric acid ( for ph adjustment ) and water for injections . see section 2 . what macugen looks like and contents of the pack macugen solution for injection in a single dose pack is supplied in a pouch . each pack contains : - a pre -
pivance contains the active substance palifermin , which is produced by biotechnology in the plant called escherichia coli . it works by inhibiting the growth of epithelial cells in the mouth and digestive tract , and by blocking their growth in the tissues of the skin . by blocking these growths , palifermine can help to prevent oral mucositis from occurring . if you experience soreness , dryness or inflammation of the mouth , this side effect is usually mild to moderate . your doctor may decide to give you treatments to treat your blood cancer at a lower dose or to reduce the risk of your blood
do not use kepivance - if you are allergic to palifermin , escherichia coli derived proteins or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before using this medicine . children and adolescents do not give this medicine to children under 18 years of age because it has not been studied in this age group . other medicines and kepacivance tell your doctor or pharmacist if you take , have recently taken or might take any other medicines . this is particularly important if your child has recently taken heparin . pregnancy and
how kepivance is given your doctor will decide on the dose you will receive . the usual dose of cancer treatment for adults is one 60 mg film - coated tablet ( tablet ) per kilogram body weight . the tablet will be given as an intravenous injection into a vein ( intravenous ) over a period of three days . your doctor may decide to change your dose of chemotherapy or radiotherapy . the first three days of chemotherapy are given as chemotherapy and radiotherapy followed by 24 to 48 hours of rest between the chemotherapy . if you are given more radiotherapy than you should if you have been given more chemotherapy than you
like all medicines , this medicine can cause side effects , although not everybody gets them . common ( may affect up to 1 in 10 people ) side effects include skin rash , itching , redness , pruritus and erythaema ( an increase in the thickness in the mouth or tongue , change in colour of the face or tongue ), generalised swelling ( oedema ), swelling of hands , ankles or feet , pain , fever and aching joints ( arthralgia ), altered taste , raised levels of lipase and amylase levels in the blood , and decrease in the number of digestive enzymes in
what kepivance contains - the active substance is palifermin . each vial contains 6 . 25 mg paliferin . - the other ingredients are mannitol , sucrose , l - histidine , polysorbate 20 and diluted hydrochloric acid ( see section 2 ). what kepenivance looks like and contents of the pack kepiverance is a white powder for concentrate for solution for injection in a vial . each pack contains 6 vials .
cinacalcet accordpharma contains the active ingredient cinacalcitepine , which increases the levels of calcium and phosphorous in the blood . it is used to treat problems with organs called parathyroid glands . parathyroids are four small glands in the neck that are connected to the thyroid gland . cinaconcet accordpharma is used : to treat secondary hyperparathyroidism in adults with serious kidney disease who are on dialysis or whose thyroid gland is not working properly . to reduce the amount of calcium in the bloodstream ( hypercalcaemia ) in patients with par
do not take cinacalcet accordpharma : - if you are allergic to the active substance cinapalcate or any of the other ingredients of this medicine ( listed in section 6 ). - if there are low levels of calcium in your blood . if your blood calcium levels are too low . warnings and precautions talk to your doctor , pharmacist or nurse before taking cinocalcordpharma . before you start taking this medicine , tell your doctor if you have : - seizures ( fits or convulsions ). - fits or seizures . - liver problems . - heart failure . cin
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much to take the recommended dose of cinacalcet accordpharma is one tablet once a day . you should swallow the tablet whole with a glass of water . your doctor will tell you how many tablets to take . the tablets can be taken with or without food . regular blood samples will be taken during treatment . if you have secondary hyperparathyroidism , your doctor may decide to increase the dose of one tablet of the 30 mg film - coated tablet to one tablet a day
like all medicines , this medicine can cause side effects , although not everybody gets them . contact your doctor immediately if you experience : - numbness or tingling around the mouth , muscle aches , cramps or seizures . these may be signs that your calcium levels are too low ( hypocalcaemia ). - swelling of the face , lips , mouth , tongue or throat that may cause difficulty in swallowing or breathing ( angioedema ). these side effects are common ( may affect up to 1 in 10 people ) and may include nausea and vomiting . if any of the above occur , stop taking cinacalc
what cinacalcet accordpharma contains â the active substance is cinocet . each film - coated tablet contains either 30 mg , 60 mg or 90 mg of cinacealcot ( as hydrochloride ). the other ingredients are cellulose , microcrystalline - crospovidone - magnesium stearate , hypromellose , titanium dioxide ( e171 ), triacetin , indigo carmine aluminum lake ( e132 ) and iron oxide yellow ( e172 ). what cicalcordpharma looks like and contents of the pack â cin
jentadueto contains two different active substances called linagliptin and metformin . both of these active substances are made in the body called dpp - 4 inhibitors ( dipeptidyl peptidase - 4 inhibitor ) and are used in the treatment of diabetes in adults . they are called biguanides and help control blood sugar levels in adult patients with diabetes called ' type 2 diabetes mellitus '. this medicine works by helping your body make better use of insulin . this medicine is used in combination with certain other medicines used to treat diabetes ( such as sulphonylureas or empaglif
do not take jentadueto if you are allergic to linagliptin , metformin or any of the other ingredients of this medicine ( listed in section 6 ). if you have severely reduced kidney function ( uncontrolled diabetes with severe hyperglycaemia ( high blood glucose ), nausea , vomiting , diarrhoea , rapid weight loss , lactic acidosis ( see section " warnings and precautions "). if any of these apply to you , tell your doctor or pharmacist before taking this medicine . if you know that you have a condition called ' ketone bodies ' ( diabetic pre - coma ). symptoms include stomach pain
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose of jentadueto is one tablet once a day . if you currently take metformin , your doctor may prescribe individual tablets of linagliptin ( equivalent to one tablet of metformatin ) with or without food . this medicine is for oral use . swallow the tablet whole with a glass of water . do not chew , crush or split the tablet . if this medicine does not help you to get an upset stomach , take the tablet as soon as you remember . the
like all medicines , this medicine can cause side effects , although not everybody gets them . some symptoms may be serious and require immediate medical attention . stop taking jentadueto and see a doctor straight away if you experience any of the following symptoms : low blood sugar ( hypoglycaemia ) trembling , sweating , anxiety , blurred vision , tingling lips , paleness , mood change and confusion . hypocaemia is a very rare ( may affect up to 1 in 10 , 000 people ) but very serious side effect that can be life - threatening . if you are treated for lactic acidosis , stop taking
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the blister and the carton after exp . the expiration date refers to the last day of that month . store in a refrigerator ( 2 - 8 ). do not freeze . blister : store in the original package in order to protect from light . this medicine does not require any special temperature storage conditions . if you notice any visible sign of tampering , do not throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect
what jentadueto contains - the active substances are linagliptin and metformin hydrochloride . - each dosing tablet ( 2 . 5 mg / 850 mg ) contains 2. 5 mg linaglioptin and 850 mg met formin hydroxychloride , - the other ingredients are arginine , copovidone , magnesium stearate , maize starch , silica , colloidal anhydrous , hypromellose , titanium dioxide ( e171 ), talc , propylene glycol ( e1520 ). - the tablet coating ( s ) is white to off - white
edurant contains the active substance rilpivirine . edurant is used to treat human immunodeficiency virus ( hiv ) infection in adults . it belongs to a group of hiv medicines called non - nucleoside reverse transcriptase inhibitors ( nnrtis ). it is used in adults to treat hiv and in children and adolescents 12 years of age and older who are infected with hiv . it is also used in combination with other hiv medicine . if you have any further questions on the use of this product , ask your doctor or pharmacist .
do not take edurant - if you are allergic to rilpivirine or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before you are given this medicine . if you think any of these apply to you , tell your doctor or pharmacist before you take this medicine , or if you have any questions at all . if your doctor has told you that you are not suitable , ask your doctor for advice before taking this medicine : - medicines used to treat some bacterial infections ( such as tuberculosis ) - omeprazole , es
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one tablet once a day . children and adolescents edurant should not be used in children under 18 years of age . your doctor will tell you how many tablets to take and how often to take them . the dose you need to take is based on your child ' s body weight and body weight . the usual dose is two tablets of rifabutin per day . if your child is taking any of the following tablets , please tell your doctor , pharmacist or nurse before
like all medicines , this medicine can cause side effects , although not everybody gets them . headache , nausea , difficulty falling asleep , insomnia , dizziness , changes in your routine liver tests , increased levels of transaminase , increase in cholesterol and pancreatic amylase in your blood , abnormal dreams , rash , stomach pain , depression , tiredness , vomiting , drowsiness , decreased appetite , sleep disorders , stomach discomfort , depressed mood , dry mouth 36 low white blood cell and / or platelet count , decrease in haemoglobin in your bloodstream , triglycerides , lipase and bilirubin in blood uncommon ,
what edurant contains - the active substance is rilpivirine . - each tablet contains an active substance called rilpaline hydrochloride . each tablet of edurants contains rilpeline 25 mg . - the other ingredients are : tablet core : lactose monohydrate , croscarmellose sodium , povidone k30 , polysorbate 20 , silicified microcrystalline cellulose , magnesium stearate . the film - coating contains lactosemonohydrate , hypromellose 2910 , talc ( e553b ), titanium dioxide ( e171
avandamet tablets contain two different medicines called rosiglitazone and metformin . these two medicines help to control the level of sugar in your blood when you have type 2 diabetes . type 2abetes usually develops when your body does not make enough insulin to control your blood sugar levels . insulin is a substance produced in the body that helps to keep the body ' s blood sugar under control . rosaiglitrazone and meetformin work together by helping your body make better use of the insulin it produces . your doctor may also adjust your dose , if necessary , if you continue to increase your blood
follow all your doctor ' s instructions carefully , even if they differ from the general information contained in this leaflet . check with your doctor , pharmacist or nurse if you are not sure . if your diabetes is not controlled with avandamet . if you have been told by your doctor that you are allergic ( hypersensitive ) to rosiglitazone or metformin . warnings and precautions talk to your doctor or pharmacist before you are given avandamanet if : you have had a heart attack , severe angina , heart failure or have had heart failure in the past you have severe breathing difficulties you
always take avandamet tablets exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much to take the recommended starting dose is 2 mg rosiglitazone ( equivalent to 1000 mg metformin ). this dose is achieved gradually over 1 to 8 hours . the maximum dose is reached gradually over 4 hours . your doctor will decide the right dose for you . the dose may be divided into two equal doses . if you have the impression that the effect is too strong or too weak , talk to your doctor . how long to take your doctor may decide to increase
like all medicines , avandamet can cause side effects , although not everybody gets them . allergic reactions have been reported in patients treated with avandamanet . signs include raised and itchy rash ( hives ) swelling mainly of the face or mouth ( angioedema ), which may cause difficulty in breathing collapse . if you notice any of these symptoms , stop taking the medicine and contact your doctor straightaway . avANDamet may cause lactic acidosis ( a build - up of lactic acids in the blood ( lacticacidosis is a common side effect of metformin in patients with severe kidney
your doctor , pharmacist or nurse knows how to store avandamet properly .
what avandamet contains - the active substances are rosiglitazone and metformin . each tablet contains either one or two of the following active substances ( see section 2 ' avandamset tablets contain rosciglitasone '): 500 mg metforman . each 2 tablet contains rosigllitazon 500 mg ( metformatin ). each 4 tablet contain rosIGlitazione 1000 mg ( meetformin ). - the other ingredients are sodium starch glycollate , hypromellose , microcrystalline cellulose , lactose monohydrate , povidone
clopidogrel mylan is a medicine that belongs to a group of medicines called antiplatelet medicinal products . platelets are very small structures in the blood , which clump together during blood clotting . by preventing this clumping , anti platelet medicinalproducts reduce the chances of blood clots forming ( a process known as thrombosis ). clopidoggingrel melan is taken by adults to reduce the number of bloodclots ( thrombi ) that can form in hardened blood vessels ( arteries ), an event known as atherothrombinosis , a condition which can lead to athero
do not take clopidogrel mylan 31 - if you are allergic to clopilogrel or any of the other ingredients of this medicine ( listed in section 6 ). - have a medical condition that is currently causing bleeding such as a stomach ulcer or bleeding within the brain . - have severe liver disease . if any of these apply to you , tell your doctor or pharmacist . warnings and precautions talk to your doctor , pharmacist or nurse before taking clopridogrel melan : if you have an increased risk of bleeding ( e . g ., a risk of internal bleeding ) or a stomach
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose , including for patients with a condition called ' atrial fibrillation ' ( an irregular heartbeat ), is one 75 mg tablet of clopidogrel mylan per day to be taken orally with or without food , and at the same time each day . if you have experienced severe chest pain ( unstable angina or heart attack ), your doctor may prescribe a lower dose ( 300 mg ) of the same tablet once a day . your doctor will decide how long you should take clop
like all medicines , this medicine can cause side effects , although not everybody gets them . contact your doctor immediately if you experience : - fever , signs of infection or extreme tiredness . these may be due to rare decrease of some blood cells . - signs of liver problems such as yellowing of the skin and / or the eyes ( jaundice ), which may be associated with bleeding which appears under the skin as red pinpoint dots or confusion ( see section 2 ' warnings and precautions '). - swelling in the mouth or skin disorders such as rashes and itching , blisters of theskin . these could be the signs of an
what clopidogrel mylan contains - the active substance is clopridogrel . each film - coated tablet contains 75 mg of clopigrel ( as hydrochloride ). - the other ingredients are : tablet core : microcrystalline cellulose , colloidal anhydrous silica , crospovidone ( type a ), macrogol 6000 , hydrogenated castor oil ( see section 2 ' clopidaogrel melan contains hydrogenatedcastor oil '); tablet coating : polyvinyl alcohol , titanium dioxide ( e171 ), red iron oxide ( e172 ), yellow iron
doptelet belongs to a group of medicines known as thrombopoietin receptor agonists . doptelet is used to treat chronic liver disease ( low platelet count ) in adults , adolescents and children ( 12 years of age and older ), and in children ( 6 years to less than 18 years old ) with a medical procedure to stop bleeding . it works by reducing the number of platelets in the blood . platelets are a type of blood cells that help the blood to clot and reduce the risk of bleeding .
do not use doptelet if you are allergic to avatrombopag or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before using this medicine : if you have or have had blood clots in your veins or arteries . if you think you may be at increased risk of blood clotting , ask your doctor for advice . children and adolescents do not give this medicine to children under the age of 23 years because the contraceptive birth control pill has not been fully effective in this age group . hormone replacement therapy should not be used if you
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the usual dose for your procedure is one 5 mg tablet once a day for up to 8 weeks . your doctor will tell you how many tablets of doptelet you need to take at the same time each day . if you take more dopotelet than you should if you accidentally take too many tablets , talk to a doctor or go to the nearest hospital emergency unit immediately . the dose may be increased by 20 mg , 40 mg , 60 mg or 5 mg per day depending on your platelet counts
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects have been reported with doptelet : very common ( may affect more than 1 in 10 people ): feeling tired uncommon ( might affect up to 1 in 100 people ): low red blood cell count ( anaemia ) blood clot in the portal vein ( a blood vessel that transports blood from the liver to the intestines ) upper abdominal pain swelling bone pain muscle aches fever reporting of side effects if you get any side effects talk to your doctor , pharmacist or nurse . this includes any possible side effects not listed in this leaf
what doptelet contains - the active substance is avatrombopag . - each film - coated tablet contains an active substance called avATrombapag maleate . - the other ingredients are : tablet core : 20 micrograms ( 0 . 5 milliliter ) - tablet coating : lactose monohydrate ( see end of section 2 ' important information about lactose '), microcrystalline cellulose , crospovidone type b [ e110 ], silica , colloidal anhydrous , magnesium stearate - film - coating : vinyl alcohol , talc , macrogol
rapiscan belongs to a group of medicines called ' coronary vasodilators '. it is used to monitor the heart arteries ( heart rate ) and the muscles of the heart . rapiscan is used in adults for a type of heart scan called ' myocardial perfusion imaging '. the scan uses a radioactive substance called a ' radiopharmaceutical '. these images are taken as part of a series of muscles in the heart using a treadmill to measure blood flow . a scan can be performed to measure the amount of a small amount of radiopharma in the body . it is given into a vein by
do not take rapiscan if you have : slow heart rate , high degree heart block , sinus node disease , a pacemaker , chest pain ( unstable angina ), or treatment for low blood pressure ( hypotension ) or heart failure if you are allergic to regadenoson or any of the other ingredients of rapiscin ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before you are given the injection if you : have a recent serious heart problem , including a heart attack , abnormal heart rhythms ( a heart rhythm where the heartbeat is very fast or uneven , atrial fl
rapiscan will be given to you by a doctor or nurse who is experienced in the treatment of your heart . your doctor will calculate your heart rate and blood pressure . the recommended dose is 400 mg given as a 5 ml solution the injection may be given as either one 5 ml or two 10 ml injections depending on your weight , or as an injection of sodium chloride 9 mg / ml ( 0 . 9 %) solution for injection . the dose may be increased or decreased depending on the type of medicine you are being treated with . if you are given more rapiscan than you should if you have been given too much rap
like all medicines , rapiscan can cause side effects , although not everybody gets them . most of the side effects are mild to moderate . however , some may be serious and require immediate medical attention . if you notice any of the following , stop taking rapican and contact your doctor immediately : sudden stopping of the heart which may be a sign of damage to the heart ( heart block ), a disorder of theheart ' s electrical signal , rapid heart beat low blood pressure , fainting , mini strokes , weakness of the face and inability to speak . if any of these apply to you , tell your doctor straight away .
viagra contains the active substance sildenafil which belongs to a group of medicines called phosphodiesterase type 5 ( pde5 ) inhibitors . it works by helping to relax the blood vessels in your penis , allowing blood to flow into your penis when you get sexually excited . viagra is used to help you get an erection when you are sexually stimulated by your sexual activity .Viagra is a treatment for adult men with erectile dysfunction ( impotence ), a condition in which a man cannot get , keep or keep a hard , erect penis suitable for sexual activity after sex .
do not take viagra if : you are allergic to sildenafil or any of the other ingredients of this medicine ( listed in section 6 ). you are taking medicines called nitrates , which could lead to a dangerous fall in your blood pressure . you are also taking these medicines for angina pectoris ( " chest pain "). you should stop taking the medicines if any of these apply to you . you should not take nitric oxide donors ( such as amyl nitrite ) which may also increase your risk of a dangerous drop in yourblood pressure . riociguat . this drug is used
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one 50 mg tablet once a day . you can take viagra with or without food . viagra film - coated tablets are also available as viagra orodispersible tablets . if you take more viagra than you should if you accidentally take too many tablets , contact your doctor straight away . swallow the tablet whole with a glass of water . do not crush or chew the tablet . taking viagra at the same time each day will help you to get an erection . if
like all medicines , this medicine can cause side effects , although not everybody gets them . some of the side effects may be serious and need immediate medical attention . stop taking viagra and see a doctor straight away if you notice any of the following side effects : - an allergic reaction ( may affect up to 1 in 100 people ). symptoms may include sudden wheeziness , difficulty in breathing , dizziness and swelling of the eyelids , face , lips or throat . - chest pains if you are in a semi - sitting position , you should use nitrates to relieve your chest pain . - prolonged and sometimes painful erections ( may
what viagra contains - the active substance is sildenafil . each tablet contains 25 mg of sildenedafil ( as the citrate salt ). - the other ingredients are : tablet core : microcrystalline cellulose , calcium hydrogen phosphate ( anhydrous ), croscarmellose sodium , magnesium stearate . tablet coating : hypromellose , titanium dioxide ( e171 ), lactose monohydrate , triacetin , indigo carmine aluminium lake ( e132 ). what viagra looks like and contents of the pack viagra film - coated tablets have a rounded - diamond shape and
sifrol contains the active substance pramipexole and belongs to a group of medicines called dopamine agonists , which stimulate dopamine receptors in the brain . stimulation of the dopamine receptors triggers nerve impulses in thebrain that help to control body movements . sifrol is used to treat the symptoms of primary parkinson ' s disease in adults . it is used in combination with levodopa for the treatment of parkinson '. it is indicated for the symptoms in adult patients with moderate to severe primary restless legs syndrome .
do not take sifrol - if you are allergic to pramipexole or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before you are given sifol if you have any medical conditions or symptoms of kidney disease . hallucinations ( seeing , hearing or feeling things that are not there ). most hallucinations are temporary . dyskinesia ( abnormal , uncontrolled movements of the limbs ). in patients with advanced parkinson ' s disease , levodopa has been shown to increase the risk of dyskineia . if you think any of
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose of sifrol for parkinson ' s disease is 3 tablets per day for the first week . the usual starting dose is 1 tablet ( 0 . 088 mg ) in the morning and 0 . 264 mg in the evening . your doctor will tell you how many tablets to take each day . the dose may be increased or decreased depending on how you respond to the medicine . this is called the " maintenance dose ". your doctor may increase or decrease your dose to a maximum of 1 tablet
like all medicines , this medicine can cause side effects , although not everybody gets them . evaluation of these side effects is based on the following frequencies : very common ( may affect more than 1 in 10 people ) common : may affect up to 1 in every 10 people uncommon : may affects up to one in every 100 people rare : this may affect between 1 in 1 , 000 and 10 , 000 people not known ( frequency cannot be estimated from the available data ): if you have parkinson ' s disease , you may experience the following side effects : - dyskinesia ( abnormal , uncontrolled movements of the limbs ) - dizziness
what sifrol contains - the active substance is pramipexole . each tablet contains 0 . 088 mg , 0 . 18 mg or 0 . 35 mg , respectively ( 0 . 7 mg / 0 . 75 mg ). - the other ingredients are : tablet core : aminotransferase ( e1201 ) ( e1521 ) ( 1 milligram per tablet ) pramipexol dihydrochloride monohydrate , mannitol ( e421 ), maize starch , anhydrous colloidal silica , povidone k 25 , magnesium stearate . what s
emadine is a medicine used for the treatment of seasonal allergic conjunctivitis of the eye . it is used to prevent allergic conditions from occurring in your eye . the allergic reaction may be severe and may be life - threatening . the most common signs of allergy conjunctivalitis are itching , redness and swelling on the surface of your eye , which may make you feel worse . if you notice any of these , tell your doctor straight away .
do not use emadine : - if you are allergic to emedastine or any of the other ingredients of this medicine ( listed in section 6 . warnings and precautions talk to your doctor , pharmacist or nurse before using this medicine ). children and adolescents do not give this medicine to children or adolescents below the age of 3 years because benzalkonium chloride is present in the blood . do not increase or decrease the dose of the medicine in this age group . if you think any of these apply to you , tell your doctor or pharmacist . warnings , precautions , and clinical trials you should not be given emad
always use this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . how much to use the recommended dose is 3 drops in each eye . this medicine is for oral use . do not apply this medicine to your eyes unless your doctor tells you to . step 3 . step 1 step 2 step 1 take the emadine bottle out of the bottle and wash your hands . hold the bottle tightly closed with a finger . tilt the cap back . pull back the eyelid with a clean finger and squeeze until there is a ' pocket ' between the eyel
like all medicines , this medicine can cause side effects , although not everybody gets them . stop using emadine and talk to your doctor or pharmacist immediately if you notice any of the effects listed below . common side effects ( may affect up to 1 in 10 people ) effects in the eye : eye pain , itchy eye and eye redness . not known ( frequency cannot be estimated from the available data ): uncommon side effects in your eye : corneal disorder ( abnormal eye sensation , increased tear production , tired eyes , eye irritation , blurred vision , corneel staining and dry eye ). general side effects : headache
keep out of the reach and sight of children . do not use emadine after the expiry date which is stated on the carton and on the blister after exp . the expiration date refers to the last day of that month . store below 25 . store in the original package in order to protect from moisture and infections .
what emadine contains - the active substance is emadastine 0 . 5 mg / ml . - the other ingredients are difumarate , benzalkonium chloride , trometamol , sodium chloride , hypromellose , purified water , hydrochloric acid , sodium hydroxide , acidity levels ( ph levels ) and water for injections ( see section 2 ). what emADine looks like and contents of the pack emadINE is a liquid ( a solution ) supplied in a 5 ml or 10 ml plastic ( drop - bottle ) bottle with a screw cap . not all pack sizes
levetiracetam is an antiepileptic medicine ( a medicine used to treat seizures in epilepsy ). levetiratam actavis is used : on its own in adults and adolescents from 16 years of age with newly diagnosed epilepsy , to treat a certain form of epilepsy . epilepsy is a condition where the patients have repeated fits ( seizures ). the epilepsy is defined as a condition in which the fits initially affect only one side of the brain , but could thereafter extend to larger areas on both sides of that brain ( partial onset seizure with or without secondary generalisation ) and may thereafter be larger or larger . levet
do not take levetiracetam actavis : - if you are allergic to the active substance leveturacetam ( pyrrolidone derivatives ) or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before you are given this medicine : - levetira actavis should not be used if you have kidney problems . - tell your doctor if you notice any slow down in the growth or puberty of your child . - anti - epileptics have been shown to increase the risk of taking this medicine . if you think you may
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . levetiracetam actavis should be taken once a day in the morning and once in the evening . monotherapy dose the recommended starting dose for adults and adolescents 16 years of age and older is 1 , 000 mg twice a day . your doctor may prescribe a lower or higher dose depending on your condition and on how you respond to the medicine . the recommended dose for children and adolescents 3 years and older and weighing at least 3 , 000 kg is one tablet a day ( 2 tablets of 1 ,
like all medicines , this medicine can cause side effects , although not everybody gets them . contact your doctor or the nearest emergency department immediately if you experience : weakness , feel light - headed , dizzy or have difficulty breathing . these may be signs of a serious allergic ( anaphylactic ) reaction . swelling of the face , lips , tongue and throat ( quincke ' s oedema ). flu - like symptoms with a rash on the face and an extended rash with a high temperature . increased levels of liver enzymes seen in blood tests . decrease in a type of white blood cell ( 56 - eosinophilia
what levetiracetam actavis contains - the active substance is called lisinopril . each vial of levetoracetamactavis 250 mg contains 250 mg of tisselopril ( as lisinapril ). - the other ingredient is levetiraacetam . each ml of film - coated tablet ( s ) contains 500 mg of lisselapril . - the tablet can be divided into two equal doses ( 500 mg and 500 mg ). - each single dose ( 1 , 000 mg and 750 mg ) contains one half of the active ingredient ( lisselsopril ) of
what incruse ellipta is this medicine contains the active substance umeclidinium bromide which belongs to a class of bronchodilators called " inhalation inhalations ". what incrusey ellipta used for this medicine is used to treat chronic obstructive pulmonary disease ( copd ). copd is a long - term condition in which the airways in your lungs become blocked . this can lead to breathing difficulties , difficulties in breathing and tightening of the muscles around your lungs . this medicine works by tightening these muscles in the lungs so that your breathing difficulties are easier to control . if you have cop
do not use incruse ellipta 27 - if you are allergic to umeclidinium or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before using this medicine if : - you have asthma . you are not sure if this applies to you , but you should tell your doctor straight away if you think any of these apply to you . - you think you may have asthma , or if you have heart problems , or you have an eye problem called narrow - angle glaucoma ( an enlarged prostate , difficulty passing urine ,
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much to use the recommended dose is one inhalation once a day . this medicine should be used every day for 24 hours . you should use incruse ellipta every day , at the same time each day . do not change your dose unless your doctor tells you to . if you have any further questions on the use of this medicine , ask your doctor , pharmacist or nurse .
like all medicines , this medicine can cause side effects , although not everybody gets them . allergic reactions allergic reactions are rare ( may affect up to 1 in 100 people ). if you experience any of the following symptoms while taking incruse ellipta , stop taking this medicine and seek medical help immediately : itching skin rash , hives and redness 29 common side effects ( affects more than 1 user in 10 ) faster heart beat painful and frequent urination a urinary tract infection common cold infection of nose throat cough feeling of pressure and pain in the cheeks and forehead inflammation of the sinuses ( sinusitis ) headache constipation uncommon side
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the label of the inhaler after exp . store in a refrigerator ( 2 - 8 ). do not freeze . keep the sealed tray in the outer carton in order to protect from light . after first opening of the seal , use the seal within 6 hours . once the seal has been opened , remove the seal from the inner carton , and allow the inhal to reach room temperature ( up to 30 ) before using it . after using the seal for the first time ,
what incruse ellipta contains - the active substance is umeclidinium bromide . each inhalation provides a delivered dose of 55 micrograms ( 0 . 5 millilitres ) umclidatinium . each delivered dose delivers a delivered delivered dose ( equivalent to 65 microgram s ) of ummclidinitium ( as mesilate ). - the other ingredients are lactose monohydrate ( see section 2 under ' incrusemella contains lactose '), magnesium stearate ( e470b ) and water for injections ( e433b ) in the inhalation
nucala contains the active substance mepolizumab , which is a monoclonal antibody . this is a type of protein that recognises and attaches to specific proteins in the body . it is used to treat severe asthma in adults , adolescents and children aged 6 years and older . severe asthma affects many eosinophils ( an important type of white blood cell that helps the airways to breathe ) and affects the functioning of the lungs . if you have any questions about how nucala works or why this medicine has been prescribed for you by your doctor , pharmacist or nurse , ask your doctor .
do not use nucala if you are allergic to mepolizumab or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before using this medicine if : you have worsening asthma 58 you have asthma - related side effects your doctor may want to monitor your asthma more closely while you are being treated with this medicine . if you have any further questions on the use of this type ( monoclonal antibodies ), please ask your doctor or pharmacist . severe allergic reactions to other parts of the body ( see section 4 possible side effects ). if
nucala is given by injection under the skin ( subcutaneous injection ). adults and adolescents 12 years of age and older : the recommended dose is 100 mg given once a week ( 1 injection in the pre - filled pen ). if you have any further questions on the use of nucala , ask your doctor , pharmacist or nurse . duration of treatment your doctor will tell you how long you should continue to receive nucal . your doctor may decide to delay or stop the treatment . if you miss a dose of the medicine , talk to your doctor or pharmacist as soon as possible to reschedule your appointment
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects may happen with nucala : allergic reactions allergic or allergic - like reactions may occur very commonly ( may affect more than 1 in 10 people ) after the injection . sometimes symptoms may include symptoms such as chest tightness , cough , difficulty breathing fainting , dizziness , feeling lightheaded ( due to a drop in blood pressure ), swelling of eyelids , face , lips , tongue or mouth hives rash tell your doctor immediately if you experience a reaction similar reaction to any of the other side effects listed below . if
keep out of the reach and sight of children . do not use nucala after the expiry date which is stated on the carton and on the pre - filled pen label after exp . store in a refrigerator ( 2 - 8 ). do not freeze . keep the nucalo pre -filled pen in the outer carton in order to protect from light . after first opening , the pen may be stored for a maximum of 7 days in the refrigerator at room temperature ( not above 25 ) or in the original carton . discard any unused pen after 7 days if not used by the end of the 7 - day period
what nucala contains - the active substance is mepolizumab . each ml of solution contains 1 mg of 100 mg of mepoluzumab ( as besilate ). - the other ingredients are sucrose , sodium phosphate dibasic heptahydrate , citric acid monohydrate , polysorbate 80 , edta disodium dihydrate and water for injections . what nukala looks like and contents of the pack nucal 1 mg solution for injection in a pack is supplied as a 1 ml pre - filled syringe in a multipack containing 3 vials of 1
what ninlaro is and what it is used for the active substance in this medicine is ixazomib , a ' proteasome inhibitor '. what is it used for ? what is a cancer of the bone marrow ? in adults with multiple myeloma ( myelomas ) the most commonly used treatment for patients with this condition is called ' cell survival '. in adult patients with myelinoma cells , a lot of proteins called proteasomes are destroyed . what is the purpose of using ninlar ? when a patient is treated with one of the following medicines , it is important that you also read the package
do not take ninlaro - if you are allergic to ixazomib or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before taking this medicine . if you think any of these apply to you ( or you are not sure ), tell your doctor or pharmacist before taking the tablet . do not take the tablet with any other medicine that is not listed in this leaflet . you may be more at risk of bleeding if you have persistent nausea , vomiting , diarrhoea , nerve problems , tingling , numbness , swelling
do not take ninlaro if you have multiple myeloma . always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . do not take more than the recommended dose of one capsule of this medicine . your doctor will tell you how many capsules to take and how long you should continue to take it . how much to take the recommended starting dose of the medicine for adults is lenalidomide and dexamethasone once a day for the first 4 weeks . you should take one capsule in the morning and one in the evening . if you take more
like all medicines , this medicine can cause side effects , although not everybody gets them . very common serious side effects ( may affect more than 1 in 10 people ) low platelet counts ( thrombocytopenia ) nose bleeds which can easily bruise nausea , vomiting , diarrhoea numbness or tingling or burning of the hands or feet ( peripheral neuropathy ) swelling of the legs orfeet ( peripheral oedema ) skin rash ( itchy all over the body ). rare side effects may affect up to 1 in 1 , 000 people severe skin rashes with red to purple bumps ( sweet '
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the blister after exp . store below 30 . store in the original package in order to protect from moisture . the capsule can be removed from the blister and left at room temperature ( up to 30 ). do not throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what ninlaro contains the active substance in each capsule is ixazomib . each capsule of 2 . 3 mg contains ixasomib citrate . the other ingredients are : capsule content : microcrystalline cellulose , magnesium stearate , talc . the capsule shell contains gelatin , titanium dioxide ( e171 ), red iron oxide ( e172 ), shellac , propylene glycol , potassium hydroxide , black iron oxide [ e172 ]. the printing ink of the capsule is white to off - white , capsule - shaped , printed with " nvr " on one side and " 3
do not use palforzia if you are allergic to peanuts ( arachis hypogaea ) or any of the other ingredients of palforbzia ( listed in section 6 ). children and adolescents from 4 to 17 years of age should not receive treatment for peanut allergy because peanut ( desensitisation ) has not been studied in this age group . warnings and precautions talk to your doctor , pharmacist , or nurse before using palfORzia . allergic reactions are not uncommon in children with food allergies . your doctor will discuss with you whether you should be treated for any of these conditions . palf
do not take palforzia if you are allergic to peanut or soya or any of the other ingredients of this medicine ( listed in section 6 ). if you have severe asthma . if your asthma has become severe and you have a problem swallowing . if you suffer from long term problems with your digestive system such as a severe mast cell disorder or severe or life - threatening anaphylaxis . if any of these apply to you , talk to your doctor or pharmacist before you start treatment . warnings and precautions talk with your doctor , pharmacist or nurse before you are given palferzia . the symptoms of
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . allergy if you have allergic reactions ( anaphylaxis ) to palforzia , contact your doctor straight away . the recommended dose is 3 mg once a day . your doctor will decide on the dose you should take . duration of treatment your doctor may decide to increase the dose of palforbzia depending on initial doseescalation and progression of these treatment phases . the initial dose elevation and up - dosing steps should be repeated every 3 weeks . if you take more palf
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects have been reported with palforzia : severe allergic reactions - if you have any of the following symptoms while taking palforfzia , stop taking the medicine and seek medical help immediately : trouble breathing , throat tightness , feeling offulness , trouble swallowing , speaking - changes in voice , dizziness or fainting , severe stomach cramps , pain , vomiting , diarrhoea , severe flushing and itching of the skin palfORzia may cause problems with the stomach and digestive system ( e
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and the vial label after exp . store below 25 . store in the original package in order to protect from light . this medicine must not be used if you notice any hard lumps of powder or if the solution is discoloured or if there are particles in it ( see section 2 ). do not throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what palforzia contains - the active substance is 0 . 5 mg / 1 mg / 10 mg / 20 mg . - the other ingredients are microcrystalline cellulose , colloidal anhydrous silica and magnesium stearate palforbzia 100 mg / 2 mg oral powder in capsules with openingmicrocrystallose cellulose ( e460i ), colloidal Anhydroussilica ( e463i ) and magnesium strearate poalfborzia 300 mg / 3 mg / 5 mg oralpowder in sachet microcrystine celluloses ( e464i), colloidal
the active substance of zerene is benzodiazepine . it belongs to a group of medicinal products known as hypnotic actions . it is used to treat sleeping problems in adults , adolescents and children of all ages . the duration of treatment is one month . if you have problems sleeping , talk to your doctor .
you should not be given zerene : if you have hypersensitivity ( an allergy ) to zaleplon or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before you are given this medicine : if your doctor has told you that you have a condition called zerenea sleep apnoea syndrome ( which may occur for short periods ) if you suffer from severe kidney or liver problems ( myasthenia gravis ), if you feel very weak , tired muscles , severe breathing or chest problems if you are under 18 years of age
always take zerene exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one 10 mg capsule per day to be taken orally with or without food . if you have difficulty falling asleep , you should take the capsule at least one hour before or one hour after food . you should not take more than the dose recommended by your doctor . for patients over 65 years of age with mild to moderate liver problems , the recommended starting dose is two 5 mg capsules per day . your doctor will tell you how many capsules to take and how long you should continue taking z
like all medicines , zerene can cause side effects , although not everybody gets them . tell your doctor or pharmacist if you notice any other changes in your health . the frequency of possible side effects listed below is defined using the following convention : 36 very common ( affects more than 1 user in 10 ) uncommon ( affects 1 to 10 users in 100 ) very rare ( affects less than 1 users in 1 , 000 ) not known ( frequency cannot be estimated from the available data ) very common : may affect up to 1 in 10 , 000 not known : frequency cannot been estimated from available data very rare : cannot affect more than
what zerene contains - the active substance is zaleplon 5 mg . - the other ingredients are microcrystalline cellulose , pregelatinised starch , silicon dioxide , sodium lauryl sulphate , magnesium stearate , lactose monohydrate , indigo carmine ( e132 ) and titanium dioxide ( e171 ). - the printing ink contains gelatin , titanium dioxide , red iron oxide , yellow iron oxide ( e172 ) and black iron oxide (< e172 ). - printing ink containing sodium laurel sulphates , silicon diioxide ( s - 13050 ) and shellac , lec
